{"title": "IMI in the media", "author": null, "url": "http://www.imi.europa.eu/news-events/imi-media", "hostname": "europa.eu", "description": "expand all", "sitename": "IMI Innovative Medicines Initiative", "date": "2009-05-20", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "IMI in the media\n- Neuroscience News (US), 12 December 2020\n[Genetic Differences Important for Alzheimer\u2019s Diagnosis](https://neurosciencenews.com/genetic-amyloid-alzheimers-17419/)\n- Horizon Magazine (EU), 11 December 2020\n[Five things you need to know about: mRNA vaccine safety](https://horizon-magazine.eu/article/five-things-you-need-know-about-mrna-vaccine-safety.html)\n- Zorg Krant (The Netherlands), 23 November 2020\n[Ontdekking van biologische varianten bij ziekte van Alzheimer](https://zorgkrant.nl/wetenschap-en-onderwijs/12689-ontdekking-van-biologische-varianten-bij-ziekte-van-alzheimer)(Discovery of biological variants in Alzheimer's disease)\n- Science Business (EU), 12 November 2020\n[Experts want Innovative Medicines Initiative successor to be open and flexible](https://sciencebusiness.net/news/experts-want-innovative-medicines-initiative-successor-be-open-and-flexible)\n- Pharmaceutical Executive (US), 3 November 2020\n[Amplifying the Patient Voice](https://www.pharmexec.com/view/amplifying-the-patient-voice)\n- MedicalFacts.nl (The Netherlands), 13 October 2020\n[Lancering baanbrekend Europees digitaal zorgproject](https://www.medicalfacts.nl/2020/10/13/lancering-baanbrekend-europees-digitaal-zorgproject/)(Launch of groundbreaking European digital care project)\n- Science Business (EU), 15 September 2020\n[Revamped IMI successor will put patients first in health research](https://sciencebusiness.net/news/revamped-imi-successor-will-put-patients-first-health-research)\n- Science Business (EU), 10 September 2020\n[Fleet of foot response to pandemic underlines value of public-private partnership in health](https://sciencebusiness.net/news/fleet-foot-response-pandemic-underlines-value-public-private-partnership-health)\n- Welt (Germany), 25 July 2020\n[\u201eIn Deutschland ist eine gro\u00dfe Dynamik entfacht worden\u201c](https://www.welt.de/wirtschaft/article212167401/Digitale-Medizin-Die-Dynamik-in-Deutschland-ist-gross.html)\n- Labiotech.eu (EU), 15 July 2020\n[The European Fight Against The Covid-19 Coronavirus](https://www.labiotech.eu/in-depth/coronavirus-vaccine-treatment-diagnostics/)\n- Arzteblatt (Germany), 2 July 2020\n[EU-Projekt sagt \u00dcbergewicht und Begleiterkrankungen den Kampf an](https://www.aerzteblatt.de/nachrichten/114320/EU-Projekt-sagt-Uebergewicht-und-Begleiterkrankungen-den-Kampf-an)\n- Contagion Live (US), 1 July 2020\n[Ebola Vaccine Regimen Receives European Commission Marketing Authorization](https://www.contagionlive.com/news/ebola-vaccine-regimen-receives-european-commission-marketing-authorization-)\n- Trends-Tendances (Belgium), 24 May 2020\n[Intelligence artificielle: des Belges \u00e0 la t\u00eate d'un projet coronavirus](https://trends.levif.be/economie/high-tech/intelligence-artificielle-des-belges-a-la-tete-d-un-projet-coronavirus/article-normal-1290543.html?cookie_check=1590312602)\n- EU Reporter (EU), 20 May 2020\n[#Coronavirus \u2013 Commission boosts urgently needed research and innovation with additional \u20ac122 million](https://www.eureporter.co/frontpage/2020/05/20/coronavirus-commission-boosts-urgently-needed-research-and-innovation-with-additional-e122-million/)\n- Labiotech (EU), 14 May 2020\n[EU Initiative Pumps up Funding for Covid-19 Research to \u20ac117M](https://www.labiotech.eu/policy-legal-finance/innovative-medicines-initiative-covid-19/)\n- DH (Belgium), 14 May 2020\n[L'entreprise li\u00e9geoise OncoRadiomics va d\u00e9velopper un outil de diagnostic du coronavirus](https://www.dhnet.be/regions/liege/l-entreprise-liegeoise-oncoradiomics-va-developper-un-outil-de-diagnostic-du-coronavirus-5ebceb2b7b50a60f8bafd734)\n- RTBF (Belgium), 13 May 2020\n[Une entreprise li\u00e9geoise va d\u00e9velopper un outil de diagnostic du coronavirus](https://www.rtbf.be/info/economie/detail_une-entreprise-liegeoise-va-developper-un-outil-de-diagnostic-du-coronavirus?id=10501501)\n- BioWorld (US), 13 May 2020\n[Eight COVID-19 projects share $127M under Europe\u2019s Innovative Medicines Initiative](https://www.bioworld.com/articles/435049-eight-covid-19-projects-share-127m-under-europes-innovative-medicines-initiative)\n- EURACTIV (EU), 13 May 2020\n[Commission announces funding for COVID-19 diagnosis, treatment projects](https://www.euractiv.com/section/coronavirus/news/commission-announces-funding-for-covid-19-diagnosis-treatment-projects/)\n- Science|Business (EU), 13 May 2020\n[IMI announces 8 COVID-19 project winners and boosts funding to \u20ac72M](https://sciencebusiness.net/covid-19/news/imi-announces-8-covid-19-project-winners-and-boosts-funding-eu72m)\n- EUbusiness (EU), 13 May 2020\n[EU adds EUR 72m to fund 8 major coronavirus research projects](https://www.eubusiness.com/news-eu/coronavirus-research.12hp)\n- Euronews (EU), 11 May 2020\n[Europe supercharges research in the battle against Covid-19](https://www.euronews.com/2020/05/11/europe-supercharges-research-in-the-battle-against-covid-19)\n- The Irish Times (Ireland), 26 April 2020\n[Coronavirus: Race for vaccine must take no shortcuts](https://www.irishtimes.com/life-and-style/health-family/coronavirus-race-for-vaccine-must-take-no-shortcuts-1.4236155)\n- Horizon Magazine (EU), 14 April 2020\n[Repurposing drugs and networks can help find outbreak treatments against the clock](https://horizon-magazine.eu/article/repurposing-drugs-and-networks-can-help-find-outbreak-treatments-against-clock.html)\n- RTE (Ireland), 10 April 2020\n[The EU's Covid-19 crisis - How science got political](https://www.rte.ie/news/coronavirus/2020/0410/1129831-the-eus-covid-19-crisis-how-science-got-political/)\n- Horizon Magazine (EU), 7 April 2020\n[Studying animal coronavirus defences is opening route to human treatments](https://horizon-magazine.eu/article/studying-animal-coronavirus-defences-opening-route-human-treatments.html)\n- Drug Discovery News (US), 7 April 2020\n[Special Report on Neuroscience: On good behaviour](http://www.ddn-news.com/index.php?newsarticle=14158)\n- Handelsblatt (Germany), 6 April 2020\n[Das Coronavirus mahnt die Welt zu mehr Kooperation](https://www.handelsblatt.com/meinung/kommentare/kommentar-das-coronavirus-mahnt-die-welt-zu-mehr-kooperation/25718682.html)\n- Horizon Magazine (EU), 1 April 2020\n[Five things you need to know about: mRNA vaccines](https://horizon-magazine.eu/article/five-things-you-need-know-about-mrna-vaccines.html)\n- P\u00fablico (Spain), 1 April 2020\n[Coronavirus: El gran potencial del big data en la lucha contra la covid-19 | Diario P\u00fablico](https://www.publico.es/ciencias/coronavirus-gran-potencial-big-data-lucha-covid-19.html)\n- Times Higher Education (UK), 27 March 2020\n[EU science spending must not fall victim to the post-Covid cull](https://www.timeshighereducation.com/opinion/eu-science-spending-must-not-fall-victim-post-covid-cull)\n- CincoDias - El Pais (Spain), 26 March 2020\n[La industria farmac\u00e9utica ya ensaya con pacientes 20 vacunas y 30 tratamientos contra el coronavirus](https://cincodias.elpais.com/cincodias/2020/03/26/companias/1585220679_850148.html)\n- Handelsblatt.com (Germany), 25 March 2020\n[Gastkommentar: Auf die Forschung kommt es an](https://www.handelsblatt.com/meinung/gastbeitraege/gastkommentar-auf-die-forschung-kommt-es-an/25681060.html)\n- EU Reporter (EU), 24 March 2020\n[#COVID-19 \u2013 Research package welcomed, EU needs to be better equipped in future](https://www.eureporter.co/frontpage/2020/03/24/covid-19-research-package-welcomed-eu-needs-to-be-better-equipped-in-future/)\n- El Diario (Spain), 24 March 2020\n[Alfonso Valencia, bioinform\u00e1tico: En el superordenador MareNostrum estamos probando millones de f\u00e1rmacos contra la COVID-19](https://www.eldiario.es/sociedad/MareNostrum-llevamos-probando-millones-coronavirus_0_1009299317.html)\n- Parkinson's News Today (US), 20 March 2020\n[Immune Biomarkers May Better Classify Patients, Direct Therapy](https://parkinsonsnewstoday.com/2020/03/20/immune-biomarkers-may-help-classify-parkinsons-patients-aid-choosing-treatments-study-suggests/)\n- Science|Business (EU), 19 March 2020\n[Gabriel: \u2018Research and innovation is critical to tackle this global crisis\u2019](https://sciencebusiness.net/news/gabriel-research-and-innovation-critical-tackle-global-crisis)\n- MedNous (UK), 18 March 2020\n[What patients really want: involvement](https://www.mednous.com/what-patients-really-want-involvement)\n- 24 Heures (Switzerland), 10 March 2020\n[Des labos suisses veulent intensifier la lutte contre le coronavirus](https://www.24heures.ch/suisse/labos-suisses-veulent-intensifier-lutte-coronavirus/story/14168576?cache=9efAwefu)\n- European Biotechnology News (EU), 4 March 2020\n[IMI launches \u20ac45m call for coronavirus emergency](https://european-biotechnology.com/up-to-date/latest-news/news/imi-launches-eur45m-call-for-coronavirus-emergency.html)\n- Science|Business (EU), 3 March 2020\n[IMI launches \u20ac45M coronavirus research call](https://sciencebusiness.net/news/imi-launches-eu45m-coronavirus-research-call)\n- Pharmaphorum (UK), 3 March 2020\n[EU sets aside \u20ac45m for coronavirus drug and diagnostic R&D](https://pharmaphorum.com/news/eu-sets-aside-e45m-for-coronavirus-drug-and-diagnostic-rd/)\n- MSN Deutschland (Germany), 2 March 2020\n[Neue Allianz: Pharmariesen b\u00fcndeln ihre Kr\u00e4fte gegen Covid-19](https://www.msn.com/de-de/finanzen/top-stories/neue-allianz-pharmariesen-b%C3%BCndeln-ihre-kr%C3%A4fte-gegen-covid-19/ar-BB11K5n1)\n- Science|Business (EU), 25 February 2020\n[EU puts \u20ac45M into \u20ac90M public-private partnership for coronavirus vaccine research](https://sciencebusiness.net/news/eu-puts-eu45m-eu90m-public-private-partnership-coronavirus-vaccine-research)\n- EUbusiness (EU), 25 February 2020\n[EU commits EUR 232m to combat Coronavirus](https://www.eubusiness.com/news-eu/coronavirus-eu.24fp)\n- Politico Europe (EU), 24 February 2020\n[EU pumps \u20ac232M toward coronavirus as alarm grows in Italy](https://www.politico.eu/article/eu-pumps-e232m-toward-coronavirus-as-alarm-grows-in-italy/)\n- Diario de Salud (Spain), 7 February 2020\n[Las \u2018farma\u2019 aceleran en la carrera contra el coronavirus: ya hay 20 vacunas en desarrollo](https://www.diariodesalud.com.do/texto-diario/mostrar/1859760/farma-aceleran-carrera-contra-coronavirus-hay-20-vacunas-desarrollo)\n- Nature (UK), 29 January 2020\n[UK and EU: Cherish what you have achieved and stay close](https://www.nature.com/articles/d41586-020-00226-x)\n- European Biotechnology News (EU) 28 January 2020\n[AMR: IMI\u2019s Enable project reaches endpoints](https://european-biotechnology.com/up-to-date/latest-news/news/amr-imis-enable-project-reaches-endpoints.html)\n- Nursing Times (UK), 27 January 2020\n[Whooping cough study explores if bacteria can be passed \u2018silently\u2019](https://www.nursingtimes.net/news/research-and-innovation/whooping-cough-study-explores-if-bacteria-can-be-passed-silently-27-01-2020/)\n- Salud a Diario (Spaim) 25 January 2020\n[Alfonso Valencia, director del Instituto Nacional de Bioinform\u00e1tica: Llevamos semanas probando millones de f\u00e1rmacos contra el coronavirus](https://www.saludadiario.es/investigacion/alfonso-valencia-director-del-instituto-nacional-de-bioinformatica-llevamos-semanas-probando-millones-de-farmacos-contra-el-coronavirus)\n-\nTechnology Networks (UK), 5 December 2019\n[The Power of Collaboration: Tackling Pharmaceutical Challenges](https://www.technologynetworks.com/drug-discovery/articles/the-power-of-collaboration-tackling-pharmaceutical-challenges-328569)\n-\nEuropean Files (EU), 26 November 2019\n[Harnessing the power of partnerships to develop life-saving vaccines](https://www.europeanfiles.eu/health/harnessing-the-power-of-partnerships-to-develop-life-saving-vaccines)\n-\nPharmaceutical Technology (UK), 25 November 2019\n[\u2018Don\u2019t put baby in the corner\u2019: overcoming challenges in paediatric drug development](https://www.pharmaceutical-technology.com/features/challenges-paediatric-drug-development/)\n-\nPMLiVE Blogs (UK), 25 November 2019\n[Is competition the enemy of progress and collaboration the ally of success?](http://www.pmlive.com/blogs/smart_thinking/archive/2019/is_competition_the_enemy_of_progress_and_collaboration_the_ally_of_success)\n-\n\u00c4rzteblatt (Germany), 25 November 2019\n[Europaweite Studie soll personalisierte Therapie bei Autoimmunerkrankungen verbessern](https://www.aerzteblatt.de/nachrichten/107601/Europaweite-Studie-soll-personalisierte-Therapie-bei-Autoimmunerkrankungen-verbessern)\n-\nMedPage Today (US), 23 November 2019\n[Ebola Vax Seems to Work in Kids, Too](https://www.medpagetoday.com/meetingcoverage/astmh/83543)\n-\nPink Sheet (UK), 21 November 2019\n[Remote Decentralized Clinical Trials Could Solve RCT Problems](https://pink.pharmaintelligence.informa.com/PS141239/Remote-Decentralized-Clinical-Trials-Could-Solve-RCT-Problems)\n-\nLedger Insights (Cyprus), 20 November 2019\n[Novartis to go live with blockchain network in 2020](https://www.ledgerinsights.com/novartis-live-blockchain-network-2020/)\n-\nCNN Monday (Switzerland), 14 November 2019\n[Novartis to go live with blockchain projects in 2020](https://www.cnnmoney.ch/shows/blockchain/videos/novartis-go-live-blockchain-projects-2020)\n-\nEuropean Biotechnology News (EU), 6 November 2019\n[AMR: ENABLE selects Mutabilis candidate](https://european-biotechnology.com/up-to-date/latest-news/news/amr-enable-selects-mutabilis-candidate.html)\n-\nMultiple Sclerosis News Today (US), 6 November 2019\n[European 3TR Project Unites Experts in Effort to Make Treatment More Personal and Effective](https://multiplesclerosisnewstoday.com/news-posts/2019/11/04/accelerating-precision-medicine-for-immune-mediated-diseases-right-drug-right-patient-right-time/)\n-\nBioWorld (US), 6 November 2019\n[EU's new IHI program aims to 'push the boundaries,' expand innovation in health care](http://www.bioworld.com/content/eus-new-ihi-program-aims-push-boundaries-expand-innovation-health-care)\n-\nLabiotech (Germany), 31 October 2019\n[European Project Launches to Tailor Autoimmune Disease Treatments](https://www.labiotech.eu/medical/autoimmune-disease-eu-pharma/)\n-\nTelegraph (UK), 23 October 2019\n[Parents urged to vaccinate children against whooping cough as number of cases rises four-fold](https://www.telegraph.co.uk/news/2019/10/23/parents-urged-vaccinate-children-against-whooping-cough-number/)\n-\nIrish Examiner (Ireland), 23 October 2019\n[Whooping cough bacteria \u2018can hide in noses and throats of healthy people\u2019](https://www.irishexaminer.com/breakingnews/world/whooping-cough-bacteria-can-hide-in-noses-and-throats-of-healthy-people-959161.html)\n-\nDaily Mail (UK), 23 October 2019\n[Whooping cough bacteria `can hide in noses and throats of healthy people\u00b4](https://www.dailymail.co.uk/wires/pa/article-7604279/Whooping-cough-bacteria-hide-noses-throats-healthy-people.html)\n-\nPharmaFile (UK), 23 October 2019\n[Damage control: How will pharma manage the health economic impacts of Brexit?](http://www.pharmafile.com/news/531806/damage-control-how-will-pharma-manage-health-economic-impacts-brexit)\n-\nEurActiv (EU), 22 October 2019\n[Health research is where the EU can leave a mark, lawmakers agree](https://www.euractiv.com/section/health-consumers/news/health-research-is-where-the-eu-can-leave-a-mark-lawmakers-agree/)\n-\nPharmaIQ (UK), 1 October 2019\n[Why market challenges require collaboration](https://www.pharma-iq.com/business-development/articles/why-market-challenges-require-collaboration)\n-\nPharma Times (UK), 30 September 2019\n[Smart People: Elaine Irving](http://www.pharmatimes.com/magazine/2019/october_2019/smart_people_elaine_irving)\n-\nEl Diario Arag\u00f3n (Spain), 19 September 2019\n[Un proyecto internacional coordinado por el IACS establece las bases para incluir a los pacientes en el dise\u00f1o de medicamentos](https://www.eldiario.es/aragon/internacional-coordinado-IACS-establece-medicamentos_0_943855805.html)\n-\nDrug Target Review (UK), 17 September 2019\n[Under the microscope: Improving hit discovery efficiency at Europe\u00b4s leading screening centre](https://www.drugtargetreview.com/article/49476/under-the-microscope-improving-hit-discovery-efficiency-at-europes-leading-screening-centre/)\n-\nMedPage Today (US), 3 September 2019\n[ICDs Still Save Lives in HF - But underuse shown in Swedish study affirming mortality benefit persists](https://www.medpagetoday.com/meetingcoverage/esc/81945)\n- PharmaBoardroom (UK), 7 August 2019\n[Advanced Therapy Medicinal Products: The Right Time for Hope?](https://pharmaboardroom.com/articles/advanced-therapy-medicinal-products-the-right-time-for-hope/)\n- Pharmaceutical Technology (UK), 24 July 2019\n[J&J launches research consortium for new drugs against TB](https://www.pharmaceutical-technology.com/news/jj-research-consortium-tb-drugs/)\n- Bio-IT World, 2 July 2019\n[MELLODDY Using Federated Learning To Improve Drug Development](http://www.bio-itworld.com/2019/07/02/melloddy-using-federated-learning-to-improve-drug-development.aspx)\n-\nEurActiv (EU), 28 June 2019\n[New pharma boss: Next EU Commission should be clear on how to protect innovation](https://www.euractiv.com/section/health-consumers/news/new-pharma-boss-next-eu-commission-should-be-clear-on-how-to-protect-innovation/)\n- Pink Sheet (UK), 26 June 2019\n[New IMI Funding For EU Research Into ATMPs, Health Outcomes & Drug Info](https://pink.pharmaintelligence.informa.com/PS125531/New-IMI-Funding-For-EU-Research-Into-ATMPs-Health-Outcomes--Drug-Info)\n- Scribd (US), 22 June 2019\n[How Europe is building a sweeping system to study medication safety in pregnant and lactating women](https://www.scribd.com/article/414129666/How-Europe-Is-Building-A-Sweeping-System-To-Study-Medication-Safety-In-Pregnant-And-Lactating-Women)\n- Business News Wales (UK), 17 June 2019\n[International Partnership to Tackle Research Gaps in Medication Safety for Pregnant and Breastfeeding Women](https://businessnewswales.com/international-partnership-to-tackle-research-gaps-in-medication-safety-for-pregnant-and-breastfeeding-women/)\n- The Lancet (UK), 15 June 2019\n[Pharma blockchains AI for drug development](https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)31401-1/fulltext)\n- La Repubblica (Italy), 15 June 2019\n[Harmony, i big data contro i tumori del sangue](https://www.repubblica.it/salute/medicina-e-ricerca/2019/06/15/news/harmony_big_data_contro_i_tumori_del_sangue-228835841/)\n- 20 Minutes Online (France), 12 June 2019\n[Huit femmes enceintes sur dix prennent des m\u00e9docs](https://www.20min.ch/ro/news/vaud/story/Huit-femmes-enceintes-sur-dix-prennent-des-medocs-29065812)\n- Financial Times (UK), 4 June 2019\n[Pharma groups combine to promote drug discovery with AI](https://www.ft.com/content/ef7be832-86d0-11e9-a028-86cea8523dc2)\n- L\u2019Usine Nouvelle (France), 4 June 2019\n[Dix g\u00e9ants de la pharmacie s'allient pour optimiser les IA de d\u00e9couverte de m\u00e9dicaments](https://www.usinenouvelle.com/editorial/dix-geants-de-la-pharmacie-s-allient-pour-optimiser-les-ia-de-decouverte-de-medicaments.N850320)\n- scitecheuropa (EU), 28 May 2019\n[Strategising for Alzheimer\u2019s disease: a mixed picture](https://www.scitecheuropa.eu/alzheimers-disease/95280/)\n- eHealth News EU (EU), 28 May 2019\n[IMI to Boost Patient Involvement in its Activities](http://www.ehealthnews.eu/development/5855-imi-to-boost-patient-involvement-in-its-activities)\n- Science Business (EU), 23 May 2019\n[Cars, 6G and health: A closer look at possible R&D partnerships in Horizon Europe](https://sciencebusiness.net/news/cars-6g-and-health-closer-look-possible-rd-partnerships-horizon-europe)\n- PharmaBoardroom (UK), 20 May 2019\n[Technology Convergence in the Digital Era: What Implications for Innovative Medicine Development?](https://pharmaboardroom.com/articles/technology-convergence-in-the-digital-era-what-implications-for-innovative-medicine-development/)\n- Medpage Today (US), 20 May 2019\n[T2D Predicts Progression in NAFLD/NASH](https://www.medpagetoday.com/gastroenterology/generalhepatology/79935)\n- Irish Sun (Ireland), 20 May 2019\n[Diabetics at higher risk of liver disease: Study](https://www.irishsun.com/news/261091774/diabetics-at-higher-risk-of-liver-disease-study)\n- Labmate Online (UK), 15 May 2019\n[IMI Prioritises Drug Safety and Regulation](https://www.labmate-online.com/news/news-and-views/5/university-of-nottingham/imi-prioritises-drug-safety-and-regulation/49198)\n- Arzteblatt (Germany), 7 May 2019\n[Projekt soll Versorgung von Psoriasis- und Neurodermitispatienten verbessern](https://www.aerzteblatt.de/nachrichten/102819/Projekt-soll-Versorgung-von-Psoriasis-und-Neurodermitispatienten-verbessern)\n- European Biotechnology News (EU), 2 May 2019\n[European Lead Factory gets \u20ac36.5m support from IMI](https://european-biotechnology.com/up-to-date/latest-news/news/european-lead-factory-gets-eur365m-support-from-imi.html)\n- Science Business (EU), 2 May 2019\n[Q&A: What\u2019s at stake for patients in the European elections?](https://sciencebusiness.net/news/qa-whats-stake-patients-european-elections)\n-\nEU Political Report (EU), May 2019\n[More involvement for patients in developing new medicines](https://www.eupoliticalreport.eu/more-involvement-for-patients-in-developing-new-medicines/)\n- Pink Sheet (UK), 26 April 2019\n[Next IMI Projects To Include Advanced Therapies And CAR-Ts](https://pink.pharmaintelligence.informa.com/PS125186/Next-IMI-Projects-To-Include-Advanced-Therapies-And-CARTs)\n- MyScience UK (UK), 25 April 2019\n[Researchers in international drive to develop safer drugs](https://www.myscience.org.uk/en/news/2019/researchers_in_international_drive_to_develop_safer_drugs-2019-nottingham)\n- Wearable Technologies (Germany), 16 April 2019\n[European Researchers Team Up with Pharma Companies to Develop Gait Detecting Sensor](https://www.wearable-technologies.com/2019/04/european-researchers-team-up-with-pharma-companies-to-develop-gait-detecting-sensor/)\n- Gesundheitsstadt Berlin (Germany), 14 April 2019\n[Forschungsprojekt untersucht Ursachen von Neurodermitis und Schuppenflechte](https://www.gesundheitsstadt-berlin.de/forschungsprojekt-untersucht-ursachen-von-neurodermitis-und-schuppenflechte-13238/)\n- Clinical Informatics News (US), 9 April 2019\n[Movement Underway To Include Pregnant Women In Research](http://www.clinicalinformaticsnews.com/2019/04/09/movement-underway-to-include-pregnant-women-in-research.aspx)\n- Sunday Post (UK), 7 April 2019\n[Scotland\u2019s universities warn Brexit threatens world-leading dementia work that could transform lives around the globe](https://www.sundaypost.com/fp/scotlands-universities-warn-brexit-threatens-world-leading-dementia-work-that-could-transform-lives-around-the-globe/)\n- EurActiv (EU), 1 April 2019\n[Andriukaitis: I like blows from anti-vaxxers, it means I\u2019m doing my job](https://www.euractiv.com/section/health-consumers/news/andriukaitis-i-like-blows-from-anti-vaxxers-it-means-im-doing-my-job/)\n- Granada Hoy (Spain), 21 March 2019\n[Investigadores de Genyo participan en un importante proyecto europeo para estudiar el S\u00edndrome de Sj\u00f6gren](https://www.granadahoy.com/granada/Genyo-proyecto-europeo-Sindrome-Sjogren_0_1338466331.html)\n- Bio-IT World (US), 18 March 2019\n[Blockchain\u2019s Potential In Clinical Research](http://www.bio-itworld.com/2019/03/18/blockchains-potential-in-clinical-research.aspx)\n- Silicon Republic (Ireland), 13 March 2019\n[Ireland\u2019s RCSI to lead \u20ac7m Parkinson\u2019s research project](https://www.siliconrepublic.com/innovation/rcsi-parkinsons-research-project)\n- Pharmaceutical Technology (Ireland), 13 March, 2019\n[Irish scientists secure EU funding for Parkinson\u2019s research project](https://www.pharmaceutical-technology.com/news/parkinsons-disease-research/)\n- Science Business (EU), 27 February 2019\n[Auditors to probe EU efforts in tackling the worsening superbug problem](https://sciencebusiness.net/news/auditors-probe-eu-efforts-tackling-worsening-superbug-problem)\n- PharmaBoardroom (UK), 22 February 2019\n[Why We Need Public-Private Partnerships in Drug R&D](https://pharmaboardroom.com/articles/why-we-need-public-private-partnerships-in-drug-rd/)\n- Berlingske (Denmark), 13 February 2019\n[Lundbeck og Novo Nordisk g\u00e5r sammen om at snyde hjernen](https://www.berlingske.dk/virksomheder/lundbeck-og-novo-nordisk-gaar-sammen-om-at-snyde-hjernen)\n- Quotidiano Sanit\u00e0 (Italy) 11 February 2019\n[Antibiotico resistenza. Farmindustria, ecco come arginarla in cinque mosse](http://www.quotidianosanita.it/scienza-e-farmaci/articolo.php?articolo_id=70849)\n- Science Business (EU), 11 February 2019\n[Beyond Brexit: How universities and companies are trying to look past the cliff edge](https://sciencebusiness.net/news/beyond-brexit-how-universities-and-companies-are-trying-look-past-cliff-edge)\n- Precision Vaccinations (US), 5 February 2019\n[VITAL Project Addresses Seniors' Immune System Weakness](https://www.precisionvaccinations.com/infectious-disease%C2%A0prevention-through-vaccination-requirement-promote-healthy-aging)\n- Health Europa (EU), 29 January 2019\n[A PIONEER in prostate cancer](https://www.healtheuropa.eu/pioneering-the-world-of-prostate-cancer-with-pioneer/89991/)\n- scitecheuropa (EU), 24 January 2019\n[Pharmaceutical industries: a healthier future for Europe?](https://www.scitecheuropa.eu/pharmaceutical-industries-a-healthier-future-for-europe/92437/)\n- European Biotechnology News (EU), 22 January 2019\n[IMI launches \u20ac80m call](https://european-biotechnology.com/up-to-date/latest-news/news/imi-launches-eur80m-call.html)\n- eHealth News EU (EU), 22 January 2019\n[Open Access Drug Development Tools Feature in New IMI Call for Proposals](http://www.ehealthnews.eu/86-open-calls/5726-open-access-drug-development-tools-feature-in-new-imi-call-for-proposals)\n- Clinical Informatics News (US), 14 January 2019\n[Blockchain Enthusiasts Finding Their Partners](http://www.clinicalinformaticsnews.com/2019/01/14/blockchain-enthusiasts-finding-their-partners.aspx)\n- L\u00ebtzebuerger Journal (Luxembourg), 14 December 2018\n[Wenn die EU Gesundheit neu denkt](https://www.journal.lu/top-navigation/article/wenn-die-eu-gesundheit-neu-denkt/)(When the EU rethinks health)\n- MedNous (EU), 8 December 2018\n[IMI: Building a science infrastructure for Europe](https://www.mednous.com/imi-building-science-infrastructure-europe)\n- Fokus (Belgium), 1 December 2018\n[Blockchain heeft grote impact op mens en bedrijf](https://www.fokus-online.be/blockchain-heeft-grote-impact-op-mens-en-bedrijf/)(Blockchain has a large impact on people and businesses)\n- Science Business (EU), 30 November 2018\n[Horizon Europe: The obstacles still facing negotiators](https://sciencebusiness.net/framework-programmes/news/horizon-europe-obstacles-still-facing-negotiators)\n- Awoko Newspaper (Sierra Leone), 24 November 2018\n[Vaccine to end Ebola](https://awoko.org/2018/11/26/sierra-leone-news-vaccine-to-end-ebola/)\n- Financial Times (UK), 20 November 2018\n[EU\u2019s Innovative Medicines Initiative brings collaborative power to development of drugs](https://www.ft.com/content/a7df3c48-ddfe-11e8-8f50-cbae5495d92b)\n- Euronews - Futuris (EU), 12 November 2018\nEuronews English:\n[Vaccine research offers fresh hope against Ebola](https://www.euronews.com/2018/11/12/vaccine-research-offers-fresh-hope-against-ebola)\nArticle and video also available in\n[Arabic](https://arabic.euronews.com/2018/11/12/clinical-trial-in-sierra-leone-to-examine-a-vaccine-against-ebola), [French](https://fr.euronews.com/2018/11/12/sur-les-traces-d-un-futur-vaccin-contre-le-virus-ebola), [German](https://de.euronews.com/2018/11/12/ebola-die-eu-kampft-zusammen-mit-der-industrie-gegen-das-virus), [Greek](https://gr.euronews.com/2018/11/12/siera-leone-ena-neo-emvolio-dinei-elpida-gia-tin-antimetopisi-tou-iou-empola), [Hungarian](https://hu.euronews.com/2018/11/12/igeretes-az-ebola-elleni-vakcina-klinikai-tesztelese), [Italian](https://it.euronews.com/2018/11/12/passi-avanti-per-il-vaccino-contro-l-ebola), [Persian](https://fa.euronews.com/2018/11/12/ebola-vaccine-the-end-of-a-deadly-virus), [Portuguese](https://pt.euronews.com/2018/11/12/projeto-europeu-na-serra-leoa-testa-vacina-promissora-contra-o-ebola), [Russian](https://ru.euronews.com/2018/11/12/sierra-leone-ebola-health-futuris), [Spanish](https://es.euronews.com/2018/11/12/podemos-imaginar-un-futuro-sin-ebola), and [Turkish](https://tr.euronews.com/2018/11/12/ebola-virusu-hastaligi-tarihe-karisabilir-mi-sierra-leone-de-asi-kampanyasi)\n- MedNous (EU), 6 November 2018\n[EU funding opportunities for SMEs](https://www.mednous.com/news/eu-funding-opportunities-smes)\n- Health Europa (EU), 5 November 2018\n[Dementia in Europe: a public health priority?](https://www.healtheuropa.eu/dementia-in-europe/88813/)\n- European Pharmaceutical Review (UK), 29 October 2018\n[Widespread side effects from drugs on lungs](https://www.europeanpharmaceuticalreview.com/news/80552/drug-side-effects/)\n- Arzteblatt (Germany), 29 October 2018\n[Viele Medikamente k\u00f6nnen eine interstitielle Lungenerkrankung ausl\u00f6sen](https://www.aerzteblatt.de/nachrichten/98821/Viele-Medikamente-koennen-eine-interstitielle-Lungenerkrankung-ausloesen)(Many medicines can cause interstitial lung disease)\n- Science Business (EU), 15 October 2018\n[EU makes its pitch to member states for 12 research missions and 13 industry partnerships](https://sciencebusiness.net/framework-programmes/news/eu-makes-its-pitch-member-states-12-research-missions-and-13-industry)\n- Irish Examiner (Ireland), 2 October 2018\n[Infant centre will continue to lead in important research](https://www.irishexaminer.com/breakingnews/views/analysis/infant-centre-will-continue-to-lead-in-important-research-872840.html)\n- Science Business (EU), 28 September 2018\n[Austrian science minister: governments and EU Commission \u2018in conflict\u2019 over research missions](https://sciencebusiness.net/framework-programmes/news/austrian-science-minister-governments-and-eu-commission-conflict-over)\n- Health Europa (EU), 27 September 2018\n[Rapid diagnostic technologies versus antimicrobial resistance](https://www.healtheuropa.eu/antimicrobial-resistance/88272/)\n- Technology Networks (UK), 10 September 2018\n[Binding kinetics in drug discovery](https://www.technologynetworks.com/drug-discovery/articles/binding-kinetics-in-drug-discovery-309280)\n- El Global (Spain), 31 August 2018\n[La innovaci\u00f3n, reto para lograr una I+D eficiente](http://www.elglobal.net/portada/la-innovacion-reto-para-lograr-una-i-d-eficiente-DA1705588)(Innovation, a challenge to achieve efficient &D)\n- Financial Times (UK), 3 August 2018\n[FT Health: Climate change is a public health problem](https://www.ft.com/content/a1c32a34-966b-11e8-b67b-b8205561c3fe)\n- Financial Times (UK), 26 July 2018\n[No recommended Brexit dosage yet for medicine research](https://www.ft.com/content/e6691586-90bc-11e8-bb8f-a6a2f7bca546)\n- Technology Networks (UK), 24 July 2018\n[Infrared Sensor Could Speed up Drug Discovery](https://www.technologynetworks.com/drug-discovery/news/infrared-sensor-could-speed-up-drug-discovery-306643)\n- European Biotechnology News (EU), 18 July 2018\n[IMI to spur on antibiotics research amidst big pharma pullback](https://european-biotechnology.com/up-to-date/latest-news/news/imi-to-spur-on-antibiotics-research-amidst-big-pharma-pullback.html)\n- Blik op nieuws (The Netherlands), 10 July 2018\n[Onderzoekers en bedrijfsleven willen autisme ontrafelen en behandelen](http://www.blikopnieuws.nl/gezondheid/265462/onderzoekers-en-bedrijfsleven-willen-autisme-ontrafelen-en-behandelen.html)(Researchers and the business community want to unravel and treat autism)\n- CincoDias - El Pais (Spain), 4 July 2018\n[Los datos m\u00e9dicos, un tesoro que ya comienza a explotarse](https://cincodias.elpais.com/cincodias/2018/07/04/companias/1530717320_300880.html)(Medical data, a treasure that is already beginning to be exploited)\n- The New Yorker (US), 2 July 2018\n[The Neuroscience of Pain](https://www.newyorker.com/magazine/2018/07/02/the-neuroscience-of-pain)\n- Horizon Magazine (EU), 28 June 2018\n[\u2018Radical collaboration\u2019 is shaking up the pharmaceutical industry \u2013 Carlos Moedas](https://horizon-magazine.eu/article/radical-collaboration-shaking-pharmaceutical-industry-carlos-moedas_en.html)\n- Science Business (EU), 28 June 2018\n[Industry in race to keep billion-euro EU partnerships alive](https://sciencebusiness.net/framework-programmes/news/industry-race-keep-billion-euro-eu-partnerships-alive)\n- Pharmaphorum (EU), 26 June 2018\n[The time has come to optimise patient engagement](https://pharmaphorum.com/patients/time-optimise-patient-engagement/)\n- Horizon Magazine (EU), 21 June 2018\n[Ebola outbreak \u2013 this time it\u2019s different](https://horizon-magazine.eu/article/ebola-outbreak-time-it-s-different_en.html)\n- Irish Examiner (Ireland), 18 June 2018\n[Largest grant ever to research autism awarded by Innovative Medicines Initiative; Trinity College to take part](https://www.irishexaminer.com/breakingnews/business/largest-grant-ever-to-research-autism-awarded-by-innovative-medicines-initiative-trinity-college-to-take-part-in-trials-849576.html)\n- Science Business (EU), 7 June 2018\n[European Commission publishes its \u20ac94.1B Horizon Europe proposal](https://sciencebusiness.net/framework-programmes/news/european-commission-publishes-its-eu941b-horizon-europe-proposal)\n- Arzte Zeitung (Germany), 7 June 2018\n[Langfristig mehr Tote als bei Krebs](https://www.aerztezeitung.de/kongresse/kongresse2018/berlin2018-hsk/article/965307/prognose-antibiotikaresistenzen-langfristig-tote-krebs.html?sh=4&h=644675984)(More deaths than cancer in the long term)\n- ORF (Austria), 7 June 2018\n[Forscher entwickeln Leitfaden f\u00fcr Unterzuckerung](https://steiermark.orf.at//news/stories/2917585/)(Researchers are developing guide lines for low blood sugar)\n- Pharma Market Live (UK), 6 June 2018\n[Europe's public-private alliance targets pain management](http://www.pmlive.com/pharma_news/europes_public-private_alliance_targets_pain_management_1238669)\n- HIMSS Insights (EU), 25 May 2018\n[Data projects boost precision medicine in Spain | Insights](https://www.himssinsights.eu/data-projects-boost-precision-medicine-spain)\n- Horizon Magazine (EU), 23 May 2018\n[Complex diseases get the big data treatment](https://horizon-magazine.eu/article/complex-diseases-get-big-data-treatment_en.html)\n- BioCentury (US), 22 May 2018\n[European consortium launches to improve pediatric trials](https://www.biocentury.com/bc-extra/clinical-news/2018-05-21/european-consortium-launches-improve-pediatric-trials)\n- Silicon Republic (Ireland), 21 May 2018\n[Europe to become focal point of paediatric medicine, led by Irish centre](https://www.siliconrepublic.com/innovation/paediatric-medicine-infant-europe)\n- Health Europa (EU), 16 May 2018\n[IMI launches milestone project focusing on hypoglycaemia](https://www.healtheuropa.eu/imi-milestone-project-hypoglycaemia/86027/)\n- Diabetes Daily (US), 8 May\n[JDRF Participates in Study Committed to Learning about Hypoglycemia and Diabetes](https://www.diabetesdaily.com/blog/jdrf-participates-in-study-committed-to-learning-about-hypoglycemia-and-diabetes-567286/)\n- El Global (Spain), 27 April 2018\n[La Comisi\u00f3n pide a los estados que cooperen en la puesta en com\u00fan de datos sanitarios en la UE](http://www.elglobal.net/politica-sanitaria/titular-34titular-34titular-34-g-titular-g-34titular-34-KA1516491)(The Commission asks states to cooperate in the sharing of health data in the EU)\n- The Telegraph (UK), 23 April 2018\n[10 million lives could be lost to superbugs - so how far have we got in the race to beat them?](https://www.telegraph.co.uk/health-fitness/body/10-million-lives-could-lost-superbugs-far-have-got-race-beat/)\n- Science Business (EU), 22 April 2018\n[EU staff propose partnership changes for next research programme](https://sciencebusiness.net/framework-programmes/news/eu-staff-propose-partnership-changes-next-research-programme)\n- Health Europa (EU), 20 April 2018\n[Celebrating ten years of the Innovative Medicines Initiative](https://www.healtheuropa.eu/ten-years-innovative-medicines-initiative/85489/)\n- Science Business (EU), 17 April 2018\n[New collaboration to engage patients in drug development for better health outcomes](https://sciencebusiness.net/healthy-measures/news/new-collaboration-engage-patients-drug-development-better-health-outcomes)\n- Pharma Fakten (Germany), 11 April 2018\n[\u201eDie Welt ist unser Labor\u201c](https://www.pharma-fakten.de/news/details/595-die-welt-ist-unser-labor/)('The world is our laboratory')\n- Pharma Market Live (UK), 22 March 2018\n[IMI calls for advancements in machine learning and digital clinical trials](http://www.pmlive.com/pharma_news/imi_calls_for_advancements_in_machine_learning_and_digital_clinical_trials_1228827)\n- EurActiv (EU), 7 March 2018\n[Going into the real world to gather cancer data](https://www.euractiv.com/section/health-consumers/news/going-into-the-real-world-to-gather-cancer-data/)\n- The BMJ (UK), 6 March 2018\n[Lieven Annemans: We need to reach a common understanding about real world data](http://blogs.bmj.com/bmj/2018/03/06/lieven-annemans-we-need-to-reach-a-common-understanding-about-real-world-data/)\n- Intellectual Property Watch (Switzerland), 27 February 2018\n[Wellcome Trust Report Recommends UK-EU Agreement On Research & Innovation](https://www.ip-watch.org/2018/02/27/wellcome-trust-report-recommends-uk-eu-agreement-research-innovation/)\n- Life Science Daily (US), 27 February 2018\n[Trials seek solutions to bacterial infections](https://lifesciencedaily.com/stories/24764-trials-seek-solutions-bacterial-infections/)\n- Pharmaceutical Technology (UK), 27 February 2018\n[NIH joins efforts to address two common bacterial infections](http://www.pharmaceutical-technology.com/news/nih-joins-efforts-address-two-common-bacterial-)\n- Pharma Fakten (Germany), 19 February 2018\n[Vier Anreize und ein Problem](https://www.pharma-fakten.de/news/details/565-antibiotikaresistenzen-vier-anreize-und-ein-problem/)(Four incentives and one problem)\n- Mind Health (France), 16 February 2018\n[Salah-Dine Chibout (Novartis): 'Avec le num\u00e9rique nous serons plus efficaces pour identifier et investir sur de nouvelles cibles'](https://www.mindhealth.fr/article/1870/salah-dine-chibout-novartis-avec-le-numerique-nous-serons-plus-efficaces-pour-identifier-et-investir-sur-de-nouvelles-cibles/)(Salah-Dine Chibout (Novartis): With digital we will be more efficiant at identifying and investing in new targets)\n- Imfarmacias (Spain), 15 February 2018\n[La resistencia a los antibi\u00f3ticos ser\u00e1 la primera causa de muerte en 2050](http://www.imfarmacias.es/noticia/14594/la-resistencia-a-los-antibioticos-sera-la-primera-causa-de-)(Antibiotic resistance will be the main cause of death in 2050)\n- El Pais (Spain), 14 February 2018\n[Grandes oportunidades para avanzar en la investigaci\u00f3n sanitaria gracias al \u2018big data\u2019](https://elpais.com/elpais/2018/02/14/ciencia/1518627019_980101.html)(Major opportunities to advance health research thanks to 'big data')\n- El Mundo (Spain), 6 February 2018\n[La informaci\u00f3n como medicamento](http://www.elmundo.es/economia/2018/02/06/5a797a9cca4741f3238b456f.html)(Information as a medicine)\n- Die Welt (Germany), 3 February 2018\n[Damit das Leben weitergeht](https://www.welt.de/print/die_welt/article173161498/Damit-das-Leben-weitergeht.html)(So that life goes on)\n- Applied Clinical Trials (US), 1 February 2018\n[How social media is transforming pharma and healthcare](http://www.appliedclinicaltrialsonline.com/how-social-media-transforming-pharma-and-healthcare)\n- Technology Networks (UK), 22 January 2018\n[Cancer Stem Cell Survival is Controlled by Hedgehog Signaling Proteins](https://www.technologynetworks.com/tn/news/cancer-stem-cell-survival-is-controlled-by-hedgehog-signaling-proteins-296559)\n- Nutrition Insight (The Netherlands), 22 January 2018\n[Antibiotic innovation: Research group calls for 50 percent investment increase as resistance threats intensify](http://www.nutritioninsight.com/news/antibiotic-innovation-research-group-calls-for-50-percent-investment-increase-as-resistance-threats-intensify.html)\n-\neCancer (EU), 14 December 2017\n[EAPM 2017 / The Innovative Medicines Initiative](http://ecancer.org/conference/965-eapm-2017/video/6639/the-innovative-medicines-initiative.php)\n-\nEuropean Files (EU), 6 December 2017\nSeveral articles in the issue '\n[Public Private Partnerships Strengthening Innovation and Research in Europe](https://www.europeanfiles.eu/magazine/public-private-partnerships-strenghtening-innovation-research-europe)'\n-\nHorizon Magazine (EU), 23 November 2017\n[We need a new way to pay for antibiotics \u2013 Dr David Payne](https://horizon-magazine.eu/article/we-need-new-way-pay-antibiotics-dr-david-payne_en.html)\n-\nNordic Life Science (Sweden), 17 November 2017\n[Antibiotic Advances from New Drugs 4 Bad Bugs](/sites/default/files/uploads/documents/news-events/imi-in-the-media/NLS.Nov17.ND4BB.pdf)\n-\nEuropean Biotechnology (EU), 16 November 2017\n[Antibiotic Resistance: EU SME alliance calls for specific support to thrive AMR R&D](https://european-biotechnology.com/up-to-date/latest-news/news/antibiotic-resistance-eu-sme-alliance-calls-for-specific-support-to-thrive-amr-rd.html)\n-\nDer Standard (Austria), 8 November 2017\n[St.-Anna-Kinderkrebsforschung beteiligt sich an EU-Projekt](http://derstandard.at/2000067410509/St-Anna-Kinderkrebsforschung-beteiligt-sich-an-EU-Projekt)(St Anna Children's Cancer Research takes part in EU project)\n-\nParliament Magazine (EU), 3 October 2017\n[Research breakthroughs happen more easily when information is shared](https://www.theparliamentmagazine.eu/articles/partner_article/imi/research-breakthroughs-happen-more-easily-when-information-shared)\n-\nEUobserver (EU), 9 August 2017\n[Holiday season means risk of tropical diseases in Europe](https://euobserver.com/health/138689)\n-\nDiario Medico (Spain), 28 July 2017\n['Big data' para mejorar el abordaje cardiovascular](http://cardiologia.diariomedico.com/2017/07/28/area-cientifica/especialidades/cardiologia/big-data-para-mejorar-el-abordaje-cardiovascular)\n-\nHorizon Magazine (EU), 27 July 2017\n[Depression, schizophrenia may become redundant terms](https://horizon-magazine.eu/article/depression-schizophrenia-may-become-redundant-terms_en.html)\n-\nTechnologist (EU), 10 July 2017\n[How engineers and doctors are reinventing healthcare](http://www.technologist.eu/how-engineers-and-doctors-are-reinventing-healthcare/)\n-\nPharmaPhorum Deep Dive (UK), July 2017\n[Healthcare in 2030: what role for pharma?](http://deep-dive.pharmaphorum.com/deep-dive-future-pharma-july-2017#!/healthcare-in-2030-what-role-for-pharma)\n-\nPolitico (EU), 29 June 2017\n[Q and A with IMI Executive Director Pierre Meulien](http://www.politico.eu/pro/q-and-a-with-imi-executive-director-pierre-meulien/)\n-\nDaily Mail (UK), 15 June 2017\n[UK researchers helping to create new whooping cough vaccine](http://www.dailymail.co.uk/wires/pa/article-4606218/UK-researchers-helping-create-new-whooping-cough-vaccine.html#ixzz4r8Eq7HSv)\n-\nDaily Express (UK), 15 June 2017\n[Whooping cough vaccine being developed by British researchers](http://www.express.co.uk/life-style/health/816967/whooping-cough-vaccine-being-developed-British-researchers)\n-\nCorriere del Mezzogiorno (Italy), 5 June 2017\n[Rivoluzione nel corso di formazione Cos\u00ec i pazienti diventano \u201cesperti\u201d](http://corrieredelmezzogiorno.corriere.it/napoli/salute/17_giugno_05/rivoluzione-corso-formazione-cosi-pazienti-diventano-esperti-7ec07744-49d2-11e7-aee8-6748474b0aba.shtml)(Revolution in training so patients become \"experts\")\n- The Lancet Infectious Diseases (UK), June 2017\n[Breaking up is hard to do: Brexit and European science](http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(17)30264-5/fulltext)\n- Health Capital (Germany), 30 May 2017\n[Big Data. Hope for patients](http://www.healthcapital.de/biotechnologie/artikel/details/big-data-hope-for-patients/)\n- Sunday Post (UK), 29 May 2017\n[\u2018Dementia research will suffer when we leave EU\u2019: Top Alzheimer\u2019s professor issues stark warning](https://www.sundaypost.com/fp/dementia-research-will-suffer-when-we-leave-eu/)\n- The Scientist (US), 24 May 2017\n[Brexit will cost U.K. research funding, report indicates](http://www.the-scientist.com/?articles.view/articleNo/49511/title/Brexit-Will-Cost-U-K--Research-Funding--Report-Indicates/)\n- Health IT Central (Germany), 12 May 2017\n[Pharmaceutical research goes big data](http://www.hitcentral.eu/insights/pharmaceutical-research-goes-big-data)\n- Granada Hoy (Spain), 25 April 2017\n[Genyo se afianza en la medicina personalizada y de precision](http://www.granadahoy.com/granada/Genyo-afianza-medicina-personalizada-precision_0_1129987089.html)(Genyo anchors its position in personalised and precision medicine)\n- Regio 024 (Netherlands), 13 April 2017\n[12 miljoen subsidie van IMI voor project TRISTAN](http://www.regio024.nl/nieuws/nijmegen/103-redactie/29541-12-miljoen-subsidie-van-imi-voor-project-tristan)(12 million subsidy from IMI for TRISTAN project)\n- Cadureso (France), 11 April 2017\n[Innovative Medicines Initiative \u2013 IMI](http://www.cadureso.com/actualite/actualite-sante/9057-innovative-medicines-initiative-imi)\n- EurActiv.com (EU), 7 April 2017\n[IMI chief: \u2018We need to learn how to share data in a safe and ethical manner\u2019](http://www.euractiv.com/section/health-consumers/interview/imi-chief-we-need-to-learn-how-to-share-data-in-a-safe-and-ethical-manner/)\n- Photonics.com (US), 7 April 2017\n[Multiple factors shape market for innovations](https://www.photonics.com/Article.aspx?AID=61912)\n- SpringerMedizin (Austria), 7 April 2017\n[Die Ethik der Daten](http://www.springermedizin.at/praxis/?full=58003)(The ethics of data)\n- Aarhus University News (Denmark), 6 April 2017\n[The IMI is a sure path to an invaluable network](http://newsroom.au.dk/en/news/show/artikel/imi-er-en-sikker-vej-til-ubetalelige-netvaerk/)\n- PharmaBiz.com (India), 3 April 2017\n[Text mining with automation becomes boon for ADR reporting](http://www.pharmabiz.com/NewsDetails.aspx?aid=101187&sid=1)\n- Der Standard (Austria), 31 March 2017\n[Konsortium will Standards bei Fl\u00fcssigbiopsien verbessern](http://derstandard.at/2000055182077/Konsortium-will-Standards-bei-Fluessigbiopsien-verbessern)(Consortium wants to improve standards for liquid biopsies)\n- Malta Today (Malta), 21 March 2017\n[Innovative Medicines Initiative: an opportunity for local researchers](http://www.maltatoday.com.mt/news/national/75541/innovative_medicines_initiative_an_opportunity_for_local_researchers)\n- Manufacturing Chemist (UK), 17 March 2017\n[Environment award for research on chemical contaminants](https://www.manufacturingchemist.com/news/article_page/Environment_award_for_research_on_chemical_contaminants/127108)\n- Magyar H\u00edrlap (Hungary), 6 March 2017\n[Sz\u00f3cska Mikl\u00f3s: Magyarorsz\u00e1g eg\u00e9szs\u00e9g\u00fcgyi adatnagyhatalom](http://magyarhirlap.hu/cikk/81735/Szocska_Miklos_Magyarorszag_egeszsegugyi_adatnagyhatalom)(Hungary health data superpower)\n- PharmaVOICE (US), 1 March 2017\n[Ebola research update](http://www.pharmavoice.com/article/2017-3-ebola-research/)\n- Medical News Today (UK), 14 February 2017\n[New biomarkers for bowel cancer treatment](http://www.medicalnewstoday.com/releases/315829.php)\n- ZorgKrant (Netherlands), 7 February 2017\n[Start internationaal onderzoek naar Personalized Medicine bij diabetische nierschade](http://zorgkrant.zorgportaal.nl/index.php/bericht/10707-start-internationaal-onderzoek-naar-personalized-medicine-bij-diabetische-nierschade.html)(Start of international research for personalised medicine for diabetic kidney damage)\n- PharmaTimes (UK), 26 January 2017\n[Liverpool Uni to run \u00a314m drug safety study](http://www.pharmatimes.com/news/liverpool_uni_to_run_14m_drug_safety_study_1185264)\n- \u00c4rzteblatt (Germany), 26 January 2017\n[Leuk\u00e4mie: Internationale Datenbank f\u00fcr verbesserte Prognose und Therapie](http://www.aerzteblatt.de/nachrichten/72666/Leukaemie-Internationale-Datenbank-fuer-verbesserte-Prognose-und-Therapie)(Leukaemia: International database for improved prognosis and therapy)\n- Pink Sheet (US), 24 January 2017\n[EU mobile app for reporting ADRs to be tested in Burkina Faso and Zambia](https://pink.pharmamedtechbi.com/PS119889/EU-Mobile-App-For-Reporting-ADRs-To-Be-Tested-In-Burkina-Faso-And-Zambia)\n- Mobi Health News (US), 23 January 2017\n[Researchers developing smartphone-based microscope for low-cost DNA sequencing](http://www.mobihealthnews.com/content/researchers-developing-smartphone-based-microscope-low-cost-dna-sequencing)\n- PharmaFile (UK), 23 January 2017\n[Thinking big data](http://www.pharmafile.com/news/512608/thinking-big-data)\n- Narod (Croatia), 19 January 2017\n[Zagreb doma\u0107in me\u0111unarodnog poslovnog umre\u017eavanja prijavitelja EU projekata](http://narod.hr/gospodarstvo/zagreb-domacin-medunarodnog-poslovnog-umrezavanja-prijavitelja-eu-projekata)(Zagreb is hosting an international networking event for EU project applicants)\n- Politico (EU), 12 January 2017\n[Transforming health care through disruptive innovation: Will your data cure you?](http://www.politico.eu/article/transforming-health-care-through-disruptive-innovation-will-your-data-cure-you-working-group-report/)\n- Der Standard (Austria), 10 January 2017\n[Sensible Patientendaten: MedUni Wien entwickelt Richtlinien](http://derstandard.at/2000050479953/sensiblen-PatientendatenMedUni-Wien-entwickelt-Richtlinien-im-Umgang-mit)(Sensitive patient data: Medical University of Vienna develops guidelines)\n- ITV (UK), 10 January 2017\n[Newcastle University involved in \u00a334.7m blood disorder project](http://www.itv.com/news/tyne-tees/2017-01-10/newcastle-university-involved-in-34-7m-blood-disorder-project/)\n- The Herald (UK), 17 November 2016\n[Beyond Brexit: We need to build upon historic strengths](http://www.heraldscotland.com/politics/beyondbrexit/14911035.Beyond_Brexit__We_need_to_build_upon_historic_strengths/)\n- Nature (UK), 9 November 2016\n[How to defeat dementia](http://www.nature.com/news/how-to-defeat-dementia-1.20949)\n- Science| Business (EU), 2 November 2016\n[In the lab: a big data project is trying to improve outcomes for patients](http://sciencebusiness.net/health/news/2016/in-the-lab-a-big-data-project-is-trying-to-improve-outcomes-for-patients/)\n- Euronews - Business Planet (EU), 28 October 2016\nEuronews Deutsch:\n[Europ\u00e4ische Substanz-Bibliothek spart Zeit und Geld in der Medikamentenforschung](http://de.euronews.com/2016/10/28/europaeische-substanz-bibliothek-spart-zeit-und-geld-in-der)\nEuronews English:\n[The vital role of SMEs in medical research](http://www.euronews.com/2016/10/28/business-planet-innovative-medicines-initiative-imi)\nEuronews Espa\u00f1ol:\n[Una plataforma paneurop\u00e9a \u00fanica para desarrollar medicamentos innovadores](http://es.euronews.com/2016/10/28/una-plataforma-paneuropea-unica-para-desarrollar-medicamentos-innovadores)\nEuronews Fran\u00e7ais:\n[Les PME, leviers indispensables de l'innovation pharmaceutique](http://fr.euronews.com/2016/10/28/les-pme-leviers-indispensables-de-l-innovation-pharmaceutique)\nEuronews Italiano:\n[Ricerca farmaceutica e Pmi, la rete europea dell'innovazione 'accessibile'](http://it.euronews.com/2016/10/28/ricerca-farmaceutica-e-pmi-la-rete-europea-dell-innovazione-accessibile)\nEuronews Magyar:\n[Kkv-kal gyors\u00edtan\u00e1k a gy\u00f3gyszerkutat\u00e1st](http://hu.euronews.com/2016/10/28/kkv-kal-gyorsitanak-a-gyogyszerkutatast)\nEuronews Portugues:\n[O European Lead Factory e a Iniciativa sobre Medicamentos Inovadores](http://pt.euronews.com/2016/10/28/o-european-lead-factory-e-a-iniciativa-sobre-medicamentos-inovadores)\n- Drug Discovery World (UK), 25 October 2016\n[Reconfiguring drug discovery through innovative partnerships](http://www.ddw-online.com/business/p218116-reconfiguring-drug-discovery-through-innovative-partnerships.html)\n- Science|Business (UK), 20 October 2016\n[EU Commission sketches possible directions for FP9](http://www.sciencebusiness.net/news/79966/EU-Commission-sketches-possible-directions-for-FP9)\n- Huffington Post (UK), 12 October 2016\n[Labour's 170 Brexit Questions For The Government And David Davis To Answer](http://www.huffingtonpost.co.uk/entry/170-questions-brexit-labour-government_uk_57fdef14e4b0a9568544f9c3)\n- Financial Times (UK), 14 September 2016\n[Europeans are among those most sceptical of vaccine safety](http://www.ft.com/cms/s/0/8a0b3a6c-7994-11e6-97ae-647294649b28.html)\n- Scrip (UK), 24 August 2016\n[View From The Top of IMI: Heading Up Life Sciences' Biggest Public-Private Partnership](https://scrip.pharmamedtechbi.com/SC097162/View-From-The-Top-Of-IMI-Heading-Up-Life-Sciences-Biggest-PublicPrivate-Partnership)\n- Bloomberg (US), 18 July 2016\n[Shrinking Talent Pool May Bind Biotechs After Brexit](http://www.bloomberg.com/news/articles/2016-07-18/shrinking-pools-of-money-talent-may-bind-biotechs-after-brexit)\n- Nature (UK), 13 July 2016\n[Neuropathy: A name for their pain](http://www.nature.com/nature/journal/v535/n7611_supp/full/535S10a.html)\n- Medical Device Daily (US), 24 June 2016\n[EU making progress in AMR via research, regulatory efforts](http://www.medicaldevicedaily.com/servlet/com.accumedia.web.Dispatcher?next=bioWorldHeadlines_article&forceid=93050)\n- BioWorld (US), 22 June 2016\n[Agencies push bug drug pipeline but development lacks market pull](http://www.bioworld.com/content/agencies-push-bug-drug-pipeline-development-lacks-market-pull-0)\n- The Lancet (UK), 30 May 2016\n[Better together for better dementia research and care](http://www.thelancet.com/pdfs/journals/lanpsy/PIIS2215-0366(16)30090-6.pdf)\n- Financial Times (UK), 20 May 2016\n[EU exit would lessen the influence of UK scientists](http://www.ft.com/cms/s/0/b60b5302-1dbb-11e6-a7bc-ee846770ec15.html)\n- Financial Times (UK), 19 May 2016\n[Big pharma hits back at tax to tackle superbugs](http://www.ft.com/cms/s/0/5bf75b80-1da8-11e6-a7bc-ee846770ec15.html)\n- Science Business (EU), 19 May 2016\n[Innovative Medicines Initiative says its early goals being met](http://www.sciencebusiness.net/news/79782/Innovative-Medicines-Initiative-says-its-early-goals-being-met)\n- Novi List (Croatia), 19 May 2016\n[Nova mobilna aplikacija HALMED-a: Prijave nuspojava lijeka odsad i putem smartphonea](http://www.novilist.hr/novilist_public/Znanost-i-tehnologija/Tehnologija/Nova-mobilna-aplikacija-HALMED-a-Prijave-nuspojava-lijeka-odsad-i-putem-smartphonea)(HALMED's new mobile app: from now on it will be possible to report side effects via smartphone)\n- T-Portal (Croatia), 18 May 2016\n[Kako mobitelom saznati i prijaviti nuspojave lijeka?](http://www.tportal.hr/vijesti/znanost/429059/Kako-mobitelom-saznati-i-prijaviti-nuspojave-lijeka.html)(How to find out about and report side effects of medicines via smartphone)\n- Chronicle.lu (Luxembourg), 11 May 2016\n[Strategy on Quality and Partnerships Pays Off for IBBL](http://www.chronicle.lu/categoriesbusinessinnovation/item/17005-strategy-on-quality-and-partnerships-pays-off-for-ibbl)\n- Nature (UK), 11 May 2016\n[Competition: Unlikely partnerships](http://www.nature.com/nature/journal/v533/n7602_supp/full/533S56a.html)\n- Nature (UK), 11 May 2016\n[Data sharing: Access all areas](http://www.nature.com/nature/journal/v533/n7602_supp/full/533S71a.html)\n- \u00c4rzte Zeitung (Germany), 10 May 2016\n[Mobile Ger\u00e4te sollen vor Anf\u00e4llen warnen](http://www.aerztezeitung.de/medizin/krankheiten/neuro-psychiatrische_krankheiten/epilepsie/article/910897/epilepsie-mobile-geraete-sollen-anfaellen-warnen.html)(Mobile devices should warn of attack)\n- Navarrainformacion.es (Spain), 3 May 2016\n[La European Lead Factory analizar\u00e1 una diana terap\u00e9utica emergente del CIMA de la Universidad de Navarra contra el cancer](http://www.navarrainformacion.es/2016/05/03/la-european-lead-factory-analizara-una-diana-terapeutica-emergente-del-cima-la-universidad-navarra-cancer/)(The European Lead Factory will analyse an emerging anti-cancer therapeutic target from the University of Navarra)\n- Corriere Della Sera (Italy), 29 April 2016\n[Uno smartphone anti-depressione](http://www.corriere.it/notizie-ultima-ora/Scienza_e_salute/smartphone-anti-depressione/29-04-2016/1-A_025751031.shtml)(An anti-depression smartphone)\n- Science Business (EU), 28 April 2016\n[Too much talk of innovation?](http://www.sciencebusiness.net/news/79761/Too-much-talk-of-innovation)\n- La Marseillaise (France), 27 April 2016\n[Marseille s\u2019empare de la lutte contre le virus Ebola](http://www.lamarseillaise.fr/marseille/sante/48201-marseille-s-empare-de-la-lutte-contre-le-virus-ebola)(Marseille seizes the fight against the Ebola virus)\n- Medical News Today (UK), 26 April 2016\n[Genetic barcode could pave way to bespoke liver cancer therapies](http://www.medicalnewstoday.com/releases/309580.php)\n- Financial Time (UK), 25 April 2016\n[Experimental Ebola vaccines need testing](http://www.ft.com/cms/s/2/3fc98152-e538-11e5-a09b-1f8b0d268c39.html)\n- Politico Europe (EU), 21 April 2016\n[Vaccines need a new business model](http://www.politico.eu/article/special-report-vaccines-need-a-new-business-model/)\n- Corriere Della Sera (Italy), 13 April 2016\n[L'isolamento sociale ha basi biologiche](http://www.corriere.it/notizie-ultima-ora/Scienza_e_salute/isolamento-sociale-basi-biologiche/13-04-2016/1-A_024860940.shtml)(Social isolation has a biological basis)\n- Science (US), 12 April 2016\n[European mental health project targets biological roots of social withdrawal](http://www.sciencemag.org/news/2016/04/european-mental-health-project-targets-biological-roots-social-withdrawal)\n- Manufacturing Chemist (UK), 11 April 2016\n[IMI project recommends caution when assessing medicine impact studies from different databases](http://www.manufacturingchemist.com/news/article_page/IMI_project_recommends_caution_when_assessing_medicine_impact_studies_from_different_databases/117259)\n- EurActiv (EU), 5 April 2016\n[Ebola refuses to let go of West Africa](http://www.euractiv.com/section/global-europe/news/ebola-refuses-to-let-go-of-west-africa/)\n- The Telegraph (UK), 2 April 2016\n[Lord Darzi: Leaving the EU would be 'disastrous' for UK science and health](http://www.telegraph.co.uk/news/2016/04/02/lord-darzi-leaving-the-eu-would-be-disastrous-for-uk-science-and/)\n- Science Business (EU), 30 March 2016\n[Despite potential benefits, big data faces resistance in healthcare](http://www.sciencebusiness.net/news/78724/Despite-potential-benefits-big-data-faces-resistance-in-healthcare)\n- Europa Press (Spain), 18 March 2016\n[Reina Sof\u00eda de C\u00f3rdoba e Imibic participan en un proyecto sobre enfermedades autoinmunes](http://www.europapress.es/esandalucia/cordoba/noticia-reina-sofia-cordoba-imibic-participan-proyecto-enfermedades-autoinmunes-20160318104522.html)(Reina Sof\u00eda de C\u00f3rdoba e Imibic are participating in a project on auto-immune diseases)\n- Luxemburger Wort (Luxembourg), 17 March 2016\n[Daten sind die W\u00e4hrung der modernen Medizin](http://www.wort.lu/de/wissen/umfrage-zum-thema-chronische-krankheiten-teil-5-daten-sind-die-waehrung-der-modernen-medizin-56e98e2c1bea9dff8fa7492f)(Data are the currency of modern medicine)\n- Il Sole 24 Ore (Italy), 15 March 2016\n[Big data per la salute. L\u2019Europa cerca la cura pi\u00f9 efficace](http://www.ilsole24ore.com/art/tecnologie/2016-03-15/big-data-la-salute-l-europa-cerca-cura-piu-efficace-154639.shtml?uuid=ACoHCYoC)(Big data for health. Europe seeks the most effective cure)\n- Granada Hoy (Spain), 12 March 2016\n[Genyo: el coraz\u00f3n de un proyecto mundial sobre enfermedades raras](http://www.granadahoy.com/article/granada/2238884/genyo/corazon/proyecto/mundial/sobre/enfermedades/raras.html)(Genyo: the heart of a global project on rare diseases)\n- Nature Biotechnology (UK), 10 March 2016\n[Community crystal gazing](http://www.nature.com/nbt/journal/v34/n3/full/nbt.3515.html)\n- The Malta Independent (Malta), 14 February 2016\n[Explaining the enigma in medicines research & development](http://www.independent.com.mt/articles/2016-02-14/newspaper-lifestyleculture/Explaining-the-enigma-in-Medicines-Research-Development-6736153302)\n- The Parliament Magazine (European), 8 February 2016\n[mHealth: New challenges as well as new opportunities](https://www.theparliamentmagazine.eu/articles/opinion/mhealth-new-challenges-well-new-opportunities)\n- La Libre (Belgium), 3 February 2016\n[Un projet europ\u00e9en pour mieux comprendre le diab\u00e8te de type 1](http://www.lalibre.be/dernieres-depeches/belga/un-projet-europeen-pour-mieux-comprendre-le-diabete-de-type-1-56b1fed33570fdebf5b134e1)(A European project to better understand type 1 diabetes)\n- Fierce Biotech (US), 29 January 2016\n[Allergan links with AstraZeneca on new antibiotic treatment](http://www.fiercebiotech.com/story/allergan-links-astrazeneca-new-antibiotic-treatment/2016-01-29)\n- Politico Playbook (European), 27 January 2016\n[Bill Gates to EU ministers: love your work, now pay up\u2026](http://www.politico.eu/newsletter/playbook/politico-brussels-playbook-presented-by-tata-consultancy-services-car-law-overhaul-eu-start-up-visa-juncker-drops-greece/)\n- Science Business (European), 7 January 2016\n[UK scientists throw weight behind EU membership](http://www.sciencebusiness.net/news/77376/UK-scientists-throw-weight-behind-EU-membership)\n- PharmaPhorum (UK), 31 December 2015\n[20 people who shaped healthcare in 2015: part 1](http://www.pharmaphorum.com/articles/20-people-who-shaped-healthcare-in-2015-part-1)\n- L\u00ebtzebuerger Journal (Luxembourg), 22 December 2015\n[Innovation, wo sie besonders gebraucht wird](http://www.journal.lu/article/innovation-wo-sie-besonders-gebraucht-wird/)(Innovation where it is most needed)\n- Yahoo News (France), 8 December 2015\n[Ebola : recherche volontaires pour un essai vaccinal](https://fr.news.yahoo.com/ebola-recherche-volontaires-essai-vaccinal-150437943.html)(Ebola: volunteers search for a vaccine trial)\n- La Tribune (France), 8 December 2015\n[Nosopharm int\u00e8gre un projet europ\u00e9en sur les antibiotiques](http://objectif-languedoc-roussillon.latribune.fr/innovation/innovation-medicale/2015-12-08/nosopharm-integre-un-projet-europeen-sur-les-antibiotiques.html)(Nosopharm integrates a European project on antibiotics)\n- Svenska Dagbladet (Sweden), 29 November 2015\n['Resistenta bakterier kan d\u00f6da fler \u00e4n cancer'](http://www.svd.se/resistenta-bakterier-kan-doda-fler-an-cancer)('Resistant bacteria can kill more than cancer')\n- 2. program Radia Slovenija (Slovenia), 26 November 2015\n[Antibiotik ni za vsak primer](http://val202.rtvslo.si/2015/11/ambulanta-202-23/)(The antibiotic is not for every case)\n- The Guardian (UK), 24 November 2015\n[Ebola will always return unless we develop the tools to end it](http://www.theguardian.com/global-development/2015/nov/24/ebola-develop-tools-to-end-it-vaccine-sierra-leone-virus-epidemic)\n- Politiken Weekly (Denmark), 19 November 2015\nDebat: Kom nu ind i kampen mod de resistente superbakterier (Debate: Come into the fight against resistant superbugs)\n- Il Sole 24 Ore (Italy), 23 October 2015\n[L\u2019 Europa spinge sui farmaci innovativi, lotta al cancro e all\u2019alzheimer](http://www.ilsole24ore.com/art/norme-e-tributi/2015-10-23/l-europa-spinge-farmaci-innovatiivi-lotta-cancro-e-alzheimer-104956.shtml?refresh_ce=1)(Europe pushes on innovative medicines, fight cancer and Alzheimer's)\n- Di\u00e1rio Siglo XXI (Spain), 22 October 2015\n[Comienza a probarse en voluntarios de Sierra Leona una vacuna contra el virus](http://www.diariosigloxxi.com/texto-ep/mostrar/20151022140239/comienza-a-probarse-en-voluntarios-de-sierra-leona-una-vacuna-contra-el-virus#.VovH4_krJaQ)(Tests on vaccine against Ebola have been started on volunteers in Sierra Leone)\n- Politico (European), 6 October 2015\n[IMI boss: Public gets good return on investment](http://www.politico.eu/pro/imi-boss-pierre-meulien-public-gets-good-return-on-investment/)\n- Nieuws.nl (the Netherlands), 22 September 2015\n[EU stelt 15 miljoen euro beschikbaar voor artrose onderzoek](http://utrecht.nieuws.nl/onderwijswetenschap/46661/eu-stelt-15-miljoen-euro-beschikbaar-voor-artrose-onderzoek/)(15 million EU funding for research on osteoarthritis)\n- La Voz de Galicia (Spain), 20 September 2015\n[Galicia reclutar\u00e1 a 1.000 pacientes en el mayor ensayo para tratar la artrosis](http://www.lavozdegalicia.es/noticia/sociedad/2015/09/20/galicia-reclutara-1000-pacientes-mayor-ensayo-tratar-artrosis/0003_201509G20P32991.htm)(Galicia will recruit 1,000 patients in the largest trial to treat osteoarthritis)\n- Corriere della Sera (Italy), 10 September 2015\n[La Statale nello sviluppo di nuovi antibiotici contro fibrosi cistica e bronchiectasie](http://universitime.corriere.it/2015/09/10/la-statale-nello-sviluppo-di-nuovi-antibiotici-contro-fibrosi-cistica-e-bronchiectasie/)(University of Milan for the development of new antibiotics against cystic fibrosis and bronchiectasis)\n- RTE (Ireland), 7 September 2015\n[New drugs to help patients with cystic fibrosis & bronchiectasis](http://www.rte.ie/news/2015/0907/726255-cystic-fibrosis/)\n- Nature Reviews Drug Discovery (international), 31 July 2015\n[An audience with Pierre Meulien](http://www.nature.com/nrd/journal/v14/n8/full/nrd4698.html)\n- Politico (European), 15 June 2015\n[EU drugs partnership gets new chief](http://www.politico.eu/article/pierre-meulien-innovative-medicines-initiative-executive/)\n- Science Business (European), 15 June 2015\n[Irish national Pierre Meulien appointed to run Innovative Medicines Initiative](http://sciencebusiness.net/news/77078/Irish-national-Pierre-Meulien-appointed-to-run-Innovative-Medicines-Initiative)\n- Knack (Belgium), 21 May 2015\n[Antibioticacrisis: worden banale infecties binnenkort opnieuw dodelijk?](http://www.knack.be/nieuws/gezondheid/antibioticacrisis-worden-banale-infecties-binnenkort-opnieuw-dodelijk/article-normal-572221.html)(Antibiotics crisis: will common infections become deadly again soon?)\n- Luxemburger Wort (Luxembourg), 29 April 2015\n[Spitzenforschung in Luxemburg : Biomarker anstelle von Biopsien](http://www.wort.lu/de/wissen/spitzenforschung-in-luxemburg-biomarker-anstelle-von-biopsien-553f3ce80c88b46a8ce58372)(Cutting-edge research in Luxembourg: biomarkers instead of biopsies)\n- 20 Minutos (Spain), 27 April 2015\n[Investigadores del Virgen Macarena y Virgen del Roc\u00edo participan en el proyecto europeo Combacte Care](http://www.20minutos.es/noticia/2443758/0/investigadores-virgen-macarena-virgen-rocio-participan-proyecto-europeo-combacte-care/)(Researchers at the Virgen del Roc\u00edo and Virgen Macarena participate in the European project Combacte Care)\n- EuropaPress (Spain), 27 April 2015\n[Investigadores del Virgen Macarena y Virgen del Roc\u00edo participan en el proyecto europeo Combacte Care](http://www.europapress.es/esandalucia/sevilla/noticia-investigadores-virgen-macarena-virgen-rocio-participan-proyecto-europeo-combacte-care-20150427143859.html)(Researchers at the Virgen del Roc\u00edo and Virgen Macarena participate in the European project Combacte Care)\n- The Pharmaceutical Journal (UK), 23 April 2015\n[Clinical trials and tribulations](http://www.pharmaceutical-journal.com/sign-in?rtn=news-and-analysis/features/clinical-trials-and-tribulations/20068332.article)\n- Die Welt (Germany), 22 April 2015\n[Impfstoff k\u00f6nnte im Herbst zugelassen werden](http://www.welt.de/gesundheit/article139904385/Impfstoff-koennte-im-Herbst-zugelassen-werden.html)(Ebola vaccine could be approved in autumn)\n- Berliner Morgenpost (Germany), 22 April 2015\n[Impfstoff k\u00f6nnte im Herbst zugelassen werden](http://www.morgenpost.de/politik/ausland/article139904385/Impfstoff-koennte-im-Herbst-zugelassen-werden.html)(Ebola vaccine could be approved in autumn)\n- Irish Times (Ireland), 21 April 2015\n[Educating advocates: how patients and parents can speak for change](http://www.irishtimes.com/life-and-style/health-family/educating-advocates-how-patients-and-parents-can-speak-for-change-1.2176847)\n- BioCentury Innovations (international), 16 April 2015\n[IMI's innovation ecosystem](http://www.biocentury.com/innovations/strategy/2015-04-16/how-eus-imi-2-is-tackling-broader-projects-with-more-stakeholders-than-its-prior-iteration-s02)\n- Medical News Today (UK), 15 April 2015\n[IMI and World Anti-Doping Agency to collaborate](http://www.medicalnewstoday.com/releases/292372.php)\n- ANSA (Italy), 14 April 2015\n[Un esame del sangue rivela tumore ed evita la biopsia](http://www.ansa.it/saluteebenessere/notizie/rubriche/medicina/2015/04/13/tumori-un-esame-del-sangue-rivelatore-per-evitare-biopsia_69941637-3a80-4e03-babd-a388a75a717c.html)(A blood test shows the presence of a cancer and avoid the biopsy)\n- Pan European Networks (European), 14 April 2015\n[IMI and anti-doping agency to collaborate](http://www.paneuropeannetworks.com/health/imi-and-anti-doping-agency-to-collaborate/)\n- Il Sole 24 Ore (Italy), 12 April 2015\n[Antibiotici, la ricerca punta su vecchi farmaci](http://nova.ilsole24ore.com/progetti/antibiotici-la-ricerca-punta-su-vecchi-farmaci)(Antibiotics, research bets on old drugs)\n- European Biotechnology News (European), 10 April 2015\n[Industry vet heads IMI](http://www.european-biotechnology-news.com/people/bio-people/2015/marc-de-garidel.html)\n- L\u2019Espresso (Italy), 3 April 2015\n[Influenza, ecco perch\u00e9 il vaccino ha fatto flop](http://espresso.repubblica.it/visioni/scienze/2015/04/01/news/influenza-ecco-perche-il-vaccino-ha-fatto-flop-1.206749)(Flu: here it is explained why the vaccine was a flop)\n- Ideal (Spain), 3 April 2015\n[350 granadinos prestan su cuerpo para crear el primer mapa molecular contra enfermedades raras](http://www.ideal.es/granada/201504/03/granadinos-prestan-cuerpo-para-20150402204545.html)(350 people from Granada 'lend' their body to create the first molecular map for rare diseases)\n- EyeForPharma (UK), 1 April 2015\n[Partnership: The Game Changer in Alzheimer\u2019s Research](http://social.eyeforpharma.com/patients/partnership-game-changer-alzheimers-research)\n- Forbes (international), 31 March 2015\n[From Hunting to Farming, Medicines Development Takes a Big Leap Forward](http://www.forbes.com/sites/johnlechleiter/2015/03/31/from-hunting-to-farming-medicine-development-takes-a-big-leap-forward/)\n- Industrie Pharma (France), 30 March 2015\n[Marc de Garidel nomm\u00e9 pr\u00e9sident d'IMI](http://www.industrie.com/pharma/marc-de-garidel-nomme-president-d-imi,62426)(Marc de Garidel appointed President of IMI)\n- Le Monde (France), 27 March 2015\n[Ebola : la course aux vaccins s\u2019acc\u00e9l\u00e8re](http://www.lemonde.fr/planete/article/2015/03/27/ebola-la-course-aux-vaccins-s-accelere_4602761_3244.html#)(Ebola: the race for the vaccine is accelerating)\n- Research Professional (international), 26 March 2015\nMy winning proposal: public-private partnerships for health\n- The Herald (UK), 19 March 2015\n[Stirling-based scientists pioneering role in battle against Ebola](http://www.heraldscotland.com/news/home-news/stirling-based-scientists-pioneering-role-in-battle-against-ebola.120955411)\n- Elsevier (The Netherlands), 19 March 2015\n[Waarschuwing voor resistente bacteri\u00ebn onderweg naar Nederland](http://www.elsevier.nl/Kennis/achtergrond/2015/3/Waarschuwing-voor-resistente-bacterienonderweg-naar-Nederland-1725751W/)(Warning of resistant bacteria on route to the Netherlands)\n- De Morgen (Belgium), 12 March 2015\n[Effici\u00ebntere griepvaccins dankzij beter evaluatie](http://www.demorgen.be/wetenschap/-efficientere-griepvaccins-dankzij-beter-evaluatie-a2249650/)(More effective influenza vaccines through better evaluation)\n- Het Laatste Nieuws (Belgium), 12 March 2015\n[Effici\u00ebntere griepvaccins dankzij beter evaluatie](http://www.hln.be/hln/nl/957/Binnenland/article/detail/2249650/2015/03/12/Efficientere-griepvaccins-dankzij-beter-evaluatie.dhtml)(More effective influenza vaccines through better evaluation)\n- Les Echos (France), 10 March 2015\n[Ebola : comment industriels et pouvoirs publics ont collabor\u00e9 pour contrer l'\u00e9pid\u00e9mie](http://www.lesechos.fr/industrie-services/pharmacie-sante/0204215606918-ebola-comment-industriels-et-pouvoirs-publics-ont-collabore-pour-contrer-lepidemie-1100701.php#xtor=RSS37)(Ebola: how industry and government have collaborated to the epidemic)\n- Yle (Finland), 24 February 2015\n[Antibiotika slutar verka innan vi f\u00e5r nya l\u00e4kemedel](http://svenska.yle.fi/artikel/2015/02/22/antibiotika-slutar-verka-innan-vi-far-nya-lakemedel)(When antibiotics fail, new drugs are needed)\n- European Voice (Europe), 20 February 2015\n[A stand-in at the controls of the Innovative Medicines Initiative](http://www.politico.eu/article/a-stand-in-at-the-controls-of-the-innovative-medicines-initiative/)\n- Scrip Regulatory Affairs (international), 18 February 2015\n[Summer launch forecast for EU platform to co-ordinate early drug licensing pathways](http://www.rajpharma.com/productsector/pharmaceuticals/Summer-launch-forecast-for-EU-platform-to-co-ordinate-early-drug-licensing-pathways-356805)\n- Il Sole 24 Ore \u2013 ed. Sanit\u00e0 (Italy), 11 February 2015\n[Terapie \u2018su misura' per le malattie autoimmuni: Policlinico tra i capofila del progetto europeo PreciseSads](http://www.sanita24.ilsole24ore.com/art/medicina-e-scienza/2015-02-11/terapie-misura-malattie-autoimmuni-100235.php?uuid=AbizGlAL)(\u2018Tailored\u2019 therapies for autoimmune diseases: Policlinico of Milan among the leaders of the European project PreciseSads)\n- SciDev.Net (international), 4 February 2015\n[Mobile phones to help Ebola vaccine trials](http://www.scidev.net/global/medicine/news/mobile-phones-ebola-vaccine-trials.html)\n- Yle (Finland), 28 January 2015\n[Suomalaistutkijat kehitt\u00e4m\u00e4\u00e4n ebolan kentt\u00e4diagnostiikkaa](http://yle.fi/uutiset/suomalaistutkijat_kehittamaan_ebolan_kenttadiagnostiikkaa/7765406)(Finnish researchers develop Ebola field diagnostics)\n- Di\u00e1rio Econ\u00f3mico (Portugal), 27 January 2015\nUE lan\u00e7a oito projectos de \u00a1nves\u00fcga\u00e7\u00e3o na \u00e1rea do \u00e9bola (EU launches eight projects to fight Ebola) (in print)\n- Delo (Slovenia), 25 January 2015\n[Evropa proti eboli](http://www.delo.si/znanje/znanost/evropa-proti-eboli.html)(Europe against Ebola)\n- European Biotechnology News (Europe), 20 January 2015\n[IMI funds Ebola vaccine projects](http://www.european-biotechnology-news.com/news/news/2015-01/imi-funds-ebola-vaccine-projects.html)\n- Wallstreet online (Germany), 19 January 2015\n[Johnson & Johnson k\u00fcndigt die Gr\u00fcndung der Konsortien f\u00fcr die Entwicklung eines Ebolaimpfstoffs an](http://www.wallstreet-online.de/nachricht/7309391-johnson-johnson-kuendigt-die-gruendung-der-konsortien-fuer-die-entwicklung-eines-ebolaimpfstoffs-an-und-erhaelt-finanzierung-von-der-initiative-fuer-innovative-arzneimittel)(Johnson & Johnson announced the creation of consortia for the development of an Ebola vaccine)\n- Sunday Independent (Ireland), 18 January 2015\nWorld Vision Ireland's Ebola initiative (in print)\n- MedNouse, 17 January 2015\n[IMI launches Ebola projects](http://www.mednous.com/news/imi-launches-ebola-projects)\n- Blikk (Hungary), 17 January 2015\n[Az EU \u00faj kutat\u00e1si projektekkel seg\u00edti az ebola elleni k\u00fczdelmet](http://www.blikk.hu/blikk_aktualis/az-eu-uj-kutatasi-projektekkel-segiti-az-ebola-elleni-kuzdelmet-2321229)(The EU is helping new research projects to combat Ebola)\n- Daily Mail (UK), 17 January 2015\n[J&J Ebola vaccine gets 100 million euros to speed development](http://www.dailymail.co.uk/wires/reuters/article-2914504/Reuters-Health-News-Summary.html)\n- Europa Press (Spain), 17 January 2015\n[Johnson & Johnson anuncia la formaci\u00f3n del consorcio de desarrollo de la vacuna contra el \u00c9bola, con fondos de Innovative Medicines Initiative](http://www.europapress.es/economia/noticia-comunicado-johnson-johnson-anuncia-formacion-consorcio-desarrollo-vacuna-contra-ebola-fondos-innovativ-20150117173555.html)(Johnson & Johnson announced the formation of the consortium developing a vaccine against Ebola, funded by Innovative Medicines Initiative)\n- Vil\u00e1ggazdas\u00e1g (Hungary), 16 January 2015\n[K\u00e9tsz\u00e1zmilli\u00f3 eur\u00f3val seg\u00edti az EU az ebola elleni k\u00fczdelmet](http://www.vg.hu/vallalatok/egeszsegugy/ketszazmillio-euroval-segiti-az-eu-az-ebola-elleni-kuzdelmet-442236)(Two hundred million Euros will help the EU to combat Ebola)\n- Reuters (UK), 16 January 2015\n[J&J Ebola vaccine gets 100 million euros to speed development](http://www.reuters.com/article/2015/01/16/us-health-ebola-j-j-idUSKBN0KP1F020150116)\n- NewEurope (Europe), 16 January 2015\n[EU research efforts at front line of fight against Ebola](http://www.neurope.eu/article/eu-research-efforts-front-line-fight-against-ebola)\n- Pan European Networks (Europe), 16 January 2015\n[IMI launches eight projects tackling Ebola](http://www.paneuropeannetworks.com/health/imi-launches-eight-projects-tackling-ebola/)\n- Irish Examiner (Ireland), 16 January 2015\n[Irish group working to develop Ebola vaccine](http://www.irishexaminer.com/breakingnews/ireland/irish-group-working-to-develop-ebola-vaccine-658331.html)\n- Irish Examiner (Ireland), 16 January 2015\n[Research programme bids to defuse dementia time bomb](http://www.irishexaminer.com/ireland/research-programme-bids-to-defuse-dementia-time-bomb-307261.html)\n- Politiken (Denmark), 16 January 2015\n[Bavarians ebola-program henter finansiering fra EU](http://politiken.dk/oekonomi/virksomheder/ECE2514077/bavarians-ebola-program-henter-finansiering-fra-eu/)(Bavarian's Ebola programme retrieves financing from EU funds)\n- Il Sole 24 Ore - ed. Sanit\u00e0 (Italy), 16 January 2015\n[Ebola: Siena studia uno dei tre vaccini giudicati pi\u00f9 promettenti dall'Oms](http://www.sanita24.ilsole24ore.com/art/medicina-e-scienza/2015-01-16/ebola-siena-studia-vaccini-133701.php?uuid=AbEur9wK)(Ebola: Siena studying one of the three most promising vaccines)\n- The Malta Independent (Malta), 16 January 2015\n[EU announced eight research projects into Ebola; \u20ac215 million in funding allocated](http://www.independent.com.mt/articles/2015-01-16/local-news/EU-announced-eight-research-projects-into-Ebola-215-million-in-funding-allocated-6736128867)\n- Canarias7 (Spain), 15 January 2015\n[35 instituciones europeas se al\u00edan para investigar la prevenci\u00f3n del Alzheimer](http://www.canarias7.es/articulo.cfm?id=362145)(35 European institutions join forces to investigate the prevention of Alzheimer)\n- Europa Press (Spain), 15 January 2015\n[35 instituciones europeas se al\u00edan para investigar la prevenci\u00f3n del Alzheimer](http://www.europapress.es/catalunya/noticia-35-instituciones-europeas-alian-investigar-prevencion-alzheimer-20150115135335.html)(35 European institutions join forces to investigate the prevention of Alzheimer)\n- La Vanguardia (Spain), 15 January 2015\n[35 instituciones europeas se al\u00edan para investigar la prevenci\u00f3n del Alzheimer](http://www.lavanguardia.com/local/barcelona/20150115/54423659880/35-instituciones-europeas-se-alian-para-investigar-la-prevencion-del-alzheimer.html)(35 European institutions join forces to investigate the prevention of Alzheimer)\n- Le Figaro (France), 13 January 2015\n[Les laboratoires s'int\u00e9ressent \u00e0 nouveau aux antibiotiques](http://www.lefigaro.fr/societes/2015/01/13/20005-20150113ARTFIG00321-les-laboratoires-s-interessent-a-nouveau-aux-antibiotiques.php)(Laboratories are interested in new antibiotics)\n- Diario Medico.com (Spain), 13 January 2015\n[Antoni Esteve, presidente de Farmaindustria, pide m\u00e1s colaboraci\u00f3n p\u00fablico-privada durante la inauguraci\u00f3n del IMI-2 Info Day](http://www.diariomedico.com/2015/01/13/area-profesional/gestion/farmaindustria-pide-colaboracion-publico-privada-lograr-farmacos-efectivos)(Antoni Esteve, president of Farmaindustria, calls for more public-private partnerships at the opening of IMI-2 Info Day)\n- TeleCinco (Spain), 13 January 2015\n[Farmaindustria destaca la colaboraci\u00f3n p\u00fablico-privada en el desarrollo de medicamentos m\u00e1s efectivos y seguros](http://www.lavanguardia.com/local/barcelona/20150115/54423659880/35-instituciones-europeas-se-alian-para-investigar-la-prevencion-del-alzheimer.html)(Farmaindustria highlights the public-private partnership in the development of more effective and safe medicines)\n- Le Monde (France), 17 November 2014\n[Antibiotiques: trop de consommation, pas assez de nouvelles mol\u00e9cules](http://www.lemonde.fr/economie/article/2014/11/17/antibiotiques-trop-de-consommation-pas-assez-de-nouvelles-molecules_4524692_3234.html#CxQB2DXHtYVkhYE5fhv2E7)(Antibiotics: Too much consumption and not enough new drugs)\n- ORF.at (Austria), 6 November 2014\n[Ebola-Serum: 280 Mio. Euro von EU und Pharmafirmen](http://orf.at/stories/2252681/)(Ebola serum: 280 million euros from EU and pharmaceutical companies)\n- Reuters (international), 6 November 2014\n[EU scheme commits $350 million for research on Ebola vaccines, tests](http://uk.reuters.com/article/2014/11/06/us-health-ebola-europe-idUKKBN0IQ17J20141106)\n- De Morgen (Belgium), 27 October 2014\n[UAntwerpen mee in de bres tegen resistente antibiotica](http://www.demorgen.be/wetenschap/uantwerpen-mee-in-de-bres-tegen-resistente-antibiotica-a2103063/)(UAntwerpen joins the fights against antibiotic resistance)\n- Corriere della Sera (Italy), 7 October 2014\n[Contrastare l'invecchiamento: l'obiettivo di un progetto italiano](http://www.corriere.it/salute/cardiologia/14_ottobre_07/contrastare-l-invecchiamento-l-obiettivo-un-progetto-italiano-b8f20a3a-4e04-11e4-b38c-5070a4632162.shtml)(Fighting ageing: the objective of an Italian project)\n- Nature Reviews Drug Discovery (UK), 1 October 2014\n[Momentum builds around new antibiotic business models](http://www.nature.com/nrd/journal/v13/n10/full/nrd4455.html)\n- The Independent (UK), 6 July 2014\n[The microbe is mightier than the market](http://www.independent.co.uk/voices/comment/the-microbe-is-mightier-than-the-market-9587052.html)(comment)\n- Financial Times (UK), 2 July 2014\n[Keep medicine out of the dark ages](http://www.ft.com/intl/cms/s/0/76d57ee0-01d6-11e4-ab5b-00144feab7de.html?siteedition=intl#axzz36OIDzHlC)(editorial)\n- RTBF \u2013 Matiere Grise (Belgium), 3 June 2014\n[Le combat des scientifiques contre les bact\u00e9ries mortelles](http://www.rtbf.be/tv/emission/detail_matiere-grise/actualites/article_envie-de-re-voir-ou-d-en-savoir-plus-sur-le-combat-des-scientifiques-contre-les-bacteries-mortelles-au-centre-de-matiere-grise?id=8283819&emissionId=65)(The fight of scientists against deadly bacteria)\n- Radio Rai (Italy), 25 May 2014\nIMI Stakeholder Forum 2014\n- The Economist (UK), 24 May 2014\n[Decentralising drug research](http://www.economist.com/news/business/21602689-why-row-over-giant-drug-company-takeovers-misses-point-pharmed-out?fsrc=rss)\n- Washington Post (US), 7 April 2014\n[What we need to do about antibiotic-resistant infections](http://www.washingtonpost.com/news/to-your-health/wp/2014/04/07/what-we-need-to-do-about-antibiotic-resistant-infections/)\n- El Pais (Spain), 17 March 2014\n[Curar las enfermedades de \u2018House\u2019](http://sociedad.elpais.com/sociedad/2014/03/17/actualidad/1395083912_279137.html)(Curing the diseases from \u2018House\u2019)\n- EurActiv (European), 21 February 2014\n[Public-private partnerships point way forward for brain research](http://www.euractiv.com/specialreport-brain-multiple-scl/public-private-partnerships-way-news-533679)\n- TV2 (Denmark), 18 February 2014\nNy antibiotika skal bek\u00e6mpe resistente bakterier (New antibiotics to combat resistant bacteria)\n- Deutsche-apotheker-zeitung (Germany), 14 February 2014\n[Geb\u00fcndelte Kr\u00e4fte f\u00fcr die Antibiotika-Forschung / Combined strengths for antibiotic research](http://www.deutsche-apotheker-zeitung.de/pharmazie/news/2014/02/14/gebuendelte-kraefte-fuer-die-antibiotika-forschung/12093.html)\n- Kauppalethi (Finland), 12 February 2014\n[Tiedote/Northern Antibiotics Oy: 85 miljoonan euron ohjelma uusien antibioottien kehitt\u00e4miseksi Euroopassa](http://www.kauppalehti.fi/5/i/yritykset/lehdisto/stt-info/tiedote.jsp?selected=kaikki&oid=20140201/13921922482430)(Data / Northern Antibiotics Ltd, 85 million program to develop new antibiotics in Europe)\n- Biotechnologia.pl (Poland), 12 February 2014\n[IMI \u2013 tego zazdroszcz\u0105 nam w USA. Rozmawiamy z Magd\u0105 Gunn, Scientific Project Manager w IMI JU](http://biotechnologia.pl/biotechnologia/aktualnosci/imi-tego-zazdroszcza-nam-w-usa-rozmawiamy-z-magda-gunn-scientific-project-manager-w-imi-ju,13658)(IMI - they envy us in the USA. We talk with Magda Gunn, Scientific Project Manager at IMI)\n- El Global (Spain), 12 February 2014\n[Universidades e industria europea se unen en la b\u00fasqueda de nuevos antibi\u00f3ticos](http://www.elglobal.net/noticias-medicamento/2014-02-12/industria-farmaceutica/universidades-e-industria-europea-se-unen-en-la-busqueda-de-nuevos-antibioticos/pagina.aspx?idart=815538)(Universities and European industry join the search for new antibiotics)\n- Aftonbladet (Sweden), 12 February 2014\n[Ny antibiotika tas fram i Uppsala](http://article.wn.com/view/2014/02/12/Ny_antibiotika_tas_fram_i_Uppsala/)(New antibiotics developed in Uppsala)\n- Dagbladet (Sweden), 12 February 2014\n[Ny antibiotika tas fram i Uppsala](http://www.dagbladet.se/alla)(New antibiotics developed in Uppsala)\n- Radio Sweden (Sweden), 12 February 2014\n[Uppsala on a mission to develop new antibiotics](http://sverigesradio.se/sida/artikel.aspx?programid=2054&artikel=5782537)\n- Mokslo Lietuva (Lithuania), 11 February 2014\n[Vilniaus inovacij\u0173 forume diskutuota apie inovacijas versle: nuo startuoli\u0173 iki klasteri\u0173](http://mokslolietuva.lt/2014/02/vilniaus-inovaciju-forume-diskutuota-apieinovacijas-versle-nuo-startuoliu-iki-klasteriu/)(Vilnius innovation forum discussion on innovation in business: from clusters to startups)\n- Poslovni Devnik (Croatia), 07 February 2014\n[Hrvatski znanstvenici pozvani na istra\u017eivanje novih lijekova](http://www.poslovni.hr/eu-fondovi/hrvatski-znanstvenici-pozvani-na-istrazivanje-novih-lijekova-263458)(Croatian scientists invited to explore new drugs)\n- Medical Tribune (Czech Republic), 27 January 2014\n[Jeden\u00e1ct\u00e1 v\u00fdzva IMI nab\u00eddne 4,7 miliardy korun](http://www.tribune.cz/clanek/32011-jedenacta-vyzva-imi-nabidne-miliardy-korun)(Eleventh IMI challenge offers 4.7 billion crowns)\n- EurActiv (European), 27 January 2014\n[MEPs vote for new public-private scheme for innovative medicines](http://www.euractiv.com/health/meps-agree-new-iniative-innovati-news-533011)\n- Lekarze i pielegniarki (Poland), 20 January 2014\n[Unia i firmy farmaceutyczne sfinansuj\u0105 projekty medyczne](http://prawo.rp.pl/artykul/1080477.html?print=tak&p=0)(The Union and the pharmaceutical companies will fund medical projects)\n- Rynekydrowia.pl (Poland), 17 January 2014\n[Finansowanie innowacji w medycynie z funduszy UE](http://www.rynekzdrowia.pl/Patronat/Finansowanie-innowacji-w-medycynie-z-funduszy-UE,137212.html)(Financing innovation in medicine from EU funds )\n- PMLive (UK), 16 January 2014\n[IMI appoints new chair of scientific committee](http://www.pmlive.com/pharma_appointments/imi_appoints_new_chair_of_scientific_committee_534108)\n- TV Ciencia (Portugal), 15 January 2014\n[Cientista portuguesa nomeada para presidir Comit\u00e9 Cient\u00edfico da Iniciativa Medicamentos Inovadores da UE](http://www.tvciencia.pt/tvcnot/pagnot/tvcnot03.asp?codpub=34&codnot=15)(Portuguese scientist appoitned as president of the EU Innovative Medicines Initiative)\n- Nature Medicine (UK), 07 January 2014\n[Infectious disease leads in first phase of Europe's IMI effort](http://www.nature.com/nm/journal/v20/n1/full/nm0114-5.html)\n- Focus (Germany), 02 January 2014\n[Tierversuche sollen dank Stammzellen \u00fcberfl\u00fcssig warden](http://www.focus.de/gesundheit/ratgeber/zukunftsmedizin/visionen/visionen-in-der-stammzellforschung-tierversuche-werden-dank-stammzellen-ueberfluessig_id_3494016.html)(Thanks to stem cells, animal experiments can be avoided)\n- MedNous (Europe), 23 December 2013\n[Genetic variants affect cognition](http://www.mednous.com/news/genetic-variants-affect-cognition)\n- Wall Street Journal (US), 30 December 2013\n[Researchers Aim to Speed Cures to Patients](http://online.wsj.com/news/articles/SB10001424052702304361604579290572010514840)\n- La Voz de Galicia (Spain), 23 December 2013\n[Los medicamentos que nos cambiar\u00e1n la vida / The medicines that will change our lives](http://www.lavozdegalicia.es/noticia/salud/2013/12/22/medicamentos-cambiaran-vida/0003_201312SX22P8991.htm)\n- Focus (Germany), 20 December 2013\n[Werden k\u00fcnftig Stammzellen am Flie\u00dfband produziert? Will stem cells be made made on a production line in the future?](http://www.focus.de/gesundheit/ratgeber/zukunftsmedizin/visionen/visionen-in-der-stammzellforschung-forscher-planen-stammzellenproduktion-am-fliessband_id_3493977.html)\n- Die Welt (Germany), 19 December 2013\n[Gesch\u00e4ft mit der Hoffnung bei Stammzellforschung Promising business in stem cell research](http://www.welt.de/gesundheit/article123116519/Geschaeft-mit-der-Hoffnung-bei-Stammzellforschung.html)\n- Nature (UK), 16 December 2013\n[Man versus microbe: warfare at its worst](http://www.nature.com/nrmicro/journal/v12/n1/full/nrmicro3188.html)\n- Zdravotnick\u00e9 noviny (Czech Republic), 16 December 2013 (print)\nInovativn\u00ed farmaceutick\u00e9 spole\u010dnosti nab\u00edzej\u00ed \u010desk\u00fdm v\u011bdc\u016fm pomocnou ruku / Innovative pharmaceutical companies offer Czech scientists a helping hand\n- BioCentury (US), 13 December 2013\n[IMI launching project for adaptive Alzheimer's trial](http://www.biocentury.com/dailynews/politics/2013-12-13/imi-launching-project-for-adaptive-alzheimers-trial)\n- Scrip (US), 11 December 2013\n[IMI to revolutionize the hunt for Alzheimer's drugs as part of \u20ac371m call](http://www.scripintelligence.com/home/IMI-to-revolutionize-the-hunt-for-Alzheimers-drugs-as-part-of-371m-call-348746)\n- European Biotechnology News (Europe), 11 December 2013\n[First adaptive Alzheimer trials](http://www.european-biotechnology-news.com/news/news/2013-04/imi-debuts-with-adaptive-alzheimer-trials.html)\n- MedWatch (Denmark), 11 December 2013\n[Trecifret millionbel\u00f8b bag IMI-satsning p\u00e5 Alzheimers / Three-digit million figure behind IMI focus on Alzheimer's](http://medwatch.dk/secure/Medicinal___Biotek/article6324679.ece)\n- ITV (UK), 10 December 2013\n[Dementia replaces cancer as disease people fear most](http://www.itv.com/news/2013-12-10/dementia-replaces-cancer-as-disease-people-fear-most/)\n- Financial Times (UK), 06 December 2013\n[Science: High-tech drug research gives us a fuller picture](http://www.ft.com/intl/cms/s/2/6661db3e-5c6e-11e3-931e-00144feabdc0.html#!)\n- Lietuvos Rytas (Lithuania), 06 December 2013 (print)\nVaist\u0173 gamintojams krypt\u012f rodo mokslas / Pharmaceutical manufacturers' direction of science\n- Belga Agency (Belgium), 02 December 2013 (print)\nEuropees project wil system ontwikkelen om veiligheid vaccins te kunnen onderzoeken / European project wants to develop system in order to be able to research vaccine safety\n- Agora Magazine (Italy), 02 December 2013\n[Nasce ADVANCE, progetto europeo per il monitoraggio dei benefici e rischi dei vaccine / ADVANCE, European project for vaccines benefits and risks monitoring, was created](http://www.agoramagazine.it/it/benessere-e-salute/cremona-nasce-advance-progetto-europeo-per-il-monitoraggio-dei-benefici-e-rischi-dei-vaccini.html)\n- European Files (Europe), December 2013 (print)\nIMI: Delivering results for patients\n- BioCentury (US), 27 November 2013\n[Stakeholders launch pan-Europe vaccine monitoring project](http://www.biocentury.com/dailynews/politics/2013-11-27/stakeholders-launch-pan-europe-vaccine-monitoring-project)\n- De Telegraaf (The Netherlands), 26 November 2013\n[Effect vaccinatie sneller in kaart / Effects of vaccination mapped faster](http://www.telegraaf.nl/gezondheid/actueel/22088894/__effect_vaccinatie_sneller_in_kaart__.html)\n- Corriere Della Sera (Italy), 26 November 2013\n[Vaccini, progetto europeo per monitorare benefici e rischi](http://www.corriere.it/salute/13_novembre_26/vaccini-progetto-europeo-monitorare-benefici-rischi-6259c4e0-56ae-11e3-9a32-8b8b5da15961.shtml)\n- SverigesRadio - Kropp & Sj\u00e4l (Sweden), 29 October 2013\n[Bakteriekriget / Bacterial war](http://sverigesradio.se/sida/avsnitt/273344?programid=1272)\n- Scrip (US), 29 October 2013\n[IMI offers \u20ac12.2m for better ways of testing effectiveness of flu vaccines](http://www.scripintelligence.com/policyregulation/IMI-offers-12.2m-for-better-ways-of-testing-effectiveness-of-flu-vaccines-347693)\n- Financial Times (UK), 17 October 2013\n[Collaboration: University ties with industry offer mutually assured development](http://www.ft.com/intl/cms/s/0/27997fa4-2a9d-11e3-8fb8-00144feab7de.html#axzz2j0p3InnA)\n- Financial Times (UK), 17 October 2013\n[Doctor prescribes boost for biomedicine in EU](http://on.ft.com/18nNoYd)\n- Arzt Aspekte (Germany), 25 September 2013\n[Schmerztherapie: so fr\u00fch wie m\u00f6glich \u2013 um Ver\u00e4nderungen des Gehirns vorzubeugen / Pain management: as early as possible - in order to prevent changes in the brain](http://www.arzt-aspekte.de/Schmerztherapie-so-frueh-wie-moeglich-um-Veraenderungen-des-Gehirns-vorzubeugen_43308.html)\n- Medical Tribune (Czech Republic), 23 September 2013\n[Jak \u00fasp\u011b\u0161n\u011b \u017e\u00e1dat o evropsk\u00e9 dotace na v\u011bdu a v\u00fdzkum?/ How to apply for European funding in science and research successfully?](http://www.tribune.cz/clanek/30995)\n- La Stampa (Italy), 06 September 2013\n[Sos antibiotici: li usiamo cos\u00ec male che molti sono diventati inutili / Sos antibiotics: we use them so bad that many are becoming useless](http://www.lastampa.it/2013/09/06/scienza/tuttoscienze/sos-antibiotici-li-usiamo-cos-male-che-molti-sono-diventati-inutili-baLvniqyn8ktRAUoLE5xiM/pagina.html)\n- Agentschap NL (The Netherlands), 29 August 2013\n[Astma is persoonlijk \u2013 de behandeling ook / Asthma is personal - as is the treatment](http://www.agentschapnl.nl/actueel/nieuws/astma-persoonlijk-)\n- Financial Times (UK), 12 August 2013\n[Pharmaceuticals: Back to the lab](http://www.ft.com/cms/s/0/e5679dae-e565-11e2-ad1a-00144feabdc0.html#axzz2fin1DcIk)\n- EKT (Greece), 29 July 2013\n[\u03a0\u03b5\u03c1\u03b9\u03c3\u03c3\u03cc\u03c4\u03b5\u03c1\u03b1 \u03b1\u03c0\u03cc 22 \u03b4\u03b9\u03c3. \u03b5\u03c5\u03c1\u03ce \u03b5\u03c0\u03b5\u03bd\u03b4\u03cd\u03bf\u03c5\u03bd \u03b7 \u0395\u0395 \u03ba\u03b1\u03b9 \u03b7 \u03b5\u03c5\u03c1\u03c9\u03c0\u03b1\u03ca\u03ba\u03ae \u03b2\u03b9\u03bf\u03bc\u03b7\u03c7\u03b1\u03bd\u03af\u03b1 \u03c3\u03c4\u03b7\u03bd \u03ad\u03c1\u03b5\u03c5\u03bd\u03b1 \u03ba\u03b1\u03b9 \u03c4\u03b7\u03bd \u03ba\u03b1\u03b9\u03bd\u03bf\u03c4\u03bf\u03bc\u03af\u03b1 / More than 22 billion invested by the EU and European industry in research and innovation](http://www.ekt.gr/content/display?prnbr=87292)\n- Medical Tribune (Czech Republic), 15 July 2013\n[IMI: otev\u0159en\u00e1 p\u0159\u00edle\u017eitost pro \u0161pi\u010dkov\u00e9 odborn\u00edky / IMI: open opportunities for leading experts](http://www.tribune.cz/clanek/30537-imi-otevrena-prilezitost-pro-spickove-odborniky)\n- Science (US), 12 July 2013\n[E.U. Commission Beefs up Research Partnerships with Industry](http://news.sciencemag.org/2013/07/e.u.-commission-beefs-research-partnerships-industry)\n- Eye for Pharma (international), 11 July 2013\n[IMI Call for Social Media Detection of Adverse Events](http://social.eyeforpharma.com/epharma/imi-call-social-media-detection-adverse-events)\n- Aifp.cz (Czech Republic), 11 July 2013\n[Dev\u00e1t\u00e1 v\u00fdzva IMI nab\u00edz\u00ed v\u011bdc\u016fm a\u017e 3,6 miliard korun na v\u00fdvoj nov\u00fdch l\u00e9\u010div / IMI offers researchers up to 3.6 billion for the development of new drugs](http://www.aifp.cz/cz/clanek-detail.php?clanek=555)\n- Euractiv (Europe) , 11 July 2013\n[EU, industry to invest \u20ac22 billion in research and innovation](http://www.euractiv.com/specialreport-innovation-digital/eu-industry-invest-22-research-i-news-529214)\n- Times Higher Education (UK), 10 July 2013\n[European cash injection for innovation](http://www.timeshighereducation.co.uk/news/european-cash-injection-for-innovation/2005698.article)\n- Apifarma.pt (Portugal), 10 July 2013\n[Comiss\u00e3o Europeia lan\u00e7a Innovative Medicines Initiative 2 / European Commission Launches Innovative Medicines Initiative 2](http://www.apifarma.pt/salaimprensa/noticias/Paginas/Comiss.aspx)\n- Pharma Times (international), 10 July 2013\n[EU/industry IMI: new 135M-euro call for proposals](http://www.pharmatimes.com/Article/13-07-10/EU_industry_IMI_new_135M-euro_call_for_proposals.aspx)\n- Science Business (Europe), 10 July 2013\n[Commission unveils plans for \u20ac9B of Horizon 2020 budget](http://www.sciencebusiness.net/news/76203/Commission-unveils-plans-for-)\n- Inovacijos (Lithuania), 04 July 2013\n[Naujovi\u0161k\u0173 vaist\u0173 iniciatyva planuoja 9-\u0105j\u012f kvietim\u0105 / The Innovative Medicines Initiative is planning to 9th call](http://www.inovacijos.lt/lt/naujiena/id/naujovik_vaist_iniciatyva_planuoja__j_kvietim/)\n- HaziPatika (Hungary), 13 June 2013\n[A j\u00f6v\u0151 gy\u00f3gyszereit ma fejlesztik / The future of medicines being developed today](http://www.hazipatika.com/eletmod/tudomanyos_erdekessegek/cikkek/a_jovo_gyogyszereit_ma_fejlesztik/20130613172913)\n- SLAS Electronic Laboratory Neighborhood (US), 28 May 2013\n[European Lead Factory: An Open Innovation Experiment in Drug Discovery](http://eln.slas.org/story/1/98-european-lead-factory-an-open-innovation-experiment-in-drug-discovery)\n- Irish Examiner (Ireland), 28 May 2013\n[Understanding the brain is in all our interests](http://www.irishexaminer.com/analysis/understanding-the-brain-is-in-all-our-interests-232549.html)\n- Pharmanews (Europe), 28 May 2013\n[NEWMEDS unites researchers to speed the quest for schizophrenia and depression treatments](http://www.pharmanews.eu/research-and-development/1278-newmeds-unites-researchers-to-speed-the-quest-for-schizophrenia-and-depression-treatments)\n- Diario Medico (Spain), 27 May 2013\n[Los emprendedores son esenciales/ Entrepreneurs are essential](http://www.diariomedico.com/2013/05/27/area-profesional/gestion/emprendedores-esenciales)\n- Eesti P\u00e4evaleht (Estonia), 25 May 2013\n[Euroopa Liit koondab joud ajuhaiguste vastu / The European Union joined forces on brain disease](http://ajaleht.epl.ee/digi/2169#!p/41)\n- Medical Independent (Ireland), 23 May 2013\n[Paternal age may have autism link](http://www.medicalindependent.ie/28441/paternal_age_may_have_autism_link)\n- Pharmanews (Europe), 23 May 2013\n[Pharma-Cog and EMIF-AD projects bring Alzheimer's treatments closer to reality](http://www.pharmanews.eu/research-and-development/1275-pharma-cog-and-emif-ad-projects-bring-alzheimers-treatments-closer-to-reality)\n- Pharmanews (Europe), 14 May 2013\n[EUROPAIN addresses challenges in the treatment of chronic pain](http://www.pharmanews.eu/research-and-development/1271-europain-addresses-challenges-in-the-treatment-of-chronic-pain)\n- Euractiv (Europe), 14 May 2013\n[EU calls for more research into \u2018complex brain\u2019](http://www.euractiv.com/health/european-research-complex-brain-news-519685)\n- RTBF (Belgium), 14 May 2013\n[Envie d'en savoir plus sur : \"Sur les traces de l'autisme g\u00e9n\u00e9tique\"](http://www.rtbf.be/tv/actualite/detail_envie-d-en-savoir-plus-sur-sur-les-traces-de-l-autisme-genetique?id=7994614)\n- Gazeta dla Lekarzy (Poland), 12 May 2013\n[Innovative Medicine Initiative Stakeholder Forum](http://gazeta-dla-lekarzy.com/index.php/nowosci/8-artykuly-gdl/17-innovative-medicine-initiative-stakeholder-forum)\n- 1 Czerwca (Poland), 26 April 2013\n[Szkolenia dla pacjent\u00f3w w ramach projektu EUPATI / Training for patients in the project EUPATI](http://www.1czerwca.pl/index.php?option=com_content&view=article&id=160:szkolenia-dla-pacjentow-w-ramach-projektu-eupati&catid=36:aktualnoci&Itemid=63)\n- Quotidiano Sanita (Italy), 19 April 2013\n[Il progetto Eupati. Pazienti pi\u00f9 \"informati\" per incidere su ricerca e autorizzazione nuovi farmaci / The project EUPATI. Patients more \"informed\" to influence research and new drug approval](http://www.quotidianosanita.it/scienza-e-farmaci/articolo.php?articolo_id=14519)\n- Nature Careers (UK), 17 April 2013\n[Regulatory science: Researchers in the pipeline](http://www.nature.com/naturejobs/science/articles/10.1038)\n- Science (US), 12 April 2013\n[Opening Industry-Academic Partnerships](http://sciencecareers.sciencemag.org/career_magazine/previous_issues/articles/2013_04_12/science.opms.r1300132)\n- Chemistry World (UK), 13 March 2013\n[Antibiotic resistance is a \u2018ticking time bomb\u2019](http://www.rsc.org/chemistryworld/2013/03/antibiotic-resistance-ticking-time-bomb)\n- EurActiv (Europe), 13 March 2013\n[EU body may provide \u2018solution\u2019 to antibiotics resistance threat, says UK medical chief](http://www.euractiv.com/health/uk-chief-medical-officer-eu-fund-news-518442)\n- The Guardian (UK), 11 March 2013\n[New wave of 'superbugs' poses dire threat, says chief medical officer](http://www.guardian.co.uk/society/2013/mar/11/superbugs-antibiotics-bacterial-diseases-infections)\n- BBC (UK), 11 March 2013\n[Antibiotics resistance 'as big a risk as terrorism' - medical chief](http://www.bbc.co.uk/news/health-21737844)\n- Independent (Ireland), 11 March 2013\n[Resistance to antibiotics risks health 'catastrophe' to rank with terrorism and climate change](http://www.independent.ie/lifestyle/health/resistance-to-antibiotics-risks-health-catastrophe-to-rank-with-terrorism-and-climate-change-29122012.html)\n- Talouselama (Finland), 11 March 2013\n[Globaali aikapommi uhkaa terveydenhoidossa - \"samanlainen kansakunnan uhka kuin terrorismikin\" / Global time bomb threatening to health care - \"similar to the nation as the threat of terrorism\"](http://www.talouselama.fi/uutiset/globaali+aikapommi+uhkaa+terveydenhoidossa++samanlainen+kansakunnan+uhka+kuin+terrorismikin/a2174061?s=r)\n- Profesia Pravda (Slovakia), 5 March 2013\n[Univerzita Komensk\u00e9ho prispieva k \u0161pi\u010dkov\u00e9mu vzdel\u00e1vaniu o liekoch / University contributes to the excellent education about medicines](http://profesia.pravda.sk/studium/clanok/273092-uk-je-v-konzorciu-10-univerzit-pre-spickove-vzdelavanie-o-liekoch/)\n- Deutsche Welle - Spectrum (Germany), 4 March 2013\n[Make drugs not war](http://www.dw.de/spectrum-make-drugs-not-war-2013-03-04/e-16561624)\n- S\u00fcedkurier (Germany), 18 February 2013\n[Infos \u00fcber Pharmabranche](http://www.suedkurier.de/region/hochrhein/kreis-loerrach/Infos-ueber-Pharmabranche;art372585,5912956?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed+suedkurier-kreis-loerrach+.de+-+Kreis+L)\n- Scrip Intelligence (US), 11 February 2013\n[Bayer leads seven Big Pharmas in \u20ac196m European Lead Factory](http://www.scripintelligence.com/home/Bayer-leads-seven-Big-Pharmas-in-196m-European-Lead-Factory-339886)\n- Medical Tribune (Czech Republic), 11 February 2013\n[IMI \u2013 cesta k partnerstv\u00ed p\u0159i v\u00fdzkumu i realizaci / IMI - the path to partnership in research and implementation](http://www.tribune.cz/clanek/29162-imi-cesta-k-partnerstvi-pri-vyzkumu-i-realizaci)\n- European Biotechnology News (Europe), 8 February 2013\n[IMI launches \u20ac196m project](http://www.eurobiotechnews.eu/news/news/2013-01/imi-launches-eur196m-project/pos/2.html)\n- Fierce Biotech (US), 7 February 2013\n[\u20ac196 million pan-European drug discovery platform launched](http://www.fiercebiotech.com/press-releases/196-million-pan-european-drug-discovery-platform-launched)\n- Scottish Government (UK), 7 February 2013\n[Lanarkshire and Dundee in \u00a3100M life science project](http://www.scotland.gov.uk/News/Releases/2013/02/lanarkshire-and-dundee-in-life-science-project0702)\n- Nature (UK), 7 February 2013\n[Europe bets on drug discovery](http://www.nature.com/news/europe-bets-on-drug-discovery-1.12372)\n- Reuters (UK), 7 February 2013\n[Drugmakers, academics pool R&D in $265 mln EU project](http://www.reuters.com/article/2013/02/07/pharmaceuticals-europe-rd-idUSL5N0B65QD20130207)\n- BBC (UK), 7 February 2013\n[Scottish consortium wins \u00a3100m drug research contract](http://www.bbc.co.uk/news/uk-scotland-scotland-business-21366197)\n- Nature Biotechnology (UK), 7 February 2013\n[Industry backs biocatalysis for greener manufacturing](http://www.nature.com/nbt/journal/v31/n2/full/nbt0213-95.html)\n- The Guardian (UK), 27 January 2013\n[Science funding and the EU: you've got to be in it to win it](http://www.guardian.co.uk/science/2013/jan/27/europe-science-funding-paul-nurse?INTCMP=SRCH)\n- BioCentury (US), 24 January 2013\n[IMI's collaborative chemistry](http://www.biocentury.com/scibx/translationalnotes/2013-01-24/translational-notes-imis-collaborative-chemistry-s4a)\n- Nature Biotechnology (UK), January 2013\n[Banking iPS cells](http://www.nature.com/nbt/journal/v31/n1/full/nbt0113-11.html)\n- Nature Reviews Drug Discovery (UK), January 2013\n[News and Analysis - 2012 in reflection](http://www.nature.com/nrd/journal/v12/n1/full/nrd3927.html)\n- Pharmatimes, published online December 2012\n[IMI and rethinking the R&D paradigm](http://www.pharmatimes.com/magazine/latest%20issue/dec/pp22.pdf)\n- Pan European Networks, published online 11 December 2012\n[Innovative injections](http://www.paneuropeannetworks.com/science-and-technology.html)\n- British Medical Journal, published online 7 December 2012\n[New \u20ac55.6m European project will use stem cells to increase understanding of diseases](http://www.bmj.com/content/345/bmj.e8325)\n- Financial Times, published online 5 December 2012\n[UK to lead stem cell research project](http://www.ft.com/cms/s/77f4c16c-3ee8-11e2-a095-00144feabdc0,Authorised=false.html?_i_location=http.ft.com.html&_i_referer=)\n- The Wall Street Journal, published online 5 December 2012\n[Drug Makers, Universities Team Up on Stem Cells](http://online.wsj.com/article/SB10001424127887323316804578161390654183194.html?mod=googlenews_wsj)\n- Reuters, 5 December 2012\n[European stem cell bank aims to speed drug development](http://uk.reuters.com/article/2012/12/05/health-stemcells-bank-idUKL5E8N59Q620121205)\n- Nature, News Blog, 5 December 2012\n[\u20ac50 million project aims to produce 1,500 stem cell lines for drug discovery](http://blogs.nature.com/news/2012/12/e50-million-project-aims-to-produce-1500-stem-cell-lines-for-drug-discovery.html)\n- MedNous, November/December 2012\n[As Big Pharma pulls back, IMI steps in](/sites/default/files/uploads/documents/news-events/imi-in-the-media/MEDNOUS_Nov_Dec_2012.pdf)\n- Deutschland Radio Kultur, 8 November 2012\n[Interview with Michel Goldman about antimicrobial resistance](http://www.dradio.de/dkultur/sendungen/forschungundgesellschaft/1914839/)\n- European Voice, November 2012\n[Public-private partnerships are the way forward to improve drug safety \u2013 the example of the Innovative Medicines Initiative](http://www.europeanvoice.com/)\n- Deutsch Welle, October 2012\n[New future with pre-competitive science](http://www.dw.de/spectrum-the-drugs-industry-dont-work-2012-10-22/e-16205549#16324068)\n- Nature Biotechnology, 7 August 2012\n[Incentives aim to boost antibiotic development](http://www.nature.com/nbt/journal/v30/n8/full/nbt0812-735a.html)\n- The Lancet, 15 June 2012\n[Europe to boost development of new antimicrobial drugs](http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(12)60964-7/fulltext)\n- Biocentury, 4 June 2012\n[Innovating Antibiotics](http://www.biocentury.com/biotech-pharma-news/coverstory/2012-06-04/why-imi-launched-eu-industry-consortium-to-transform-antibiotic-development-a1)\n- Parliament Magazine, 28 May 2012\n[Joint Action](http://www.theparliament.com/fileadmin/theParliament/pdfs/PM_29_may_2012.pdf)\n- Financial Times, 27 May 2012\n[Public health: Raised resistance](http://www.ft.com/intl/cms/s/a796ecc0-a644-11e1-9453-00144feabdc0,Authorised=false.html?_i_location=http.ft.com.html&_i_referer=#axzz1wBolAaEu)\n- RTBF, 25 May 2012\n[Les bact\u00e9ries, Le Point avec l\u2019invit\u00e9 Dr. Michel Goldman](http://www.rtbf.be/video/v_les-bacteries-le-point-avec-l-invite-dr-michel-goldman?id=1731997&category=info)\n- SkyNews, 24 May 2012\n[Drug Companies Unite in Battle Against Bugs](http://news.sky.com/home/uk-news/article/16234353)\n- The Wall Street Journal, 24 May 2012\n[EU joins widening push to find new antibiotics](http://online.wsj.com/article/SB10001424052702304707604577423683954355876.html)\n- The Guardian, 24 May 2012\n[GlaxoSmithKline and AstraZeneca invest in biotech research](http://www.guardian.co.uk/business/2012/may/24/glaxosmithkline-astrazeneca-antibiotic-research)\n- The Times, 24 May 2012\n[Drugs giants put rivalries aside to tackle the scourge of the superbug](http://www.thetimes.co.uk/tto/public/sitesearch.do?querystring=Drugs+giants+put+rivalries+aside+to+tackle+the+scourge+of+the+superbug&p=tto&pf=all&bl=on)\n- Nature News, 24 May 2012\n[Europe targets superbugs with public-private effort](http://blogs.nature.com/news/2012/05/europe-targets-superbugs-with-public-private-effort.html)\n- Scrip, 24 May 2012\n[IMI launches \u20ac224m R&D programme to tackle antibiotics resistance](http://www.scripintelligence.com/home/IMI-launches-224m-RandD-programme-to-tackle-antibiotic-resistance-330955)\n- Parliament Magazine, 10 May 2012\n[Public private partnerships key to growth of EU pharma research](http://www.theparliament.com/latest-news/article/newsarticle/public-private-partnerships-key-to-growth-of-eu-pharma-research/)\n- Science-Business eXchange, 10 May 2012\n[A mind for precompetitive collaboration](http://www.nature.com/scibx/journal/v5/n19/full/scibx.2012.483.html)\n- Science-Business eXchange, 19 April 2012\n[Building tools against autism](http://www.nature.com/scibx/journal/v5/n16/full/scibx.2012.406.html)\n- Nature Medicine, 5 April 2012\n[Europe plans molecular screening center for translational research](http://www.nature.com/nm/journal/v18/n4/full/nm0412-477a.html)\n- Science-Business eXchange, 29 March 2012\n[IMI's leadoff hitter](http://www.biocentury.com/scibx/publicprivateinterface/2012-03-29/public-private-interface-imis-leadoff-hitter-s8?utm)\n- Nature, 27 March 2012\n[Chemistry\u2019s web of data expands](http://www.nature.com/news/chemistry-s-web-of-data-expands-1.10328)\n- InPharm, 12 March 2012\n[UCB chief executive to chair IMI](http://www.inpharm.com/appointment/171711/ucb-chief-executive-chair-imi)\n- SCRIP Intelligence, 8 March 2012\n[Seven pharma fuel \u20ac170m EU-wide screening honeypot](http://www.scripintelligence.com/home/Bayer-Janssen-M-S-AZ-Sanofi-Lundbeck-UCB-fuel-170M-EU-wide-screening-honeypot-327832)\n- Pharma Times, 8 March 2012\n[IMI to set up European Lead Factory for new drug opportunities](http://www.pharmatimes.com/Article/12-03-08/IMI_to_set_up_European_Lead_Factory_for_new_drug_opportunities.aspx)\n- Pharma Times, 8 March 2012\n[UCB chief Doliveux to head IMI](http://www.pharmatimes.com/Article/12-03-08/UCB_chief_Doliveux_to_head_IMI.aspx)\n- PharmaNews, 8 March 2012\n[IMI funds platform to discover new medicines](http://www.pharmanews.eu/research-and-development/1012-imi-funds-platform-to-discover-new-medicines)\n- PMLiVE, 7 March 2012\n[Europe's IMI plans compound library and screening centre](http://www.pmlive.com/pharma_news/innovative_medicines_initiative_pharma_companies_compound_screening_390168)\n- Microbiology Today, February 2012 (p.55)\n[IMI to launch major antimicrobial resistance project](http://mag.digitalpc.co.uk/fvx/sgm/mbt/1202/)\n- Science Translational Medicines, February 2012\n[Recalibrating Intellectual Property Rights to Enhance Translational Research Collaborations](http://stm.sciencemag.org/content/4/122/122cm3.abstract)\n- Nature, 12 January 2012\n[Rules tighten on use of antibiotics on farms](http://www.nature.com/news/rules-tighten-on-use-of-antibiotics-on-farms-1.9761)\n- Innovation Excellence, 6 January 2012\n[Open Innovation, Technology Platforms and a New Business Model- All-in-One Biggie!](http://paul4innovating.com/2012/01/05/open-innovation-technology-platforms-and-a-new-business-model-all-in-one-biggie/)\n- Pharma Times, 20 December 2011\n[IMI, CDISC hook up for standardised data management](http://www.pharmatimes.com/Article/11-12-20/IMI_CDISC_hook_up_for_standardised_data_management.aspx)\n- Scrip Intelligence, 9 December 2011\n[EU launches \u20ac80bn R&D plan to cut red tape, create jobs and boost competitiveness](http://www.scripintelligence.com/policyregulation/EU-launches-80bn-RandD-plan-to-cut-red-tape-create-jobs-and-boost-competitiveness-324271)\n- Pharmacuetical Market Europe, 6 December 2011\n[Interview: Michel Goldman, Innovative Medicines Initiative](http://www.pmlive.com/find_an_article/allarticles/categories/General/2011/december_2011/features/interview_michel_goldman,_innovative_medicines_initiative)\n- TV5Monde, 3 December 2011\n[Bar de l'Europe](http://www.tv5.org/cms/chaine-francophone/Revoir-nos-emissions/Le-Bar-de-l-Europe/Episodes/p-19201-Michel-Goldman.htm)\n- Pharmaceutical Market Europe, December 2011\n[Interview: Michel Goldman, Innovative Medicines Initiative](http://www.pmlive.com/find_an_article/allarticles/categories/General/2011/december_2011/features/interview_michel_goldman,_innovative_medicines_initiative)\n- Nature Reviews Drug Discovery, December 2011\n[Expanding precompetitive space](http://www.nature.com/nrd/journal/v10/n12/full/nrd3602.html)(editorial)\n- Science Business, 23 November 2011\n[Commission lures pharma industry back into antibiotics](http://bulletin.sciencebusiness.net/news/75558/Commission-lures-pharma-industry-back-into-antibiotics)\n- Nature, 22 November 2011\n[Antibiotic resistance marching across Europe](http://www.nature.com/news/antibiotic-resistance-marching-across-europe-1.9413)\n- Parliament Magazine, 21 November 2011\n[Joint technology initiatives: Maria da Gra\u00e7a Carvalho](http://www.theparliament.com/latest-news/article/newsarticle/joint-undertaking-1/)\n- Scrip Intelligence, 18 November 2011\n[IMI plans \"unprecedented\" programme for novel antibiotics as drug resistance continues to rise](http://www.scripintelligence.com/policyregulation/IMI-plans-unprecedented-programme-for-novel-antibiotics-as-drug-resistance-continues-to-rise-323819)\n- Reuters, 17 November 2011\n[Europe kickstarts R&D fightback against superbugs](http://www.reuters.com/article/2011/11/17/antibiotic-superbugs-europe-idUSL5E7MH2A420111117)\n- European Federation of Neurological Associations (EFNA), Autumn 2011\n[Innovative Medicines Initiative (IMI): A revolution in the drug development world](http://efna.net/pdfs/publications/ScienceAndSociety/S_S%20Issue%2004.pdf)\n- European Voice, 22 September 2011\n[Pushing at the doors of innovation](http://www.europeanvoice.com/article/imported/pushing-at-the-doors-of-innovation/72090.aspx)\n- Pharmaceutiques, September 2011\n[L\u2019Initiative medicaments innovants (IMI)](http://www.pharmaceutiques.com/)\n- Trends, 1 September 2011\n[L'IMI, l'agence qui dessine la m\u00e9decine de demain](http://trends.levif.be/economie/magazine/magazines/01-09-2011/#)\n- BioCentury TV, 31 July 2011\n[Public + Private Part 2: Turning Great Science into Medicine -- and Jobs](http://www.biocenturytv.com/fullplayer.aspx#/BC+Show+46+Public+Part+2/BioCentury+07.31.11+++California+Stem+Cells/608459720001/1086638620001/1086689179001)\n- Nature Reviews Drug Discovery, August 2011\n[Partnering between pharma peers on the rise](http://www.nature.com/nrd/journal/v10/n8/full/nrd3526.html)\n- Scrip Intelligence, 1 August 2011\n[EU firms targeted in calls for new biomarkers and drug development tools](http://www.scripintelligence.com/home/EU-firms-targeted-in-calls-for-new-biomarkers-and-drug-development-tools-319238)\n- BioCentury TV, 24 July 2011\n[Public + Private: Turning great science into medicine \u2013 and Jobs](http://www.biocenturytv.com/fullplayer.aspx#/BC+Private/BioCentury.24.11[1]/608459720001/1074206634001/1074418586001)\n- Science Business, 22 July 2011\n[Patients take control of innovation](http://bulletin.sciencebusiness.net/news/75297/Patients-take-control-of-innovation)\n- Scrip Intelligence, 15 June 2011\n[EU IMI and US Critical Path avoid duplication](http://www.scripintelligence.com/policyregulation/EU-IMI-and-US-Critical-Path-avoid-duplication-317187)\n- Science Business, 15 June 2011\n[EU\u2019s Innovative Medicines Initiative to collaborate with FDA\u2019s Critical Path](http://www.sciencebusiness.net/news/75170/EU)\n- Pharma Times, 15 June 2011\n[US and EU link faster pharma R&D initiatives](http://www.pharmatimes.com/article/11-06-15/US_and_EU_link_faster_pharma_R_D_initiatives.aspx)\n- Projects, June 2011 (Issue 24)\n[A new wave of innovative drugs projects](http://viewer.zmags.com/publication/dc678def#/dc678def/16)(pp. 14-16)\n- HealthTechWire, 13 May 2011\n[What is coming next at IMI?](http://www.healthtechwire.com/PremiumPro-Single.244+M57649e252f9.0.html)\n- BMJ, 10 March 2011\n[Europe provides \u20ac172m for research into innovative medicines](http://www.bmj.com/content/342/bmj.d1577.extract)\n- La Libre Belgique, 9 March 2011\n[L\u2019union sacr\u00e9e du secteur pharma](http://www.lalibre.be/economie/actualite/article/647621/l-union-sacree-du-secteur-pharma.html)\n- Nature, 11 November 2010\n[The drug deadlock](http://www.nature.com/news/2010/101110/full/468158a.html)\n- Financial Times, 11 June 2010\n[Drug companies pool Alzheimer\u2019s information](http://www.ft.com/cms/s/0/ed4ed88a-74f6-11df-aed7-00144feabdc0.html)\n- Wallstreet Online DE, 15 June 2010\n[Joint Venture zwischen EU und Pharmaindustrie erm\u00f6glicht 15 Projekte zur Erforschung schwerer Krankheiten](http://www.wallstreet-online.de/nachricht/2965462-joint-venture-zwischen-eu-und-pharmaindustrie-ermoeglicht-15-projekte-zur-erforschung-schwerer-krankheiten)\n- International Innovation, 6 May 2010\n[Michel Goldman, Executive Director of Innovative Medicines Initiative (IMI)](http://www.research-europe.com/index.php/2010/05/michel-goldman-executive-director-of-innovative-medicines-initiative-imi/)\n- Irish Times, 3 March 2010\n[Dip your toe in](http://www.irishtimes.com/newspaper/innovation/2010/0305/1224265343581.html)\n- Chemical and Engineering News, 22 February 2010\n[Cracking the Tough Ones](http://pubs.acs.org/cen/coverstory/88/8808cover.html)\n- El Medico, January 2010\n[La Iniciative de Medicamontos Innovadores, un empuje a la investigaci\u00f3n europea en f\u00e1rmacos](http://www.elmedicointeractivo.com/)\n- Scrip Intelligence, 17 September 2009\n[Innovative Medicines Initiative to save pharma's floundering R&D model](http://www.scripintelligence.com/home/Innovative-Medicines-Initiative-to-save-pharmas-floundering-RandD-model-176849)\n- Euractiv, 15 September 2009\n[EU to inject millions into developing innovative medicines](http://www.euractiv.com/en/innovation/eu-inject-millions-developing-innovative-medicines/article-185427)\n- Nature Reviews Drug Discovery, July 2009\n[Novel consortium to address shortfall in innovative medicines for psychiatric disorders](http://www.nature.com/nrd/journal/v8/n7/full/nrd2939.html)\n- Nature, 20 May 2009\n[Flagship drug-development initiative picks projects](http://www.nature.com/news/2009/090520/full/news.2009.499.html)", "language": null, "image": "http://www.imi.europa.eu/themes/custom/imi/images/seo/budget.jpg", "pagetype": "website", "links": ["#main-content", "/", "javascript:void(0);", "/", "/about-imi", "#", "/about-imi/mission-objectives", "/about-imi/how-imi-works", "/about-imi/imi-funding-model", "/about-imi/strategic-research-agenda", "/about-imi/history-imi-story-so-far", "/news-events/10-years-transforming-medical-research", "/about-imi/innovative-health-initiative", "/about-imi/reference-documents", "/about-imi/governance", "/about-imi/governance/governing-board", "/about-imi/governance/strategic-governing-groups", "/about-imi/governance/executive-director", "/about-imi/governance/programme-office", "/about-imi/governance/scientific-committee", "/about-imi/governance/states-representatives-group", "/about-imi/governance/imi-stakeholder-forum", "/get-involved", "#", "/get-involved/how-get-involved", "/get-involved/submit-your-ideas", "/get-involved/smes", "/get-involved/smes/testimonials", "/get-involved/academia", "/get-involved/academia/testimonials", "/get-involved/patients", "/get-involved/patients/testimonials", "/get-involved/patients/imi-pool-patient-experts", "/get-involved/regulators-htas-and-payers", "/get-involved/associated-partners", "/get-involved/industry", "/get-involved/industry/testimonials", "/apply-funding", "#", "/apply-funding/general-overview", "/apply-funding/imi-call-process", "/apply-funding/general-overview/tips-applicants", "/apply-funding/general-overview/intellectual-property", "/apply-funding/general-overview/finding-partners", "/apply-funding/general-overview/get-support", "/apply-funding/future-topics", "/apply-funding/open-calls", "/apply-funding/closed-calls", "/apply-funding/closed-calls/imi2-call-23", "https://www.imi.europa.eu/apply-funding/closed-calls/imi2-call-22", "/apply-funding/closed-calls/imi2-call-21", "/apply-funding/closed-calls/imi2-call-20", "/apply-funding/closed-calls/imi2-call-19", "/apply-funding/closed-calls/imi2-call-18", "/apply-funding/closed-calls/imi2-call-17", "/apply-funding/open-calls/imi2-call-16", "/apply-funding/closed-calls/imi2-call-15", "/apply-funding/closed-calls/imi2-call-14", "/apply-funding/open-calls/imi2-call-13", "/apply-funding/closed-calls/imi2-call-12", "/apply-funding/open-calls/imi2-call-11", "/apply-funding/closed-calls/imi2-call-10", "/apply-funding/closed-calls/imi2-call-9", "/apply-funding/closed-calls/imi2-call-8", "/apply-funding/closed-calls/imi2-call-7", "/apply-funding/closed-calls/imi2-call-6", "/apply-funding/closed-calls/imi2-call-5", "/apply-funding/closed-calls/imi2-call-4", "/apply-funding/closed-calls/imi2-call-3", "/apply-funding/closed-calls/imi2-call-2", "/apply-funding/closed-calls/imi2-call-1", "/apply-funding/closed-calls/imi1-call-11", "/apply-funding/closed-calls/imi1-call-10", "/apply-funding/closed-calls/imi1-call-9", "/apply-funding/closed-calls/imi1-call-8", "/apply-funding/closed-calls/imi1-call-7", "/apply-funding/closed-calls/imi1-call-6", "/apply-funding/closed-calls/imi1-call-5", "/apply-funding/closed-calls/imi1-call-4", "/apply-funding/closed-calls/imi1-call-3", "/apply-funding/closed-calls/imi1-call-2", "/apply-funding/closed-calls/imi1-call-1", "/apply-funding/call-documents", "/apply-funding/call-documents/imi1-call-documents", "/apply-funding/call-documents/imi2-call-documents", "/projects-results", "#", "/projects-results/project-factsheets", "/projects-results/success-stories-projects", "/projects-results/maps-statistics", "/projects-results/imi-impact-series", "/projects-results/catalogue-project-tools", "/news-events", "#", "/news-events/newsroom", "/news-events/newsletter", "/news-events/events", "/news-events/press-releases", "/news-events/imi-media", "/news-events/scientific-publications-imi", "/news-events/newsletter", "/resources-projects", "#", "/resources-projects/project-communications", "/resources-projects/guidelines-engaging-regulators", "/resources-projects/project-dissemination", "/resources-projects/project-reporting-documents", "/resources-projects/open-access-and-data-management-projects", "/resources-projects/exploitation-project-results", "javascript:void(0);", "/", "/news-events", null, "https://www.facebook.com/sharer.php?u=http://www.imi.europa.eu/news-events/imi-media", "https://twitter.com/share?text=IMI in the media&url=http://www.imi.europa.eu/news-events/imi-media&via=IMI", "https://www.linkedin.com/shareArticle?url=http://www.imi.europa.eu/news-events/imi-media&title=IMI in the media", "#", "#media-coverage-highlights-collapsible-12", "https://neurosciencenews.com/genetic-amyloid-alzheimers-17419/", "https://horizon-magazine.eu/article/five-things-you-need-know-about-mrna-vaccine-safety.html", "https://zorgkrant.nl/wetenschap-en-onderwijs/12689-ontdekking-van-biologische-varianten-bij-ziekte-van-alzheimer", "https://sciencebusiness.net/news/experts-want-innovative-medicines-initiative-successor-be-open-and-flexible", "https://www.pharmexec.com/view/amplifying-the-patient-voice", "https://www.medicalfacts.nl/2020/10/13/lancering-baanbrekend-europees-digitaal-zorgproject/", "https://sciencebusiness.net/news/revamped-imi-successor-will-put-patients-first-health-research", "https://sciencebusiness.net/news/fleet-foot-response-pandemic-underlines-value-public-private-partnership-health", "https://www.welt.de/wirtschaft/article212167401/Digitale-Medizin-Die-Dynamik-in-Deutschland-ist-gross.html", "https://www.labiotech.eu/in-depth/coronavirus-vaccine-treatment-diagnostics/", "https://www.aerzteblatt.de/nachrichten/114320/EU-Projekt-sagt-Uebergewicht-und-Begleiterkrankungen-den-Kampf-an", "https://www.contagionlive.com/news/ebola-vaccine-regimen-receives-european-commission-marketing-authorization-", "https://trends.levif.be/economie/high-tech/intelligence-artificielle-des-belges-a-la-tete-d-un-projet-coronavirus/article-normal-1290543.html?cookie_check=1590312602", "https://www.eureporter.co/frontpage/2020/05/20/coronavirus-commission-boosts-urgently-needed-research-and-innovation-with-additional-e122-million/", "https://www.labiotech.eu/policy-legal-finance/innovative-medicines-initiative-covid-19/", "https://www.dhnet.be/regions/liege/l-entreprise-liegeoise-oncoradiomics-va-developper-un-outil-de-diagnostic-du-coronavirus-5ebceb2b7b50a60f8bafd734", "https://www.rtbf.be/info/economie/detail_une-entreprise-liegeoise-va-developper-un-outil-de-diagnostic-du-coronavirus?id=10501501", "https://www.bioworld.com/articles/435049-eight-covid-19-projects-share-127m-under-europes-innovative-medicines-initiative", "https://www.euractiv.com/section/coronavirus/news/commission-announces-funding-for-covid-19-diagnosis-treatment-projects/", "https://sciencebusiness.net/covid-19/news/imi-announces-8-covid-19-project-winners-and-boosts-funding-eu72m", "https://www.eubusiness.com/news-eu/coronavirus-research.12hp", "https://www.euronews.com/2020/05/11/europe-supercharges-research-in-the-battle-against-covid-19", "https://www.irishtimes.com/life-and-style/health-family/coronavirus-race-for-vaccine-must-take-no-shortcuts-1.4236155", "https://horizon-magazine.eu/article/repurposing-drugs-and-networks-can-help-find-outbreak-treatments-against-clock.html", "https://www.rte.ie/news/coronavirus/2020/0410/1129831-the-eus-covid-19-crisis-how-science-got-political/", "https://horizon-magazine.eu/article/studying-animal-coronavirus-defences-opening-route-human-treatments.html", "http://www.ddn-news.com/index.php?newsarticle=14158", "https://www.handelsblatt.com/meinung/kommentare/kommentar-das-coronavirus-mahnt-die-welt-zu-mehr-kooperation/25718682.html", "https://horizon-magazine.eu/article/five-things-you-need-know-about-mrna-vaccines.html", "https://www.publico.es/ciencias/coronavirus-gran-potencial-big-data-lucha-covid-19.html", "https://www.timeshighereducation.com/opinion/eu-science-spending-must-not-fall-victim-post-covid-cull", "https://cincodias.elpais.com/cincodias/2020/03/26/companias/1585220679_850148.html", "https://www.handelsblatt.com/meinung/gastbeitraege/gastkommentar-auf-die-forschung-kommt-es-an/25681060.html", "https://www.eureporter.co/frontpage/2020/03/24/covid-19-research-package-welcomed-eu-needs-to-be-better-equipped-in-future/", "https://www.eldiario.es/sociedad/MareNostrum-llevamos-probando-millones-coronavirus_0_1009299317.html", "https://parkinsonsnewstoday.com/2020/03/20/immune-biomarkers-may-help-classify-parkinsons-patients-aid-choosing-treatments-study-suggests/", "https://sciencebusiness.net/news/gabriel-research-and-innovation-critical-tackle-global-crisis", "https://www.mednous.com/what-patients-really-want-involvement", "https://www.24heures.ch/suisse/labos-suisses-veulent-intensifier-lutte-coronavirus/story/14168576?cache=9efAwefu", "https://european-biotechnology.com/up-to-date/latest-news/news/imi-launches-eur45m-call-for-coronavirus-emergency.html", "https://sciencebusiness.net/news/imi-launches-eu45m-coronavirus-research-call", "https://pharmaphorum.com/news/eu-sets-aside-e45m-for-coronavirus-drug-and-diagnostic-rd/", "https://www.msn.com/de-de/finanzen/top-stories/neue-allianz-pharmariesen-b%C3%BCndeln-ihre-kr%C3%A4fte-gegen-covid-19/ar-BB11K5n1", "https://sciencebusiness.net/news/eu-puts-eu45m-eu90m-public-private-partnership-coronavirus-vaccine-research", "https://www.eubusiness.com/news-eu/coronavirus-eu.24fp", "https://www.politico.eu/article/eu-pumps-e232m-toward-coronavirus-as-alarm-grows-in-italy/", "https://www.diariodesalud.com.do/texto-diario/mostrar/1859760/farma-aceleran-carrera-contra-coronavirus-hay-20-vacunas-desarrollo", "https://www.nature.com/articles/d41586-020-00226-x", "https://european-biotechnology.com/up-to-date/latest-news/news/amr-imis-enable-project-reaches-endpoints.html", "https://www.nursingtimes.net/news/research-and-innovation/whooping-cough-study-explores-if-bacteria-can-be-passed-silently-27-01-2020/", "https://www.saludadiario.es/investigacion/alfonso-valencia-director-del-instituto-nacional-de-bioinformatica-llevamos-semanas-probando-millones-de-farmacos-contra-el-coronavirus", "#media-coverage-highlights-collapsible-11", "https://www.technologynetworks.com/drug-discovery/articles/the-power-of-collaboration-tackling-pharmaceutical-challenges-328569", "https://www.europeanfiles.eu/health/harnessing-the-power-of-partnerships-to-develop-life-saving-vaccines", "https://www.pharmaceutical-technology.com/features/challenges-paediatric-drug-development/", "http://www.pmlive.com/blogs/smart_thinking/archive/2019/is_competition_the_enemy_of_progress_and_collaboration_the_ally_of_success", "https://www.aerzteblatt.de/nachrichten/107601/Europaweite-Studie-soll-personalisierte-Therapie-bei-Autoimmunerkrankungen-verbessern", "https://www.medpagetoday.com/meetingcoverage/astmh/83543", "https://pink.pharmaintelligence.informa.com/PS141239/Remote-Decentralized-Clinical-Trials-Could-Solve-RCT-Problems", "https://www.ledgerinsights.com/novartis-live-blockchain-network-2020/", "https://www.cnnmoney.ch/shows/blockchain/videos/novartis-go-live-blockchain-projects-2020", "https://european-biotechnology.com/up-to-date/latest-news/news/amr-enable-selects-mutabilis-candidate.html", "https://multiplesclerosisnewstoday.com/news-posts/2019/11/04/accelerating-precision-medicine-for-immune-mediated-diseases-right-drug-right-patient-right-time/", "http://www.bioworld.com/content/eus-new-ihi-program-aims-push-boundaries-expand-innovation-health-care", "https://www.labiotech.eu/medical/autoimmune-disease-eu-pharma/", "https://www.telegraph.co.uk/news/2019/10/23/parents-urged-vaccinate-children-against-whooping-cough-number/", "https://www.irishexaminer.com/breakingnews/world/whooping-cough-bacteria-can-hide-in-noses-and-throats-of-healthy-people-959161.html", "https://www.dailymail.co.uk/wires/pa/article-7604279/Whooping-cough-bacteria-hide-noses-throats-healthy-people.html", "http://www.pharmafile.com/news/531806/damage-control-how-will-pharma-manage-health-economic-impacts-brexit", "https://www.euractiv.com/section/health-consumers/news/health-research-is-where-the-eu-can-leave-a-mark-lawmakers-agree/", "https://www.pharma-iq.com/business-development/articles/why-market-challenges-require-collaboration", "http://www.pharmatimes.com/magazine/2019/october_2019/smart_people_elaine_irving", "https://www.eldiario.es/aragon/internacional-coordinado-IACS-establece-medicamentos_0_943855805.html", "https://www.drugtargetreview.com/article/49476/under-the-microscope-improving-hit-discovery-efficiency-at-europes-leading-screening-centre/", "https://www.medpagetoday.com/meetingcoverage/esc/81945", "https://pharmaboardroom.com/articles/advanced-therapy-medicinal-products-the-right-time-for-hope/", "https://www.pharmaceutical-technology.com/news/jj-research-consortium-tb-drugs/", "http://www.bio-itworld.com/2019/07/02/melloddy-using-federated-learning-to-improve-drug-development.aspx", "https://www.euractiv.com/section/health-consumers/news/new-pharma-boss-next-eu-commission-should-be-clear-on-how-to-protect-innovation/", "https://pink.pharmaintelligence.informa.com/PS125531/New-IMI-Funding-For-EU-Research-Into-ATMPs-Health-Outcomes--Drug-Info", "https://www.scribd.com/article/414129666/How-Europe-Is-Building-A-Sweeping-System-To-Study-Medication-Safety-In-Pregnant-And-Lactating-Women", "https://businessnewswales.com/international-partnership-to-tackle-research-gaps-in-medication-safety-for-pregnant-and-breastfeeding-women/", "https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)31401-1/fulltext", "https://www.repubblica.it/salute/medicina-e-ricerca/2019/06/15/news/harmony_big_data_contro_i_tumori_del_sangue-228835841/", "https://www.20min.ch/ro/news/vaud/story/Huit-femmes-enceintes-sur-dix-prennent-des-medocs-29065812", "https://www.ft.com/content/ef7be832-86d0-11e9-a028-86cea8523dc2", "https://www.usinenouvelle.com/editorial/dix-geants-de-la-pharmacie-s-allient-pour-optimiser-les-ia-de-decouverte-de-medicaments.N850320", "https://www.scitecheuropa.eu/alzheimers-disease/95280/", "http://www.ehealthnews.eu/development/5855-imi-to-boost-patient-involvement-in-its-activities", "https://sciencebusiness.net/news/cars-6g-and-health-closer-look-possible-rd-partnerships-horizon-europe", "https://pharmaboardroom.com/articles/technology-convergence-in-the-digital-era-what-implications-for-innovative-medicine-development/", "https://www.medpagetoday.com/gastroenterology/generalhepatology/79935", "https://www.irishsun.com/news/261091774/diabetics-at-higher-risk-of-liver-disease-study", "https://www.labmate-online.com/news/news-and-views/5/university-of-nottingham/imi-prioritises-drug-safety-and-regulation/49198", "https://www.aerzteblatt.de/nachrichten/102819/Projekt-soll-Versorgung-von-Psoriasis-und-Neurodermitispatienten-verbessern", "https://european-biotechnology.com/up-to-date/latest-news/news/european-lead-factory-gets-eur365m-support-from-imi.html", "https://sciencebusiness.net/news/qa-whats-stake-patients-european-elections", "https://www.eupoliticalreport.eu/more-involvement-for-patients-in-developing-new-medicines/", "https://pink.pharmaintelligence.informa.com/PS125186/Next-IMI-Projects-To-Include-Advanced-Therapies-And-CARTs", "https://www.myscience.org.uk/en/news/2019/researchers_in_international_drive_to_develop_safer_drugs-2019-nottingham", "https://www.wearable-technologies.com/2019/04/european-researchers-team-up-with-pharma-companies-to-develop-gait-detecting-sensor/", "https://www.gesundheitsstadt-berlin.de/forschungsprojekt-untersucht-ursachen-von-neurodermitis-und-schuppenflechte-13238/", "http://www.clinicalinformaticsnews.com/2019/04/09/movement-underway-to-include-pregnant-women-in-research.aspx", "https://www.sundaypost.com/fp/scotlands-universities-warn-brexit-threatens-world-leading-dementia-work-that-could-transform-lives-around-the-globe/", "https://www.euractiv.com/section/health-consumers/news/andriukaitis-i-like-blows-from-anti-vaxxers-it-means-im-doing-my-job/", "https://www.granadahoy.com/granada/Genyo-proyecto-europeo-Sindrome-Sjogren_0_1338466331.html", "http://www.bio-itworld.com/2019/03/18/blockchains-potential-in-clinical-research.aspx", "https://www.siliconrepublic.com/innovation/rcsi-parkinsons-research-project", "https://www.pharmaceutical-technology.com/news/parkinsons-disease-research/", "https://sciencebusiness.net/news/auditors-probe-eu-efforts-tackling-worsening-superbug-problem", "https://pharmaboardroom.com/articles/why-we-need-public-private-partnerships-in-drug-rd/", "https://www.berlingske.dk/virksomheder/lundbeck-og-novo-nordisk-gaar-sammen-om-at-snyde-hjernen", "http://www.quotidianosanita.it/scienza-e-farmaci/articolo.php?articolo_id=70849", "https://sciencebusiness.net/news/beyond-brexit-how-universities-and-companies-are-trying-look-past-cliff-edge", "https://www.precisionvaccinations.com/infectious-disease%C2%A0prevention-through-vaccination-requirement-promote-healthy-aging", "https://www.healtheuropa.eu/pioneering-the-world-of-prostate-cancer-with-pioneer/89991/", "https://www.scitecheuropa.eu/pharmaceutical-industries-a-healthier-future-for-europe/92437/", "https://european-biotechnology.com/up-to-date/latest-news/news/imi-launches-eur80m-call.html", "http://www.ehealthnews.eu/86-open-calls/5726-open-access-drug-development-tools-feature-in-new-imi-call-for-proposals", "http://www.clinicalinformaticsnews.com/2019/01/14/blockchain-enthusiasts-finding-their-partners.aspx", "#media-coverage-highlights-collapsible-10", "https://www.journal.lu/top-navigation/article/wenn-die-eu-gesundheit-neu-denkt/", "https://www.mednous.com/imi-building-science-infrastructure-europe", "https://www.fokus-online.be/blockchain-heeft-grote-impact-op-mens-en-bedrijf/", "https://sciencebusiness.net/framework-programmes/news/horizon-europe-obstacles-still-facing-negotiators", "https://awoko.org/2018/11/26/sierra-leone-news-vaccine-to-end-ebola/", "https://www.ft.com/content/a7df3c48-ddfe-11e8-8f50-cbae5495d92b", "https://www.euronews.com/2018/11/12/vaccine-research-offers-fresh-hope-against-ebola", "https://arabic.euronews.com/2018/11/12/clinical-trial-in-sierra-leone-to-examine-a-vaccine-against-ebola", "https://fr.euronews.com/2018/11/12/sur-les-traces-d-un-futur-vaccin-contre-le-virus-ebola", "https://de.euronews.com/2018/11/12/ebola-die-eu-kampft-zusammen-mit-der-industrie-gegen-das-virus", "https://gr.euronews.com/2018/11/12/siera-leone-ena-neo-emvolio-dinei-elpida-gia-tin-antimetopisi-tou-iou-empola", "https://hu.euronews.com/2018/11/12/igeretes-az-ebola-elleni-vakcina-klinikai-tesztelese", "https://it.euronews.com/2018/11/12/passi-avanti-per-il-vaccino-contro-l-ebola", "https://fa.euronews.com/2018/11/12/ebola-vaccine-the-end-of-a-deadly-virus", "https://pt.euronews.com/2018/11/12/projeto-europeu-na-serra-leoa-testa-vacina-promissora-contra-o-ebola", "https://ru.euronews.com/2018/11/12/sierra-leone-ebola-health-futuris", "https://es.euronews.com/2018/11/12/podemos-imaginar-un-futuro-sin-ebola", "https://tr.euronews.com/2018/11/12/ebola-virusu-hastaligi-tarihe-karisabilir-mi-sierra-leone-de-asi-kampanyasi", "https://www.mednous.com/news/eu-funding-opportunities-smes", "https://www.healtheuropa.eu/dementia-in-europe/88813/", "https://www.europeanpharmaceuticalreview.com/news/80552/drug-side-effects/", "https://www.aerzteblatt.de/nachrichten/98821/Viele-Medikamente-koennen-eine-interstitielle-Lungenerkrankung-ausloesen", "https://sciencebusiness.net/framework-programmes/news/eu-makes-its-pitch-member-states-12-research-missions-and-13-industry", "https://www.irishexaminer.com/breakingnews/views/analysis/infant-centre-will-continue-to-lead-in-important-research-872840.html", "https://sciencebusiness.net/framework-programmes/news/austrian-science-minister-governments-and-eu-commission-conflict-over", "https://www.healtheuropa.eu/antimicrobial-resistance/88272/", "https://www.technologynetworks.com/drug-discovery/articles/binding-kinetics-in-drug-discovery-309280", "http://www.elglobal.net/portada/la-innovacion-reto-para-lograr-una-i-d-eficiente-DA1705588", "https://www.ft.com/content/a1c32a34-966b-11e8-b67b-b8205561c3fe", "https://www.ft.com/content/e6691586-90bc-11e8-bb8f-a6a2f7bca546", "https://www.technologynetworks.com/drug-discovery/news/infrared-sensor-could-speed-up-drug-discovery-306643", "https://european-biotechnology.com/up-to-date/latest-news/news/imi-to-spur-on-antibiotics-research-amidst-big-pharma-pullback.html", "http://www.blikopnieuws.nl/gezondheid/265462/onderzoekers-en-bedrijfsleven-willen-autisme-ontrafelen-en-behandelen.html", "https://cincodias.elpais.com/cincodias/2018/07/04/companias/1530717320_300880.html", "https://www.newyorker.com/magazine/2018/07/02/the-neuroscience-of-pain", "https://horizon-magazine.eu/article/radical-collaboration-shaking-pharmaceutical-industry-carlos-moedas_en.html", "https://sciencebusiness.net/framework-programmes/news/industry-race-keep-billion-euro-eu-partnerships-alive", "https://pharmaphorum.com/patients/time-optimise-patient-engagement/", "https://horizon-magazine.eu/article/ebola-outbreak-time-it-s-different_en.html", "https://www.irishexaminer.com/breakingnews/business/largest-grant-ever-to-research-autism-awarded-by-innovative-medicines-initiative-trinity-college-to-take-part-in-trials-849576.html", "https://sciencebusiness.net/framework-programmes/news/european-commission-publishes-its-eu941b-horizon-europe-proposal", "https://www.aerztezeitung.de/kongresse/kongresse2018/berlin2018-hsk/article/965307/prognose-antibiotikaresistenzen-langfristig-tote-krebs.html?sh=4&h=644675984", "https://steiermark.orf.at//news/stories/2917585/", "http://www.pmlive.com/pharma_news/europes_public-private_alliance_targets_pain_management_1238669", "https://www.himssinsights.eu/data-projects-boost-precision-medicine-spain", "https://horizon-magazine.eu/article/complex-diseases-get-big-data-treatment_en.html", "https://www.biocentury.com/bc-extra/clinical-news/2018-05-21/european-consortium-launches-improve-pediatric-trials", "https://www.siliconrepublic.com/innovation/paediatric-medicine-infant-europe", "https://www.healtheuropa.eu/imi-milestone-project-hypoglycaemia/86027/", "https://www.diabetesdaily.com/blog/jdrf-participates-in-study-committed-to-learning-about-hypoglycemia-and-diabetes-567286/", "http://www.elglobal.net/politica-sanitaria/titular-34titular-34titular-34-g-titular-g-34titular-34-KA1516491", "https://www.telegraph.co.uk/health-fitness/body/10-million-lives-could-lost-superbugs-far-have-got-race-beat/", "https://sciencebusiness.net/framework-programmes/news/eu-staff-propose-partnership-changes-next-research-programme", "https://www.healtheuropa.eu/ten-years-innovative-medicines-initiative/85489/", "https://sciencebusiness.net/healthy-measures/news/new-collaboration-engage-patients-drug-development-better-health-outcomes", "https://www.pharma-fakten.de/news/details/595-die-welt-ist-unser-labor/", "http://www.pmlive.com/pharma_news/imi_calls_for_advancements_in_machine_learning_and_digital_clinical_trials_1228827", "https://www.euractiv.com/section/health-consumers/news/going-into-the-real-world-to-gather-cancer-data/", "http://blogs.bmj.com/bmj/2018/03/06/lieven-annemans-we-need-to-reach-a-common-understanding-about-real-world-data/", "https://www.ip-watch.org/2018/02/27/wellcome-trust-report-recommends-uk-eu-agreement-research-innovation/", "https://lifesciencedaily.com/stories/24764-trials-seek-solutions-bacterial-infections/", "http://www.pharmaceutical-technology.com/news/nih-joins-efforts-address-two-common-bacterial-", "https://www.pharma-fakten.de/news/details/565-antibiotikaresistenzen-vier-anreize-und-ein-problem/", "https://www.mindhealth.fr/article/1870/salah-dine-chibout-novartis-avec-le-numerique-nous-serons-plus-efficaces-pour-identifier-et-investir-sur-de-nouvelles-cibles/", "http://www.imfarmacias.es/noticia/14594/la-resistencia-a-los-antibioticos-sera-la-primera-causa-de-", "https://elpais.com/elpais/2018/02/14/ciencia/1518627019_980101.html", "http://www.elmundo.es/economia/2018/02/06/5a797a9cca4741f3238b456f.html", "https://www.welt.de/print/die_welt/article173161498/Damit-das-Leben-weitergeht.html", "http://www.appliedclinicaltrialsonline.com/how-social-media-transforming-pharma-and-healthcare", "https://www.technologynetworks.com/tn/news/cancer-stem-cell-survival-is-controlled-by-hedgehog-signaling-proteins-296559", "http://www.nutritioninsight.com/news/antibiotic-innovation-research-group-calls-for-50-percent-investment-increase-as-resistance-threats-intensify.html", "#media-coverage-highlights-collapsible-1", "http://ecancer.org/conference/965-eapm-2017/video/6639/the-innovative-medicines-initiative.php", "https://www.europeanfiles.eu/magazine/public-private-partnerships-strenghtening-innovation-research-europe", "https://horizon-magazine.eu/article/we-need-new-way-pay-antibiotics-dr-david-payne_en.html", "/sites/default/files/uploads/documents/news-events/imi-in-the-media/NLS.Nov17.ND4BB.pdf", "https://european-biotechnology.com/up-to-date/latest-news/news/antibiotic-resistance-eu-sme-alliance-calls-for-specific-support-to-thrive-amr-rd.html", "http://derstandard.at/2000067410509/St-Anna-Kinderkrebsforschung-beteiligt-sich-an-EU-Projekt", "https://www.theparliamentmagazine.eu/articles/partner_article/imi/research-breakthroughs-happen-more-easily-when-information-shared", "https://euobserver.com/health/138689", "http://cardiologia.diariomedico.com/2017/07/28/area-cientifica/especialidades/cardiologia/big-data-para-mejorar-el-abordaje-cardiovascular", "https://horizon-magazine.eu/article/depression-schizophrenia-may-become-redundant-terms_en.html", "http://www.technologist.eu/how-engineers-and-doctors-are-reinventing-healthcare/", "http://deep-dive.pharmaphorum.com/deep-dive-future-pharma-july-2017#!/healthcare-in-2030-what-role-for-pharma", "http://www.politico.eu/pro/q-and-a-with-imi-executive-director-pierre-meulien/", "http://www.dailymail.co.uk/wires/pa/article-4606218/UK-researchers-helping-create-new-whooping-cough-vaccine.html#ixzz4r8Eq7HSv", "http://www.express.co.uk/life-style/health/816967/whooping-cough-vaccine-being-developed-British-researchers", "http://corrieredelmezzogiorno.corriere.it/napoli/salute/17_giugno_05/rivoluzione-corso-formazione-cosi-pazienti-diventano-esperti-7ec07744-49d2-11e7-aee8-6748474b0aba.shtml", "http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(17)30264-5/fulltext", "http://www.healthcapital.de/biotechnologie/artikel/details/big-data-hope-for-patients/", "https://www.sundaypost.com/fp/dementia-research-will-suffer-when-we-leave-eu/", "http://www.the-scientist.com/?articles.view/articleNo/49511/title/Brexit-Will-Cost-U-K--Research-Funding--Report-Indicates/", "http://www.hitcentral.eu/insights/pharmaceutical-research-goes-big-data", "http://www.granadahoy.com/granada/Genyo-afianza-medicina-personalizada-precision_0_1129987089.html", "http://www.regio024.nl/nieuws/nijmegen/103-redactie/29541-12-miljoen-subsidie-van-imi-voor-project-tristan", "http://www.cadureso.com/actualite/actualite-sante/9057-innovative-medicines-initiative-imi", "http://www.euractiv.com/section/health-consumers/interview/imi-chief-we-need-to-learn-how-to-share-data-in-a-safe-and-ethical-manner/", "https://www.photonics.com/Article.aspx?AID=61912", "http://www.springermedizin.at/praxis/?full=58003", "http://newsroom.au.dk/en/news/show/artikel/imi-er-en-sikker-vej-til-ubetalelige-netvaerk/", "http://www.pharmabiz.com/NewsDetails.aspx?aid=101187&sid=1", "http://derstandard.at/2000055182077/Konsortium-will-Standards-bei-Fluessigbiopsien-verbessern", "http://www.maltatoday.com.mt/news/national/75541/innovative_medicines_initiative_an_opportunity_for_local_researchers", "https://www.manufacturingchemist.com/news/article_page/Environment_award_for_research_on_chemical_contaminants/127108", "http://magyarhirlap.hu/cikk/81735/Szocska_Miklos_Magyarorszag_egeszsegugyi_adatnagyhatalom", "http://www.pharmavoice.com/article/2017-3-ebola-research/", "http://www.medicalnewstoday.com/releases/315829.php", "http://zorgkrant.zorgportaal.nl/index.php/bericht/10707-start-internationaal-onderzoek-naar-personalized-medicine-bij-diabetische-nierschade.html", "http://www.pharmatimes.com/news/liverpool_uni_to_run_14m_drug_safety_study_1185264", "http://www.aerzteblatt.de/nachrichten/72666/Leukaemie-Internationale-Datenbank-fuer-verbesserte-Prognose-und-Therapie", "https://pink.pharmamedtechbi.com/PS119889/EU-Mobile-App-For-Reporting-ADRs-To-Be-Tested-In-Burkina-Faso-And-Zambia", "http://www.mobihealthnews.com/content/researchers-developing-smartphone-based-microscope-low-cost-dna-sequencing", "http://www.pharmafile.com/news/512608/thinking-big-data", "http://narod.hr/gospodarstvo/zagreb-domacin-medunarodnog-poslovnog-umrezavanja-prijavitelja-eu-projekata", "http://www.politico.eu/article/transforming-health-care-through-disruptive-innovation-will-your-data-cure-you-working-group-report/", "http://derstandard.at/2000050479953/sensiblen-PatientendatenMedUni-Wien-entwickelt-Richtlinien-im-Umgang-mit", "http://www.itv.com/news/tyne-tees/2017-01-10/newcastle-university-involved-in-34-7m-blood-disorder-project/", "#media-coverage-highlights-collapsible-2", "http://www.heraldscotland.com/politics/beyondbrexit/14911035.Beyond_Brexit__We_need_to_build_upon_historic_strengths/", "http://www.nature.com/news/how-to-defeat-dementia-1.20949", "http://sciencebusiness.net/health/news/2016/in-the-lab-a-big-data-project-is-trying-to-improve-outcomes-for-patients/", "http://de.euronews.com/2016/10/28/europaeische-substanz-bibliothek-spart-zeit-und-geld-in-der", "http://www.euronews.com/2016/10/28/business-planet-innovative-medicines-initiative-imi", "http://es.euronews.com/2016/10/28/una-plataforma-paneuropea-unica-para-desarrollar-medicamentos-innovadores", "http://fr.euronews.com/2016/10/28/les-pme-leviers-indispensables-de-l-innovation-pharmaceutique", "http://it.euronews.com/2016/10/28/ricerca-farmaceutica-e-pmi-la-rete-europea-dell-innovazione-accessibile", "http://fr.euronews.com/2016/10/28/les-pme-leviers-indispensables-de-l-innovation-pharmaceutique", "http://hu.euronews.com/2016/10/28/kkv-kal-gyorsitanak-a-gyogyszerkutatast", "http://pt.euronews.com/2016/10/28/o-european-lead-factory-e-a-iniciativa-sobre-medicamentos-inovadores", "http://www.ddw-online.com/business/p218116-reconfiguring-drug-discovery-through-innovative-partnerships.html", "http://www.sciencebusiness.net/news/79966/EU-Commission-sketches-possible-directions-for-FP9", "http://www.huffingtonpost.co.uk/entry/170-questions-brexit-labour-government_uk_57fdef14e4b0a9568544f9c3", "http://www.ft.com/cms/s/0/8a0b3a6c-7994-11e6-97ae-647294649b28.html", "https://scrip.pharmamedtechbi.com/SC097162/View-From-The-Top-Of-IMI-Heading-Up-Life-Sciences-Biggest-PublicPrivate-Partnership", "http://www.bloomberg.com/news/articles/2016-07-18/shrinking-pools-of-money-talent-may-bind-biotechs-after-brexit", "http://www.nature.com/nature/journal/v535/n7611_supp/full/535S10a.html", "http://www.medicaldevicedaily.com/servlet/com.accumedia.web.Dispatcher?next=bioWorldHeadlines_article&forceid=93050", "http://www.bioworld.com/content/agencies-push-bug-drug-pipeline-development-lacks-market-pull-0", "http://www.thelancet.com/pdfs/journals/lanpsy/PIIS2215-0366(16)30090-6.pdf", "http://www.ft.com/cms/s/0/b60b5302-1dbb-11e6-a7bc-ee846770ec15.html", "http://www.ft.com/cms/s/0/5bf75b80-1da8-11e6-a7bc-ee846770ec15.html", "http://www.sciencebusiness.net/news/79782/Innovative-Medicines-Initiative-says-its-early-goals-being-met", "http://www.novilist.hr/novilist_public/Znanost-i-tehnologija/Tehnologija/Nova-mobilna-aplikacija-HALMED-a-Prijave-nuspojava-lijeka-odsad-i-putem-smartphonea", "http://www.tportal.hr/vijesti/znanost/429059/Kako-mobitelom-saznati-i-prijaviti-nuspojave-lijeka.html", "http://www.chronicle.lu/categoriesbusinessinnovation/item/17005-strategy-on-quality-and-partnerships-pays-off-for-ibbl", "http://www.nature.com/nature/journal/v533/n7602_supp/full/533S56a.html", "http://www.nature.com/nature/journal/v533/n7602_supp/full/533S71a.html", "http://www.aerztezeitung.de/medizin/krankheiten/neuro-psychiatrische_krankheiten/epilepsie/article/910897/epilepsie-mobile-geraete-sollen-anfaellen-warnen.html", "http://www.navarrainformacion.es/2016/05/03/la-european-lead-factory-analizara-una-diana-terapeutica-emergente-del-cima-la-universidad-navarra-cancer/", "http://www.corriere.it/notizie-ultima-ora/Scienza_e_salute/smartphone-anti-depressione/29-04-2016/1-A_025751031.shtml", "http://www.sciencebusiness.net/news/79761/Too-much-talk-of-innovation", "http://www.lamarseillaise.fr/marseille/sante/48201-marseille-s-empare-de-la-lutte-contre-le-virus-ebola", "http://www.medicalnewstoday.com/releases/309580.php", "http://www.ft.com/cms/s/2/3fc98152-e538-11e5-a09b-1f8b0d268c39.html", "http://www.politico.eu/article/special-report-vaccines-need-a-new-business-model/", "http://www.corriere.it/notizie-ultima-ora/Scienza_e_salute/isolamento-sociale-basi-biologiche/13-04-2016/1-A_024860940.shtml", "http://www.sciencemag.org/news/2016/04/european-mental-health-project-targets-biological-roots-social-withdrawal", "http://www.manufacturingchemist.com/news/article_page/IMI_project_recommends_caution_when_assessing_medicine_impact_studies_from_different_databases/117259", "http://www.euractiv.com/section/global-europe/news/ebola-refuses-to-let-go-of-west-africa/", "http://www.telegraph.co.uk/news/2016/04/02/lord-darzi-leaving-the-eu-would-be-disastrous-for-uk-science-and/", "http://www.sciencebusiness.net/news/78724/Despite-potential-benefits-big-data-faces-resistance-in-healthcare", "http://www.europapress.es/esandalucia/cordoba/noticia-reina-sofia-cordoba-imibic-participan-proyecto-enfermedades-autoinmunes-20160318104522.html", "http://www.wort.lu/de/wissen/umfrage-zum-thema-chronische-krankheiten-teil-5-daten-sind-die-waehrung-der-modernen-medizin-56e98e2c1bea9dff8fa7492f", "http://www.ilsole24ore.com/art/tecnologie/2016-03-15/big-data-la-salute-l-europa-cerca-cura-piu-efficace-154639.shtml?uuid=ACoHCYoC", "http://www.granadahoy.com/article/granada/2238884/genyo/corazon/proyecto/mundial/sobre/enfermedades/raras.html", "http://www.nature.com/nbt/journal/v34/n3/full/nbt.3515.html", "http://www.independent.com.mt/articles/2016-02-14/newspaper-lifestyleculture/Explaining-the-enigma-in-Medicines-Research-Development-6736153302", "https://www.theparliamentmagazine.eu/articles/opinion/mhealth-new-challenges-well-new-opportunities", "http://www.lalibre.be/dernieres-depeches/belga/un-projet-europeen-pour-mieux-comprendre-le-diabete-de-type-1-56b1fed33570fdebf5b134e1", "http://www.fiercebiotech.com/story/allergan-links-astrazeneca-new-antibiotic-treatment/2016-01-29", "http://www.politico.eu/newsletter/playbook/politico-brussels-playbook-presented-by-tata-consultancy-services-car-law-overhaul-eu-start-up-visa-juncker-drops-greece/", "http://www.sciencebusiness.net/news/77376/UK-scientists-throw-weight-behind-EU-membership", "#media-coverage-highlights-collapsible-3", "http://www.pharmaphorum.com/articles/20-people-who-shaped-healthcare-in-2015-part-1", "http://www.journal.lu/article/innovation-wo-sie-besonders-gebraucht-wird/", "https://fr.news.yahoo.com/ebola-recherche-volontaires-essai-vaccinal-150437943.html", "http://objectif-languedoc-roussillon.latribune.fr/innovation/innovation-medicale/2015-12-08/nosopharm-integre-un-projet-europeen-sur-les-antibiotiques.html", "http://www.svd.se/resistenta-bakterier-kan-doda-fler-an-cancer", "http://val202.rtvslo.si/2015/11/ambulanta-202-23/", "http://www.theguardian.com/global-development/2015/nov/24/ebola-develop-tools-to-end-it-vaccine-sierra-leone-virus-epidemic", "http://www.ilsole24ore.com/art/norme-e-tributi/2015-10-23/l-europa-spinge-farmaci-innovatiivi-lotta-cancro-e-alzheimer-104956.shtml?refresh_ce=1", "http://www.diariosigloxxi.com/texto-ep/mostrar/20151022140239/comienza-a-probarse-en-voluntarios-de-sierra-leona-una-vacuna-contra-el-virus#.VovH4_krJaQ", "http://www.politico.eu/pro/imi-boss-pierre-meulien-public-gets-good-return-on-investment/", "http://utrecht.nieuws.nl/onderwijswetenschap/46661/eu-stelt-15-miljoen-euro-beschikbaar-voor-artrose-onderzoek/", "http://www.lavozdegalicia.es/noticia/sociedad/2015/09/20/galicia-reclutara-1000-pacientes-mayor-ensayo-tratar-artrosis/0003_201509G20P32991.htm", "http://universitime.corriere.it/2015/09/10/la-statale-nello-sviluppo-di-nuovi-antibiotici-contro-fibrosi-cistica-e-bronchiectasie/", "http://www.rte.ie/news/2015/0907/726255-cystic-fibrosis/", "http://www.nature.com/nrd/journal/v14/n8/full/nrd4698.html", "http://www.politico.eu/article/pierre-meulien-innovative-medicines-initiative-executive/", "http://sciencebusiness.net/news/77078/Irish-national-Pierre-Meulien-appointed-to-run-Innovative-Medicines-Initiative", "http://www.knack.be/nieuws/gezondheid/antibioticacrisis-worden-banale-infecties-binnenkort-opnieuw-dodelijk/article-normal-572221.html", "http://www.wort.lu/de/wissen/spitzenforschung-in-luxemburg-biomarker-anstelle-von-biopsien-553f3ce80c88b46a8ce58372", "http://www.20minutos.es/noticia/2443758/0/investigadores-virgen-macarena-virgen-rocio-participan-proyecto-europeo-combacte-care/", "http://www.europapress.es/esandalucia/sevilla/noticia-investigadores-virgen-macarena-virgen-rocio-participan-proyecto-europeo-combacte-care-20150427143859.html", "http://www.pharmaceutical-journal.com/sign-in?rtn=news-and-analysis/features/clinical-trials-and-tribulations/20068332.article", "http://www.welt.de/gesundheit/article139904385/Impfstoff-koennte-im-Herbst-zugelassen-werden.html", "http://www.morgenpost.de/politik/ausland/article139904385/Impfstoff-koennte-im-Herbst-zugelassen-werden.html", "http://www.irishtimes.com/life-and-style/health-family/educating-advocates-how-patients-and-parents-can-speak-for-change-1.2176847", "http://www.biocentury.com/innovations/strategy/2015-04-16/how-eus-imi-2-is-tackling-broader-projects-with-more-stakeholders-than-its-prior-iteration-s02", "http://www.medicalnewstoday.com/releases/292372.php", "http://www.ansa.it/saluteebenessere/notizie/rubriche/medicina/2015/04/13/tumori-un-esame-del-sangue-rivelatore-per-evitare-biopsia_69941637-3a80-4e03-babd-a388a75a717c.html", "http://www.paneuropeannetworks.com/health/imi-and-anti-doping-agency-to-collaborate/", "http://nova.ilsole24ore.com/progetti/antibiotici-la-ricerca-punta-su-vecchi-farmaci", "http://www.european-biotechnology-news.com/people/bio-people/2015/marc-de-garidel.html", "http://espresso.repubblica.it/visioni/scienze/2015/04/01/news/influenza-ecco-perche-il-vaccino-ha-fatto-flop-1.206749", "http://www.ideal.es/granada/201504/03/granadinos-prestan-cuerpo-para-20150402204545.html", "http://social.eyeforpharma.com/patients/partnership-game-changer-alzheimers-research", "http://www.forbes.com/sites/johnlechleiter/2015/03/31/from-hunting-to-farming-medicine-development-takes-a-big-leap-forward/", "http://www.industrie.com/pharma/marc-de-garidel-nomme-president-d-imi,62426", "http://www.lemonde.fr/planete/article/2015/03/27/ebola-la-course-aux-vaccins-s-accelere_4602761_3244.html#", "http://www.heraldscotland.com/news/home-news/stirling-based-scientists-pioneering-role-in-battle-against-ebola.120955411", "http://www.elsevier.nl/Kennis/achtergrond/2015/3/Waarschuwing-voor-resistente-bacterienonderweg-naar-Nederland-1725751W/", "http://www.demorgen.be/wetenschap/-efficientere-griepvaccins-dankzij-beter-evaluatie-a2249650/", "http://www.hln.be/hln/nl/957/Binnenland/article/detail/2249650/2015/03/12/Efficientere-griepvaccins-dankzij-beter-evaluatie.dhtml", "http://www.lesechos.fr/industrie-services/pharmacie-sante/0204215606918-ebola-comment-industriels-et-pouvoirs-publics-ont-collabore-pour-contrer-lepidemie-1100701.php#xtor=RSS37", "http://svenska.yle.fi/artikel/2015/02/22/antibiotika-slutar-verka-innan-vi-far-nya-lakemedel", "http://www.politico.eu/article/a-stand-in-at-the-controls-of-the-innovative-medicines-initiative/", "http://www.rajpharma.com/productsector/pharmaceuticals/Summer-launch-forecast-for-EU-platform-to-co-ordinate-early-drug-licensing-pathways-356805", "http://www.sanita24.ilsole24ore.com/art/medicina-e-scienza/2015-02-11/terapie-misura-malattie-autoimmuni-100235.php?uuid=AbizGlAL", "http://www.scidev.net/global/medicine/news/mobile-phones-ebola-vaccine-trials.html", "http://yle.fi/uutiset/suomalaistutkijat_kehittamaan_ebolan_kenttadiagnostiikkaa/7765406", "http://www.delo.si/znanje/znanost/evropa-proti-eboli.html", "http://www.european-biotechnology-news.com/news/news/2015-01/imi-funds-ebola-vaccine-projects.html", "http://www.wallstreet-online.de/nachricht/7309391-johnson-johnson-kuendigt-die-gruendung-der-konsortien-fuer-die-entwicklung-eines-ebolaimpfstoffs-an-und-erhaelt-finanzierung-von-der-initiative-fuer-innovative-arzneimittel", "http://www.mednous.com/news/imi-launches-ebola-projects", "http://www.blikk.hu/blikk_aktualis/az-eu-uj-kutatasi-projektekkel-segiti-az-ebola-elleni-kuzdelmet-2321229", "http://www.dailymail.co.uk/wires/reuters/article-2914504/Reuters-Health-News-Summary.html", "http://www.europapress.es/economia/noticia-comunicado-johnson-johnson-anuncia-formacion-consorcio-desarrollo-vacuna-contra-ebola-fondos-innovativ-20150117173555.html", "http://www.vg.hu/vallalatok/egeszsegugy/ketszazmillio-euroval-segiti-az-eu-az-ebola-elleni-kuzdelmet-442236", "http://www.reuters.com/article/2015/01/16/us-health-ebola-j-j-idUSKBN0KP1F020150116", "http://www.neurope.eu/article/eu-research-efforts-front-line-fight-against-ebola", "http://www.paneuropeannetworks.com/health/imi-launches-eight-projects-tackling-ebola/", "http://www.irishexaminer.com/breakingnews/ireland/irish-group-working-to-develop-ebola-vaccine-658331.html", "http://www.irishexaminer.com/ireland/research-programme-bids-to-defuse-dementia-time-bomb-307261.html", "http://politiken.dk/oekonomi/virksomheder/ECE2514077/bavarians-ebola-program-henter-finansiering-fra-eu/", "http://www.sanita24.ilsole24ore.com/art/medicina-e-scienza/2015-01-16/ebola-siena-studia-vaccini-133701.php?uuid=AbEur9wK", "http://www.independent.com.mt/articles/2015-01-16/local-news/EU-announced-eight-research-projects-into-Ebola-215-million-in-funding-allocated-6736128867", "http://www.canarias7.es/articulo.cfm?id=362145", "http://www.europapress.es/catalunya/noticia-35-instituciones-europeas-alian-investigar-prevencion-alzheimer-20150115135335.html", "http://www.lavanguardia.com/local/barcelona/20150115/54423659880/35-instituciones-europeas-se-alian-para-investigar-la-prevencion-del-alzheimer.html", "http://www.lefigaro.fr/societes/2015/01/13/20005-20150113ARTFIG00321-les-laboratoires-s-interessent-a-nouveau-aux-antibiotiques.php", "http://www.diariomedico.com/2015/01/13/area-profesional/gestion/farmaindustria-pide-colaboracion-publico-privada-lograr-farmacos-efectivos", "http://www.lavanguardia.com/local/barcelona/20150115/54423659880/35-instituciones-europeas-se-alian-para-investigar-la-prevencion-del-alzheimer.html", "#media-coverage-highlights-collapsible-4", "http://www.lemonde.fr/economie/article/2014/11/17/antibiotiques-trop-de-consommation-pas-assez-de-nouvelles-molecules_4524692_3234.html#CxQB2DXHtYVkhYE5fhv2E7", "http://orf.at/stories/2252681/", "http://uk.reuters.com/article/2014/11/06/us-health-ebola-europe-idUKKBN0IQ17J20141106", "http://www.demorgen.be/wetenschap/uantwerpen-mee-in-de-bres-tegen-resistente-antibiotica-a2103063/", "http://www.corriere.it/salute/cardiologia/14_ottobre_07/contrastare-l-invecchiamento-l-obiettivo-un-progetto-italiano-b8f20a3a-4e04-11e4-b38c-5070a4632162.shtml", "http://www.nature.com/nrd/journal/v13/n10/full/nrd4455.html", "http://www.independent.co.uk/voices/comment/the-microbe-is-mightier-than-the-market-9587052.html", "http://www.ft.com/intl/cms/s/0/76d57ee0-01d6-11e4-ab5b-00144feab7de.html?siteedition=intl#axzz36OIDzHlC", "http://www.rtbf.be/tv/emission/detail_matiere-grise/actualites/article_envie-de-re-voir-ou-d-en-savoir-plus-sur-le-combat-des-scientifiques-contre-les-bacteries-mortelles-au-centre-de-matiere-grise?id=8283819&emissionId=65", "http://www.economist.com/news/business/21602689-why-row-over-giant-drug-company-takeovers-misses-point-pharmed-out?fsrc=rss", "http://www.washingtonpost.com/news/to-your-health/wp/2014/04/07/what-we-need-to-do-about-antibiotic-resistant-infections/", "http://sociedad.elpais.com/sociedad/2014/03/17/actualidad/1395083912_279137.html", "http://www.euractiv.com/specialreport-brain-multiple-scl/public-private-partnerships-way-news-533679", "http://www.deutsche-apotheker-zeitung.de/pharmazie/news/2014/02/14/gebuendelte-kraefte-fuer-die-antibiotika-forschung/12093.html", "http://www.kauppalehti.fi/5/i/yritykset/lehdisto/stt-info/tiedote.jsp?selected=kaikki&oid=20140201/13921922482430", "http://biotechnologia.pl/biotechnologia/aktualnosci/imi-tego-zazdroszcza-nam-w-usa-rozmawiamy-z-magda-gunn-scientific-project-manager-w-imi-ju,13658", "http://www.elglobal.net/noticias-medicamento/2014-02-12/industria-farmaceutica/universidades-e-industria-europea-se-unen-en-la-busqueda-de-nuevos-antibioticos/pagina.aspx?idart=815538", "http://article.wn.com/view/2014/02/12/Ny_antibiotika_tas_fram_i_Uppsala/", "http://www.dagbladet.se/alla", "http://sverigesradio.se/sida/artikel.aspx?programid=2054&artikel=5782537", "http://mokslolietuva.lt/2014/02/vilniaus-inovaciju-forume-diskutuota-apieinovacijas-versle-nuo-startuoliu-iki-klasteriu/", "http://www.poslovni.hr/eu-fondovi/hrvatski-znanstvenici-pozvani-na-istrazivanje-novih-lijekova-263458", "http://www.tribune.cz/clanek/32011-jedenacta-vyzva-imi-nabidne-miliardy-korun", "http://www.euractiv.com/health/meps-agree-new-iniative-innovati-news-533011", "http://prawo.rp.pl/artykul/1080477.html?print=tak&p=0", "http://www.rynekzdrowia.pl/Patronat/Finansowanie-innowacji-w-medycynie-z-funduszy-UE,137212.html", "http://www.pmlive.com/pharma_appointments/imi_appoints_new_chair_of_scientific_committee_534108", "http://www.tvciencia.pt/tvcnot/pagnot/tvcnot03.asp?codpub=34&codnot=15", "http://www.nature.com/nm/journal/v20/n1/full/nm0114-5.html", "http://www.focus.de/gesundheit/ratgeber/zukunftsmedizin/visionen/visionen-in-der-stammzellforschung-tierversuche-werden-dank-stammzellen-ueberfluessig_id_3494016.html", "#media-coverage-highlights-collapsible-5", "http://www.mednous.com/news/genetic-variants-affect-cognition", "http://online.wsj.com/news/articles/SB10001424052702304361604579290572010514840", "http://www.lavozdegalicia.es/noticia/salud/2013/12/22/medicamentos-cambiaran-vida/0003_201312SX22P8991.htm", "http://www.focus.de/gesundheit/ratgeber/zukunftsmedizin/visionen/visionen-in-der-stammzellforschung-forscher-planen-stammzellenproduktion-am-fliessband_id_3493977.html", "http://www.welt.de/gesundheit/article123116519/Geschaeft-mit-der-Hoffnung-bei-Stammzellforschung.html", "http://www.nature.com/nrmicro/journal/v12/n1/full/nrmicro3188.html", "http://www.biocentury.com/dailynews/politics/2013-12-13/imi-launching-project-for-adaptive-alzheimers-trial", "http://www.scripintelligence.com/home/IMI-to-revolutionize-the-hunt-for-Alzheimers-drugs-as-part-of-371m-call-348746", "http://www.european-biotechnology-news.com/news/news/2013-04/imi-debuts-with-adaptive-alzheimer-trials.html", "http://medwatch.dk/secure/Medicinal___Biotek/article6324679.ece", "http://www.itv.com/news/2013-12-10/dementia-replaces-cancer-as-disease-people-fear-most/", "http://www.ft.com/intl/cms/s/2/6661db3e-5c6e-11e3-931e-00144feabdc0.html#!", "http://www.agoramagazine.it/it/benessere-e-salute/cremona-nasce-advance-progetto-europeo-per-il-monitoraggio-dei-benefici-e-rischi-dei-vaccini.html", "http://www.biocentury.com/dailynews/politics/2013-11-27/stakeholders-launch-pan-europe-vaccine-monitoring-project", "http://www.telegraaf.nl/gezondheid/actueel/22088894/__effect_vaccinatie_sneller_in_kaart__.html", "http://www.corriere.it/salute/13_novembre_26/vaccini-progetto-europeo-monitorare-benefici-rischi-6259c4e0-56ae-11e3-9a32-8b8b5da15961.shtml", "http://sverigesradio.se/sida/avsnitt/273344?programid=1272", "http://www.scripintelligence.com/policyregulation/IMI-offers-12.2m-for-better-ways-of-testing-effectiveness-of-flu-vaccines-347693", "http://www.ft.com/intl/cms/s/0/27997fa4-2a9d-11e3-8fb8-00144feab7de.html#axzz2j0p3InnA", "http://on.ft.com/18nNoYd", "http://www.arzt-aspekte.de/Schmerztherapie-so-frueh-wie-moeglich-um-Veraenderungen-des-Gehirns-vorzubeugen_43308.html", "http://www.tribune.cz/clanek/30995", "http://www.lastampa.it/2013/09/06/scienza/tuttoscienze/sos-antibiotici-li-usiamo-cos-male-che-molti-sono-diventati-inutili-baLvniqyn8ktRAUoLE5xiM/pagina.html", "http://www.agentschapnl.nl/actueel/nieuws/astma-persoonlijk-", "http://www.ft.com/cms/s/0/e5679dae-e565-11e2-ad1a-00144feabdc0.html#axzz2fin1DcIk", "http://www.ekt.gr/content/display?prnbr=87292", "http://www.tribune.cz/clanek/30537-imi-otevrena-prilezitost-pro-spickove-odborniky", "http://news.sciencemag.org/2013/07/e.u.-commission-beefs-research-partnerships-industry", "http://social.eyeforpharma.com/epharma/imi-call-social-media-detection-adverse-events", "http://www.aifp.cz/cz/clanek-detail.php?clanek=555", "http://www.euractiv.com/specialreport-innovation-digital/eu-industry-invest-22-research-i-news-529214", "http://www.timeshighereducation.co.uk/news/european-cash-injection-for-innovation/2005698.article", "http://www.apifarma.pt/salaimprensa/noticias/Paginas/Comiss.aspx", "http://www.pharmatimes.com/Article/13-07-10/EU_industry_IMI_new_135M-euro_call_for_proposals.aspx", "http://www.sciencebusiness.net/news/76203/Commission-unveils-plans-for-", "http://www.inovacijos.lt/lt/naujiena/id/naujovik_vaist_iniciatyva_planuoja__j_kvietim/", "http://www.hazipatika.com/eletmod/tudomanyos_erdekessegek/cikkek/a_jovo_gyogyszereit_ma_fejlesztik/20130613172913", "http://eln.slas.org/story/1/98-european-lead-factory-an-open-innovation-experiment-in-drug-discovery", "http://www.irishexaminer.com/analysis/understanding-the-brain-is-in-all-our-interests-232549.html", "http://www.pharmanews.eu/research-and-development/1278-newmeds-unites-researchers-to-speed-the-quest-for-schizophrenia-and-depression-treatments", "http://www.diariomedico.com/2013/05/27/area-profesional/gestion/emprendedores-esenciales", "http://ajaleht.epl.ee/digi/2169#!p/41", "http://www.medicalindependent.ie/28441/paternal_age_may_have_autism_link", "http://www.pharmanews.eu/research-and-development/1275-pharma-cog-and-emif-ad-projects-bring-alzheimers-treatments-closer-to-reality", "http://www.pharmanews.eu/research-and-development/1271-europain-addresses-challenges-in-the-treatment-of-chronic-pain", "http://www.euractiv.com/health/european-research-complex-brain-news-519685", "http://www.rtbf.be/tv/actualite/detail_envie-d-en-savoir-plus-sur-sur-les-traces-de-l-autisme-genetique?id=7994614", "http://gazeta-dla-lekarzy.com/index.php/nowosci/8-artykuly-gdl/17-innovative-medicine-initiative-stakeholder-forum", "http://www.1czerwca.pl/index.php?option=com_content&view=article&id=160:szkolenia-dla-pacjentow-w-ramach-projektu-eupati&catid=36:aktualnoci&Itemid=63", "http://www.quotidianosanita.it/scienza-e-farmaci/articolo.php?articolo_id=14519", "http://www.nature.com/naturejobs/science/articles/10.1038", "http://sciencecareers.sciencemag.org/career_magazine/previous_issues/articles/2013_04_12/science.opms.r1300132", "http://www.rsc.org/chemistryworld/2013/03/antibiotic-resistance-ticking-time-bomb", "http://www.euractiv.com/health/uk-chief-medical-officer-eu-fund-news-518442", "http://www.guardian.co.uk/society/2013/mar/11/superbugs-antibiotics-bacterial-diseases-infections", "http://www.bbc.co.uk/news/health-21737844", "http://www.independent.ie/lifestyle/health/resistance-to-antibiotics-risks-health-catastrophe-to-rank-with-terrorism-and-climate-change-29122012.html", "http://www.talouselama.fi/uutiset/globaali+aikapommi+uhkaa+terveydenhoidossa++samanlainen+kansakunnan+uhka+kuin+terrorismikin/a2174061?s=r", "http://profesia.pravda.sk/studium/clanok/273092-uk-je-v-konzorciu-10-univerzit-pre-spickove-vzdelavanie-o-liekoch/", "http://www.dw.de/spectrum-make-drugs-not-war-2013-03-04/e-16561624", "http://www.suedkurier.de/region/hochrhein/kreis-loerrach/Infos-ueber-Pharmabranche;art372585,5912956?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed+suedkurier-kreis-loerrach+.de+-+Kreis+L", "http://www.scripintelligence.com/home/Bayer-leads-seven-Big-Pharmas-in-196m-European-Lead-Factory-339886", "http://www.tribune.cz/clanek/29162-imi-cesta-k-partnerstvi-pri-vyzkumu-i-realizaci", "http://www.eurobiotechnews.eu/news/news/2013-01/imi-launches-eur196m-project/pos/2.html", "http://www.fiercebiotech.com/press-releases/196-million-pan-european-drug-discovery-platform-launched", "http://www.scotland.gov.uk/News/Releases/2013/02/lanarkshire-and-dundee-in-life-science-project0702", "http://www.nature.com/news/europe-bets-on-drug-discovery-1.12372", "http://www.reuters.com/article/2013/02/07/pharmaceuticals-europe-rd-idUSL5N0B65QD20130207", "http://www.bbc.co.uk/news/uk-scotland-scotland-business-21366197", "http://www.nature.com/nbt/journal/v31/n2/full/nbt0213-95.html", "http://www.guardian.co.uk/science/2013/jan/27/europe-science-funding-paul-nurse?INTCMP=SRCH", "http://www.biocentury.com/scibx/translationalnotes/2013-01-24/translational-notes-imis-collaborative-chemistry-s4a", "http://www.nature.com/nbt/journal/v31/n1/full/nbt0113-11.html", "http://www.nature.com/nrd/journal/v12/n1/full/nrd3927.html", "#media-coverage-highlights-collapsible-6", "http://www.pharmatimes.com/magazine/latest%20issue/dec/pp22.pdf", "http://www.paneuropeannetworks.com/science-and-technology.html", "http://www.bmj.com/content/345/bmj.e8325", "http://www.ft.com/cms/s/77f4c16c-3ee8-11e2-a095-00144feabdc0,Authorised=false.html?_i_location=http.ft.com.html&_i_referer=", "http://online.wsj.com/article/SB10001424127887323316804578161390654183194.html?mod=googlenews_wsj", "http://uk.reuters.com/article/2012/12/05/health-stemcells-bank-idUKL5E8N59Q620121205", "http://blogs.nature.com/news/2012/12/e50-million-project-aims-to-produce-1500-stem-cell-lines-for-drug-discovery.html", "/sites/default/files/uploads/documents/news-events/imi-in-the-media/MEDNOUS_Nov_Dec_2012.pdf", "http://www.dradio.de/dkultur/sendungen/forschungundgesellschaft/1914839/", "http://www.europeanvoice.com/", "http://www.dw.de/spectrum-the-drugs-industry-dont-work-2012-10-22/e-16205549#16324068", "http://www.nature.com/nbt/journal/v30/n8/full/nbt0812-735a.html", "http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(12)60964-7/fulltext", "http://www.biocentury.com/biotech-pharma-news/coverstory/2012-06-04/why-imi-launched-eu-industry-consortium-to-transform-antibiotic-development-a1", "http://www.theparliament.com/fileadmin/theParliament/pdfs/PM_29_may_2012.pdf", "http://www.ft.com/intl/cms/s/a796ecc0-a644-11e1-9453-00144feabdc0,Authorised=false.html?_i_location=http.ft.com.html&_i_referer=#axzz1wBolAaEu", "http://www.rtbf.be/video/v_les-bacteries-le-point-avec-l-invite-dr-michel-goldman?id=1731997&category=info", "http://news.sky.com/home/uk-news/article/16234353", "http://online.wsj.com/article/SB10001424052702304707604577423683954355876.html", "http://www.guardian.co.uk/business/2012/may/24/glaxosmithkline-astrazeneca-antibiotic-research", "http://www.thetimes.co.uk/tto/public/sitesearch.do?querystring=Drugs+giants+put+rivalries+aside+to+tackle+the+scourge+of+the+superbug&p=tto&pf=all&bl=on", "http://blogs.nature.com/news/2012/05/europe-targets-superbugs-with-public-private-effort.html", "http://www.scripintelligence.com/home/IMI-launches-224m-RandD-programme-to-tackle-antibiotic-resistance-330955", "http://www.theparliament.com/latest-news/article/newsarticle/public-private-partnerships-key-to-growth-of-eu-pharma-research/", "http://www.nature.com/scibx/journal/v5/n19/full/scibx.2012.483.html", "http://www.nature.com/scibx/journal/v5/n16/full/scibx.2012.406.html", "http://www.nature.com/nm/journal/v18/n4/full/nm0412-477a.html", "http://www.biocentury.com/scibx/publicprivateinterface/2012-03-29/public-private-interface-imis-leadoff-hitter-s8?utm", "http://www.nature.com/news/chemistry-s-web-of-data-expands-1.10328", "http://www.inpharm.com/appointment/171711/ucb-chief-executive-chair-imi", "http://www.scripintelligence.com/home/Bayer-Janssen-M-S-AZ-Sanofi-Lundbeck-UCB-fuel-170M-EU-wide-screening-honeypot-327832", "http://www.pharmatimes.com/Article/12-03-08/IMI_to_set_up_European_Lead_Factory_for_new_drug_opportunities.aspx", "http://www.pharmatimes.com/Article/12-03-08/UCB_chief_Doliveux_to_head_IMI.aspx", "http://www.pharmanews.eu/research-and-development/1012-imi-funds-platform-to-discover-new-medicines", "http://www.pmlive.com/pharma_news/innovative_medicines_initiative_pharma_companies_compound_screening_390168", "http://mag.digitalpc.co.uk/fvx/sgm/mbt/1202/", "http://stm.sciencemag.org/content/4/122/122cm3.abstract", "http://www.nature.com/news/rules-tighten-on-use-of-antibiotics-on-farms-1.9761", "http://paul4innovating.com/2012/01/05/open-innovation-technology-platforms-and-a-new-business-model-all-in-one-biggie/", "#media-coverage-highlights-collapsible-7", "http://www.pharmatimes.com/Article/11-12-20/IMI_CDISC_hook_up_for_standardised_data_management.aspx", "http://www.scripintelligence.com/policyregulation/EU-launches-80bn-RandD-plan-to-cut-red-tape-create-jobs-and-boost-competitiveness-324271", "http://www.pmlive.com/find_an_article/allarticles/categories/General/2011/december_2011/features/interview_michel_goldman,_innovative_medicines_initiative", "http://www.tv5.org/cms/chaine-francophone/Revoir-nos-emissions/Le-Bar-de-l-Europe/Episodes/p-19201-Michel-Goldman.htm", "http://www.pmlive.com/find_an_article/allarticles/categories/General/2011/december_2011/features/interview_michel_goldman,_innovative_medicines_initiative", "http://www.nature.com/nrd/journal/v10/n12/full/nrd3602.html", "http://bulletin.sciencebusiness.net/news/75558/Commission-lures-pharma-industry-back-into-antibiotics", "http://www.nature.com/news/antibiotic-resistance-marching-across-europe-1.9413", "http://www.theparliament.com/latest-news/article/newsarticle/joint-undertaking-1/", "http://www.scripintelligence.com/policyregulation/IMI-plans-unprecedented-programme-for-novel-antibiotics-as-drug-resistance-continues-to-rise-323819", "http://www.reuters.com/article/2011/11/17/antibiotic-superbugs-europe-idUSL5E7MH2A420111117", "http://efna.net/pdfs/publications/ScienceAndSociety/S_S%20Issue%2004.pdf", "http://www.europeanvoice.com/article/imported/pushing-at-the-doors-of-innovation/72090.aspx", "http://www.pharmaceutiques.com/", "http://trends.levif.be/economie/magazine/magazines/01-09-2011/#", "http://www.biocenturytv.com/fullplayer.aspx#/BC+Show+46+Public+Part+2/BioCentury+07.31.11+++California+Stem+Cells/608459720001/1086638620001/1086689179001", "http://www.nature.com/nrd/journal/v10/n8/full/nrd3526.html", "http://www.scripintelligence.com/home/EU-firms-targeted-in-calls-for-new-biomarkers-and-drug-development-tools-319238", "http://www.biocenturytv.com/fullplayer.aspx#/BC+Private/BioCentury.24.11[1]/608459720001/1074206634001/1074418586001", "http://bulletin.sciencebusiness.net/news/75297/Patients-take-control-of-innovation", "http://www.scripintelligence.com/policyregulation/EU-IMI-and-US-Critical-Path-avoid-duplication-317187", "http://www.sciencebusiness.net/news/75170/EU", "http://www.pharmatimes.com/article/11-06-15/US_and_EU_link_faster_pharma_R_D_initiatives.aspx", "http://viewer.zmags.com/publication/dc678def#/dc678def/16", "http://www.healthtechwire.com/PremiumPro-Single.244+M57649e252f9.0.html", "http://www.bmj.com/content/342/bmj.d1577.extract", "http://www.lalibre.be/economie/actualite/article/647621/l-union-sacree-du-secteur-pharma.html", "#media-coverage-highlights-collapsible-8", "http://www.nature.com/news/2010/101110/full/468158a.html", "http://www.ft.com/cms/s/0/ed4ed88a-74f6-11df-aed7-00144feabdc0.html", "http://www.wallstreet-online.de/nachricht/2965462-joint-venture-zwischen-eu-und-pharmaindustrie-ermoeglicht-15-projekte-zur-erforschung-schwerer-krankheiten", "http://www.research-europe.com/index.php/2010/05/michel-goldman-executive-director-of-innovative-medicines-initiative-imi/", "http://www.irishtimes.com/newspaper/innovation/2010/0305/1224265343581.html", "http://pubs.acs.org/cen/coverstory/88/8808cover.html", "http://www.elmedicointeractivo.com/", "#media-coverage-highlights-collapsible-9", "http://www.scripintelligence.com/home/Innovative-Medicines-Initiative-to-save-pharmas-floundering-RandD-model-176849", "http://www.euractiv.com/en/innovation/eu-inject-millions-developing-innovative-medicines/article-185427", "http://www.nature.com/nrd/journal/v8/n7/full/nrd2939.html", "http://www.nature.com/news/2009/090520/full/news.2009.499.html", "/about-imi", "/about-imi/mission-objectives", "/about-imi/how-imi-works", "/about-imi/imi-funding-model", "/about-imi/strategic-research-agenda", "/about-imi/history-imi-story-so-far", "/about-imi/reference-documents", "/about-imi/governance", "/news-events/10-years-transforming-medical-research", "/about-imi/innovative-health-initiative", "/get-involved", "/get-involved/smes", "/get-involved/academia", "/get-involved/patients", "/get-involved/regulators-htas-and-payers", "/get-involved/associated-partners", "/get-involved/industry", "/get-involved/submit-your-ideas", "/apply-funding", "/apply-funding/general-overview", "/apply-funding/imi-call-process", "/apply-funding/future-topics", "/apply-funding/open-calls", "/apply-funding/closed-calls", "/apply-funding/call-documents", "/projects-results", "/projects-results/project-factsheets", "/projects-results/success-stories-projects", "/projects-results/maps-statistics", "/projects-results/catalogue-project-tools", "/projects-results/imi-impact-series", "/news-events", "/news-events/newsroom", "/news-events/newsletter", "/news-events/events", "/news-events/press-releases", "/news-events/imi-media", "/news-events/scientific-publications-imi", "/resources-projects", "/resources-projects/project-communications", "/resources-projects/project-dissemination", "/resources-projects/open-access-and-data-management-projects", "/resources-projects/guidelines-engaging-regulators", "/resources-projects/project-reporting-documents", "/resources-projects/exploitation-project-results", "/work-for-us", "/work-for-us/job-opportunities", "/work-for-us/procurement", "https://cloud.imi.europa.eu/web/eimi-governing-board/home?p_p_state=maximized&p_p_mode=view&saveLastPath=false&_58_struts_action=%2Flogin%2Flogin&p_p_id=58&p_p_lifecycle=0&_58_redirect=%2Fgroup%2Feimi-governing-board", "https://cloud.imi.europa.eu/group/eimi2-srg ", "https://cloud.imi.europa.eu/group/eimi-sc", "/node/6956", "/node/7265", "/contact", "https://twitter.com/IMI_JU", "https://www.linkedin.com/company/innovative-medicine-initiative-joint-undertaking/", "https://www.youtube.com/user/imichannel"]}